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Abstract 
Cartilage lesions cause pain and a loss of joint motion, and if not repaired 
will further degenerate into an osteoarthritic state. Currently the only 
treatment options for end stage osteoarthritis are total joint replacements, 
which are not preferable for younger or more active patients. Early 
intervention therapies to repair initial cartilage damage and stem the 
progression of osteoarthritis are thought to be a more favourable treatment 
option in appropriate cases. It is hypothesised that an acellular xenogeneic 
osteochondral scaffold could be used in mosaicplasty-like operations to 
provide an immunocompatible, off-the-shelf biomaterial for osteochondral 
lesion repair, retaining the same natural composition, structure and function 
as native cartilage.  
Initial characterisation of cartilages from different species (pig, cow and 
sheep) and joint regions of the hip and knee revealed differences in cartilage 
biology, biochemistry and biomechanics. Osteochondral tissues from 
skeletally immature porcine medial condyles were selected along with 
mature bovine femoral groove tissues as source materials for 
decellularisation, primarily based on cartilage thickness and 
glycosaminoglycan (GAG) content.  
Bovine osteochondral pins were subject to a number of decellularisation 
protocols and were shown to be successfully decellularised following use of 
a water pik to remove bone marrow, four cycles of freeze-thaw (two of which 
were in a hypotonic buffer with protease inhibitors), two cycles of hypotonic 
buffer followed by incubation in 0.1 % (w/v) SDS with protease inhibitors and 
treatment with nucleases and sterilisation with 0.1 % (v/v) peracetic acid. 
The process removed all whole cell nuclei, as visualised by histology and 
reduced cartilage DNA content per cartilage dry weight to 39 ng.mg-1. 
However, the process removed 99% of GAGs and resulted in reduced 
biomechanical properties. 
Porcine osteochondral pins were fully decellularised following use of the 
above process with one cycle of incubation in hypotonic buffer and 0.1 % 
(w/v) SDS in hypotonic buffer. Cartilage DNA content was reduced by 98% 
and the osteochondral tissues contained no visible cell nuclei. Cartilage 
GAG content was reduced by 60 %. Further alterations to the protocol to 
improve GAG retention revealed cartilage damage; histologically appearing 
highly porous and having greatly increased water content and almost 
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complete GAG loss. A comprehensive investigation was conducted to 
identify the cause of the damage, however no protocol could be developed 
which completely eradicated cartilage damage. 
Further characterisation of acellular bovine osteochondral scaffolds showed 
that a low concentration of SDS remained in the bone, and that this had 
cytotoxic effects when incubated in contact with BHK cells. Further washes 
in PBS were added to the protocol to remove excess SDS, however this 
increased washing led to damage of the bovine cartilage, as seen previously 
in porcine osteochondral decellularisation. 
Finally, the decellularisation process was applied to whole porcine condyles 
in which the ratio of cut edge to cartilage area was minimised and minimal 
damage to the decellularised cartilage was seen. In summary, the complex 
microstructure of cartilage has been shown to be surprisingly fragile ex vivo 
and a novel approach to the development of clinically relevant acellular 
osteochondral grafts is required; however significant advances have been 
made in the current study. 
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Chapter 1 
Introduction 
1.1 General introduction 
Osteoarthritis (OA) is a major public health concern, causing high levels of 
morbidity within the population and posing a large socioeconomic burden 
(Brooks, 2006). It is the most common disease affecting joints, and is 
characterised by irreversible progressive articular cartilage damage leading 
to joint failure (Herrero-Beaumont et al., 2009). Increasingly, OA is being 
recognised as a disease of the entire joint. Initial injury to the cartilage itself 
or other joint tissues such as ligaments can affect load distribution and 
friction during joint articulation, this abnormal activity leads to progressive 
erosion of the cartilage and malalignment of the joint resulting in further 
damage, including damage to the muscles and tissue inflammation 
(Felson, 2009).  
It is clear from the progressive nature of the disease that initially minor 
cartilage surface damage can lead to a much greater physiological 
disorder. Therefore early intervention treatments are crucial to prevent or 
delay the development of debilitating OA, and avoid end stage treatments 
such as total joint replacement. There are currently a number of therapies 
available to treat initial cartilage lesions, however these are often 
ineffective, only having short-term therapeutic benefit or causing difficulties 
such as donor site morbidity. Considering these therapies, it is proposed 
that a new tissue engineered approach may provide a better treatment 
option.  
. 
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1.2 Anatomy 
1.2.1 The hip joint (acetabulofemoral) 
The hip joint (Figure 1.1) is commonly affected by OA, as a load bearing 
joint, the surface cartilage is exposed to high mechanical stress leading to 
wear. Here the acetabulum of the pelvis articulates with the head of the 
femur through a synovial ‘ball and socket’ joint allowing for flexion, 
extension and rotation. The articulating surfaces of the acetabulum and 
femoral head are lined with hyaline cartilage which reduces friction allowing 
the joint to function. The hemi-spherical femoral head is held in the 
acetabulum by a fibrocartilaginous labrum lip which extends past the bony 
element of the acetabulum.  
 
Figure 1.1 The hip joint. Diagram entailing the main features of the joint. 
Figure adapted from http://www.noc.nhs.uk/hipandknee/information/hip/ 
joint-anatomy.aspx. 
 
Acetabulum 
Labrum 
Ligamentum Teres 
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The synovial membrane and fibrous capsule are attached to the femoral 
neck (zona orbicularis) and the labrum encasing the femoral head and 
acetabulum, they contain synovial fluid which provides lubrication and 
cushioning for the joint. The capsule along with one intracapsular 
(ligamentum teres) and three extracapsular ligaments (iliofemoral, 
ishiofemoral and pubofemoral) provide mechanical stability for the joint 
(Gray, 2000; Sinnatamby, 2006). 
  
1.2.2 The knee joint 
The knee joint (Figure 1.2) is the largest synovial joint in the body. An 
effective ‘hinge’ joint, it allows for flexion and extension, as well as slight 
rotation in some positions. It is a complex joint which articulates between a) 
the femur and the patella, via a sellar joint whereby the patella slides 
through the patellofemoral grove, and b) the tibio-femoral joint, which 
articulates the medial and lateral condyles of the femur with the tibial 
plateau; these interactions are partially divided by the two menisci. The 
condyles of the femur and the tibial plateau are, like the articular surfaces 
of the hip joint, lined by hyaline cartilage, allowing reduced friction. The 
medial and lateral menisci are composed of fibrocartilage, which has 
different biological and mechanical properties from hyaline cartilage, 
allowing it to cushion the joint effectively.  
The joint is surrounded by an articular capsule which is composed of a 
strong fibrous membrane lined by the synovial membrane. The capsule is 
attached to the cartilage margins on both the femur and the tibia and to the 
head of the fibula The presence of a suprapatellar bursa anteriorly on the 
femur results in the joint capsule being attached more proximally than the 
cartilage. As with the hip joint, the capsule provides stability to the joint, 
and encloses the synovial fluid which provides lubrication for the joint. 
Ligaments act alongside the capsule to provide stability to the joint by 
limiting movement. Intracapsular ligaments include the anterior (ACL) and 
posterior cruciate ligaments (PCL), injury to which may often result in 
damage to cartilage, leading to OA (Felson & Zhang, 1998). The 
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transverse ligament, anterior and posterior meniscofemoral and the 
meniscotibial ligaments are also intracapsular. The patellar tendon is 
associated with the quadriceps tendon to secure the patellar. The sides of 
the patellar are attached to the capsule, allowing its articulating surface to 
be intracapsular but the non-articulating face of the patellar to be 
extracapsular. The patellar tendon is attached to the extracapsular non-
articulating face of the patella. Extracapsular ligaments include the medial 
and lateral collateral ligaments and the oblique and arcuate popliteal 
ligaments. There are a number of bursae associated with the knee joint, 
these fluid sacks and synovial pockets surround and communicate with the 
joint cavity, cushioning impact between bones and tendons and/or 
muscles, and they also act to further reduce friction (Gray, 2000; 
Sinnatamby, 2006). 
 
 
Figure 1.2 The knee joint. Articulation between the femur, patella and 
tibia. Figure adapted from http://www.digital-doc.com/images/knee.jpg. 
Patella tendon 
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1.3  Cartilage 
There are three forms of cartilage; elastic cartilage (for example the ear), 
fibrocartilage (menisci) and hyaline cartilage (synovial joints; Roughley, 
2006). Hyaline cartilage covers the articulating surfaces of bones at joints, 
the function of which is to reduce friction between articulating surfaces 
during load bearing and movement. Hyaline cartilage is a tough tissue 
formed predominantly of extracellular matrix (ECM) composed of 
interwoven collagen fibres, proteoglycans and interstitial water. These 
components are secreted by chondrocytes which reside dispersed within 
the ECM. Cartilage is avascular and aneural, qualities which result in 
limited repair capacity of the tissue. 
 
1.3.1 Cartilage composition 
Cartilage is a highly specialised tissue, able to effectively lubricate articular 
joints throughout a lifetime of movements without experiencing any 
significant wear. This is possibly due to its ideal composition and structure. 
The key components of cartilage are collagen, proteoglycans, interstitial 
water, chondrocytes and lubrication by synovial fluid.  
1.3.1.1 Collagen 
Collagen comprises ~15% of cartilage ECM and it is present as a network 
of interwoven fibres. Each procollagen molecule is composed of three α-
chains which contain a repeated Gly-X-Y sequence where X is most 
commonly a proline residue and Y a hydroxyproline residue This repeat 
region is flanked by short linear telometric regions and globular N- and C-
terminal pro-peptides. The stoichiometry of these amino acids results in the 
chain being a left-handed α-helix. The three chains interact with one 
another to form a superhelix.  These chains can form hetero- or 
homotrimers, the composition of which, determine the type of collagen fibre 
produced (Cremer et al., 1998). Cleavage of the procollagen terminal 
peptides by specific proteases (metalloproteases and disintegrin) allows 
the spontaneous formation of collagen fibrils (Steplewski et al., 2007).  
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The most dominant form of collagen in cartilage ECM is type II collagen, a 
homotrimer of α1(II) chains, it constitutes ~80-85% of the total collagen 
content. Collagen IX and XI are the second most common comprising ~3-
10% each. Both are heterotrimeric, collagen type IX has a large N-terminal 
globular domain from an α1(IX) chain, it also has a ‘kink’ mid chain from 
which a chondroitin sulphate rich glycosaminoglycan (GAG) chain extends. 
It runs antiparallel to the fibre and is situated at points of regular D-
periodicity (alternating gap and overlap regions along the fibre exterior 
(Steplewski et al., 2007)). Type XI collagen resembles type II in that it is 
also a straight chain, however some molecules have an α3(XI) chain 
propeptide at the N-terminus which projects from the fibril, this molecule is 
covalently cross-linked to collagen type II molecules in the fibre backbone 
at hydroxylysine residues. Collagen X is a straight chained cartilage 
specific homotrimer, although shorter than collagens II or XI, these form a 
multimeric collagen fibril (Figure 1.3). Type VI collagen is also found 
sparsely in cartilage (Cremer et al., 1998).  
 
Figure 1.3 Collagen fibril composition. A diagrammatical representation 
of cartilage fibril composition and the collagen molecules which are specific 
to articular cartilage. Fibril composition is mainly type II collagen (solid line) 
with internal type XI collagen (dotted line) molecules and surface type IX 
molecules (bent line with globular domain). Type X is not intrinsic to the 
fibril formation and is found elsewhere in the collagenous matrix of 
cartilage. Figure cited from Cremer et al. (1998). 
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The backbone of heteropolymeric cartilaginous fibrils is mainly formed from 
type II collagen, type IX is thought to play a role in facilitating the interaction 
of fibrils with proteoglycans along with acting as a ‘spacer’ between fibrils 
and a ‘glue’ to bind the type II lattice. Collagen type XI regulates fibril length 
(Mendler et al., 1989; Cremer et al., 1998). Type VI collagen forms 
independent microfibrils in the ECM around lacunae (Cremer et al., 1998) 
and plays a role in chondrocyte attachment to the ECM (Poole, 1997) Type 
X is most abundant in areas where hypertrophic chondrocytes are found 
(Cremer et al., 1998) and is thought to play a role in the organisation and 
distribution of cartilage matrix components (Shen, 2005). 
Collagen fibres are organised with a specific orientation in the cartilage 
matrix, known as the arcade concept (Figure 1.4). In the deep calcified 
zone of cartilage, collagen fibres are anchored to the bony component and 
run vertically toward the surface in the radial zone, these then turn 
obliquely in the transitional zone and run parallel to the surface in the 
tangential zone (Jeffery et al,, 1991).  The anchorage of collagen fibres into 
the subchondral bone ensures the soft cartilage tissue and solid bone are 
firmly fixed together. The specific organisation of collagen fibres in the 
cartilage structure has a major impact on the mechanical properties of the 
tissue, as will be discussed later. This inhomogeneity of collagen fibre 
distribution within cartilage results in differing values of permeability 
throughout the layers of the tissue with the middle zone being relatively 
permeable compared to the superficial and deep zones. There are dense 
collagen fibres at the superficial zone, but a high charge density in the 
deep zone (Mow et al., 1984). 
- 8 - 
 
 
Figure 1.4 Arcade concept of collagen organisation. Collagen fibre 
orientation is altered though the different layers of the cartilage tissue. 
 
1.3.1.2 Proteoglycans 
Proteoglycans are highly glycosylated proteins comprised of a core protein 
covalently linked to one or more glycosaminoglycan (GAG) chains. A GAG 
is a disaccharide unit which is repeated to form a long unbranched chain. 
Aggrecan (Figure 1.5) is a highly abundant, key proteoglycan in cartilage; it 
exists in the form of large aggregates with hyaluronan (HA) and link protein 
(LP). Aggrecan is a modular protein with three globular domains (G1, G2 
and G3) which contain cystine residues for the formation of disulphide 
bonds. There is a short interglobular domain between G1 and G2, and 
between G2 and G3 there is a long GAG attachment region rich in keratan 
sulphate (KS) and chondroitin sulphate (CS). The N-terminal G1 domain is 
responsible for attachment to HA, the function of G2 is currently unknown, 
G3 is key for normal post-translational modification of aggrecan, ensuring 
correct secretion from the cell (Roughley, 2006). The GAG attachment 
region is divided into 3 sections, the keratan sulphate attachment region, 
which is closest to G2, and the adjacent chondroitin sulphate attachment 
region is comprised of two sections.  
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Figure 1.5 Aggrecan. Aggrecan molecule showing all three globular 
regions (G1, G2 and G3), the interglobular domain (IGD) and the GAG 
attachment region comprised of one keratan sulphate binding region (KS) 
and two chondroitin sulphate binding regions (CS1 and CS2). Figure 
adapted from Dudhia (2005).  
 
Aggrecan exists as large aggregates in cartilage (Figure 1.6) entrapped 
within the collagenous network. These aggregates are composed of one 
long HA molecule attached to up to 100 aggrecan molecules stabilised by a 
link protein (Roughley, 2006). The link protein is similar in structure to the 
aggrecan G1 region. Through its ability to bind both HA and aggrecan G1 
regions, the presence of link protein stabilises the attachment of aggrecan 
to HA, retaining association of the aggregate under physiological 
conditions. It also facilitates association of newly secreted aggrecan 
molecules with HA and finally along with the G1 region of aggrecan forms a 
protein coat surrounding the HA molecule to protect it from degradation by 
enzymes or free radicals (Roughley, 2006).  
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Figure 1.6 Proteoglycan aggregate. Proteoglycan aggregate of aggrecan 
molecules attached to a single hyaluronan chain stabilised by link protein 
(LP). Three aggrecan molecules are shown here, but up to 100 can be 
attached to a single hyaluronan molecule. Figure cited from Dudhia (2005). 
 
HA is a unique GAG of notably large molecular weight, it is unsulphated. 
The HA polysaccharide chain is composed of a repeated disaccharide unit 
of glucuronate (GlcUA) and N-acetylgalactosamine (GlcNAc; Figure 1.7), 
the size of the chain decreases as HA abundance increases with age, 
which may be relevant to osteoarthritis onset later in life. The decrease in 
size is thought to be related to degradation of the GAG post synthesis 
(Roughley, 2006). HA molecules have carboxyl groups along their length 
which are fully ionised at physiological pH, resulting in the molecule having 
high osmotic activity allowing it to affect the distribution and movement of 
water (Fraser et al., 1997). Formation of secondary hydrogen bonds along 
the chain produces twists resulting in some stiffness of the molecule and 
hydrophobic patches which assist the molecule in interacting with other HA 
chains to form a network and allow association with lipid structures such as 
cell membranes (Scott, 1992). HA is synthesised at the chondrocyte 
plasma membrane by hyaluronan synthase (HAS) of which there are three 
types. The HAS’s produce the same composition, however vary in the 
length of HA chain they synthesise, which may have implications of the 
overall matrix composition (Roughley, 2006). 
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The GAG side chains are the key to aggrecan function; they have a fixed 
negative charge which allows hydrophilic interactions between the 
proteoglycan molecules of the cartilage ECM and interstitial water, 
controlling the movement of water through the collagen network. 
Chondroitin sulphate and keratan sulphate (Figure 1.7) are the GAGs 
associated with aggrecan (Roughley, 2006), they attach at serine residues 
located along the core protein chain within the GAG attachment region of 
aggrecan.  
 
 
Figure 1.7 Glycosaminoglycan molecular structures. A - Chondroitin 
sulphate disaccharide unit, showing specific sites where the sugar can be 
sulphated, unit is repeated many times to form a GAG chain. B – keratan 
sulphate disaccharide unit, also showing possible sulphated regions, unit is 
repeated many times. C – Hyaluronan disaccharide unit, characteristically 
unsulphated, repeated to form a long polysaccharide chain. Figure adapted 
from Dudhia (2005). 
 
GAGs are polysaccharides composed of repeating disaccharide units of 
one of two modified sugars: GalNAc or N-acetylglucosamine, and a uronic 
acid: GlcUA, iduronate or galactose (Gal).  The sulphate and acidic 
substitutions on the chains of KS and CS result in the molecule being 
polyanionic. CS is post translationally modified with sulphate ester 
Chondroitin 
Sulphate 
Keratan  
Sulphate 
Hyaluronan 
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substitutions at carbon-4-O-hydroxyl or carbon-6-O-hydroxyl positions of 
many of the GalNAc residues, which can be unsulphated, monosulphated 
or disulphated. These negatively charged groups within the GAG are fixed 
to the aggrecan protein and provide the proteoglycan with its hydrophilic 
properties (Dudhia, 2005). 
KS GAG chains associate with the aggrecan protein in the KS region, 
where there is a repeated residue motif of Glu-Glu/Lys-Pro-Phe-Pro-Ser 
(Antonsson, 1989), KS molecules attach at the serine residue. There are 
also KS chains in the G1 domain attached by N- and O-linked substitutions. 
A few KS chains are also found in the CS rich regions of aggrecan 
attached via O-linked substitutions on threonine residues (Barry et al., 
1992). The proline-rich repeats of the KS attachment region have a 
moderate affinity for collagen, allowing interaction with the collagenous 
network of the cartilage matrix (Hedlund et al., 1999). The CS rich region of 
aggrecan also contains a repeated motif of either Ser-Gly-X-Gly in the CS1 
region or (Asp/Glu)-X-Ser-Gly in the CS2 region (Doege et al., 1997).  
1.3.1.3 Non-collagenous proteins 
There are other proteins in the cartilage matrix besides aggrecan 
aggregates and collagens, these include other proteoglycans, such as 
members of the small leucine-rich repeat protein (SLRP) family. There are 
also a number of structural proteins which are of importance in cartilage 
function. Other proteins found in articular cartilage play a regulatory role in 
controlling cellular activities; their involvement is not directly relevant to the 
mechanical function of the cartilage matrix (Roughley, 2001). These 
proteins play various roles in the cartilage matrix, some of which are listed 
in Tables 1.1 and 1.2. 
 Proteoglycan Function  Reference 
Decorin 
SLRP associated with collagen fibrils as a decorating proteoglycan, carries a dermatan 
or chondroitin sulphate chain, thought to play a role in fibril diameter regulation. Decorin 
knockout mice have shown reduced tensile strength of skin and tendons. 
Knudson & Knudson, 
2001, Danielson et al., 
1997  
Biglycan 
SLRP with two chondroitin or dermatan sulphate chains is found primarily in the 
pericellular matrix of cartilage. Biglycan interacts with collagen type IX and II regulating 
fibril formation and stability. 
Knudson & Knudson, 
2001  
Chen et al.,2006  
Lumican SLRP with keratan sulphate GAG chains is able to bind collagen fibres to modulate fibril 
formation and the GAG chain acts to regulate interfibrillar spacing. 
Nikitovic et al., 2008  
Fibromodulin 
Another keratan sulphate SLRP acts along with decorin, biglycan and lumican to 
regulate collagen fibril diameter and stability. It is probable that there is a level of 
redundancy between these small glycoproteins. 
Hedlund et al., 1994 
Roughley, 2001  
Perlecan 
Perlecan is commonly substituted with heparin or chondroitin sulphate GAG chains. 
Located pericellularly, perlecan is able to stimulate fibrillogenesis when glycosylated with 
4-6-disulphated chondroitin sulphate residues.  
Melrose et al., 2008 
Kvist et al.; 2006 
SZP/Lubricin 
A secreted glycoprotein, lubricin is present at the superficial zone of articular cartilage. It 
functions to lubricate the articular surface, reducing wear, and also to inhibit invasion of 
the cartilage surface by synoviocytes and prevent protein deposition onto the surface by 
synovial fluid. 
Rhee et al., 2005 
Roughley, 2001  
Table 1.1 Non-collagenous Proteins – Proteoglycans. A list of the less common cartilage structural proteins, detailing their 
function within the tissue. SZP= Superficial zone protein.  
 
  
Structural 
protein 
Function  Reference 
COMP  
A disulphide-bonded pentamer, the carboxy-terminal regions of which interact with collagen 
fibrils, the correct folding of the molecule is determined by calcium binding. The protein has 
also been shown to interact with cell surface integrins supporting cellular attachment. 
COMP is thought to play an important role in matrix assembly. 
Chen et al., 2005 
Hecht et al., 2005  
Matrilin-
1/CMP  
& Matrilin-3  
Matrilins are a family of proteins, matrilin-3 is normally associated with matrilin-1, however 
matrilin-1 is only expressed at low/negligible levels in articular cartilage whereas matrilin-3 
is more abundant. It is thought that matrilins are able to interact with aggrecan, COMP and 
decorin molecules as well as collagen fibrils, acting in a structural capacity. 
Wagener et al., 2005 
Segat et al., 2001 
CILP 
Found in the intermediate zone of articular cartilage, this protein is thought to play a role in 
modulating the architecture of the cartilage matrix, but has also shown to be an IGF-1 
antagonist. 
Johnson et al., 2003  
Fibronectin 
There is a unique splice variant of fibronectin produced by chondrocytes. This protein is 
involved in cell-matrix interactions. 
Roughley, 2001 
Burton-Wurster et al., 
1998  
Table 1.2 Non-collagenous Proteins – Structural Proteins. A list of the less common cartilage structural proteins, detailing their  
function within the tissue.  COMP= Cartilage oligomeric matrix protein (thrombospondin-5), CMP= Cartilage matrix protein (matrilin 
-1), CILP= Cartilage intermediate layer protein. 
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1.3.1.4 Interstitial water 
The interstitial water of the ECM plays an integral role in cartilage function 
through interactions with GAG molecules, it forms 60-85% wet weight of 
cartilage. Water is composed of two hydrogen atoms covalently bound to 
an oxygen atom. The molecule is not linear, and oxygen has a higher 
electronegativity than hydrogen, resulting in a dipole. The slight positive 
charge on the hydrogen atoms allows for interaction with charged 
molecules.  
Water within the cartilage tissue contains small proteins, metabolites and a 
high concentration of cations (Buckwalter & Mankin, 1998). The 
immobilised sulphate and carboxyl groups on CS and KS of aggrecan 
become charged in solution and produce a net negative charge in the 
tissue relative to the surrounding fluid. These negative fixed charges are 
situated close together in the collagen network and repel one another, this 
unbalanced charge density is neutralised by increased positive sodium ion 
concentration, and repulsion of negative chloride ions in the fluid. The 
overall increase in total inorganic ion concentration results in increased 
osmolarity of the tissue – creates a Donnan effect, causing water to enter 
the tissue and swell the cartilage. However, this Donnan osmotic pressure 
is resisted by the tensile strength of the collagen network, allowing the 
tissue to resist deformation (Mow et al., 1984; Buckwalter & Mankin, 1998). 
1.3.1.5 Chondrocytes 
Articular cartilage is exclusively populated by one cell type, chondrocytes. 
The cells are sparsely dispersed and exist in the cartilage matrix as 
chondrons, a unit comprising one cell linked at its surface to a pericellular 
glycocalyx which is encased in a fibrillar pericellular capsule.  The 
morphology of chondrons differs throughout the different layers of the 
cartilage tissue (Figure 1.8), in the superficial zone the chondrocytes are 
flattened disc-shape, these become rounded and spherical in the middle 
layers. In the deep layer, chondrocytes are rounded and arranged in linear 
columns. In the calcified layer, chondrocytes are also rounded and 
surrounded by uncalcified lacunae (Poole, 1997).   
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Figure 1.8 Chondrocyte distribution and morphology. The distribution 
and morphology of chondrocyte chondrons within the cartilage layers. 
 
There is a degree of polarity, with the chondron pole facing the articular 
surface being more dense than the basal pole (Figure 1.9). A loosely 
woven ‘tail’ can be seen at the basal pole and in columns of multiple 
chondrons these ‘tails’ form interconnecting segments between chondrons, 
ensuring that adjacent chondrons are aligned linearly (Poole, 1997).  
The composition of cartilage matrix has already been defined in terms of 
horizontal matrix subdivisions, however many studies have highlighted a 
circumferential differentiation of matrix composition, based on pericellular, 
territorial and interterritorial matrices surrounding each chondrocyte. The 
pericellular matrix is in direct contact with the chondrocyte, and contains 
high concentrations of HA, sulphated proteoglycans, biglycan and a 
number of glycopoteins including link protein, fibronectin and laminin. 
Collagen composition also differs in these concentric subdivisions, with 
thinner fibrils being tightly interwoven to encase the cell in the pericellular 
region. In the territorial region, the collagen fibrils are larger and form radial 
bundles; this region is dense in chondroitin sulphate, whereas keratan 
sulphate is most concentrated in the interterritorial regions where the 
collagen fibres are largest and can form the classical ‘collagen arcade’ 
structural organisation. As described previously, there are different types of 
collagen, these are not uniformly distributed in the matrix, with type VI 
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being exclusively pericellular. Type IX is also more concentrated in the 
pericellular region (Poole, 1997).   
The pericellular matrix of the chondron is thought to be highly specialised, 
providing hydrodynamic protection for the chondrocyte during physiological 
loading due to high pericellular concentrations of HA and aggrecan in 
combination with differential organisation of specific collagen molecules. 
The pericellular matrix also plays a metabolic role in retention, temporal 
assembly and spatial migration of synthesised macromolecules in the 
different chondron territories (Poole, 1997). 
 
Figure 1.9 Chondron composition and morphology. Three-dimensional 
cutaway representation of a single chondron showing the central 
chondrocyte, dense collagen organisation at the articular pole (Ap) and 
more loosely packed collagen tail at the basal pole (Bp). Figure from Poole 
(1997). 
 
The role of chondrocytes is to secrete and maintain components of the 
ECM, these processes are tightly controlled by a number of regulatory 
factors (Goldring, 1999). Chondrocytes are cells of the mesenchymal 
lineage (Pettenger et al., 1999) and differentiate from mesenchymal stem 
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cells to initially produce an osteochondral precursor cell, which further 
differentiates down a chondrogenic route to produce chondrocytes, thought 
to be the default differentiation state of the precursors (Hartmann, 2006). 
Sox9 is the key transcription factor responsible for ensuring differentiation 
of an osteochondral progenitor cell towards a chondrogenic rather than 
osteogenic lineage, it recruits further chondrocyte specific transcription 
factors Sox5 and Sox6 (Lefebvre et al., 2001; Hartmann, 2006).  
1.3.1.6 Synovial fluid 
The synovial intima is the thin cellular layer which lines the luminal surface 
of the synovial membrane in the joint capsule. This layer is populated by 
synoviocytes, which can be two to three cells deep. There are two different 
types of synoviocytes, type A are resident macrophages which 
phagocytose debris and waste from the joint cavity, and the more abundant 
type B are fibroblast-like cells which are involved in secretion of matrix 
constituents such as HA. Type B cells have a characteristically high 
endoplasmic reticulum content, suggesting that they are active in protein 
synthesis. These cells secrete HA, collagens, fibronectin and other 
glycosaminoglycans into the intimal interstitium and joint cavity. Type B 
cells have long membranous processes that extend into the joint cavity 
allowing a larger surface area for delivery of secreted products (Iwanaga et 
al., 2000). 
The composition of synovial fluid is almost identical to that of blood plasma, 
with the exception of larger globulins which are filtered out as plasma 
passes through synovial capillary walls. There are additional molecules 
secreted into the synovial fluid by synoviocytes. The level of glucose in 
synovial fluid is lower than that of plasma, as it is metabolised by 
chondrocytes (Gerwin et al., 2006). 
HA and lubricin have been reported to determine the viscosity of synovial 
fluid, allowing its primary function as a lubricant, they cause the fluid to be 
a thixotropic non-newtonian fluid which decreases in viscosity as the shear 
strain rate increases. The fluid forms a thin film over the synovial 
membranes and joint surfaces to provide effective hydrodynamic 
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lubrication at low shear rates. The viscoelasticity of HA allows it to behave 
as a viscous lubricant at low impact movements, and as an elastic shock 
absorber under high impact movement, maintaining joint homeostasis. 
Under high load, lubricin is thought to play a role by interacting with 
surface-active phospholipids (Gerwin et al., 2006).  
 
1.3.2  Cartilage function 
The role of cartilage in the synovial joint is to effectively transmit loads and 
articulate with low levels of friction. During normal walking conditions, 
articular cartilage in the lower joints often has to withstand very high loads 
of up to 4 times body weight, the mechanical properties of hyaline cartilage 
allow it to perform this function throughout a person’s life. Cartilage 
distributes the load across the joint, over a wide area to minimise stress 
and allow movement with minimal friction.  A number of different lubrication 
regimes operate in cartilage to allow minimal friction under a vast range of 
different loading conditions. These many different lubrication mechanisms 
can be categorised under three main types occurring in synovial joints: fluid 
film, boundary and biphasic lubrication. 
1.3.2.1 Fluid film lubrication 
Fluid film lubrication (Figure 1.10 A) works well under many physiological 
conditions, however cannot alone completely account for low friction in 
joints, as it is unsuccessful in certain conditions, such as start-up after a 
period of standing. Fluid film lubrication is based on two solid bearing 
surfaces being separated by a thin film of lubricant, so that the load bearing 
and friction capacity is governed by the laws of hydrodynamics, rather than 
the behaviour of rubbing solid surfaces (Dowson, 1995). This film must be 
thick enough to prevent any isolated asperity on one surface from touching 
a similar peak on the opposing surface. Fluid film lubrication encompasses 
hydrodynamic, elastohydrodynamic and squeeze film lubrication (Walker et 
al., 1968).  Entraining action is the mechanism by which lubricant is 
dragged back into the contact area, this is due to the motion of two 
opposing surfaces sliding across one another.  
- 20 - 
 
Hydrodynamic lubrication (Figure 1.10 B) occurs when two rigid surfaces 
are separated by a thin film of viscous lubricant, but they oppose each 
other at an angle, so the fluid is in a ‘wedge’ shape. When the surfaces 
move tangentially, fluid is moved into the diminishing gap by viscous 
forces. The pressure in the fluid is sufficient to support the transverse load 
(Walker et al., 1968). 
If the pressure in the fluid becomes too great, it may result in deformation 
of the solid surfaces and if the geometric alteration is great enough then 
elastohydrodynamic lubrication (Figure 1.10 C) operates. Here, the softer, 
more elastic surfaces allow a larger volume of fluid to be drawn into the 
converging gap. With increased relative radius of curvature of the solid, 
viscosity of the lubricant, sliding speed and increased softness of the 
material, the subsequent lubricant layer is thicker (Dowson et al., 1995). 
Squeeze film lubrication (Figure 1.10 D) occurs when the surfaces produce 
force on one another in a normal direction not necessarily with transverse 
movement. Increased load results in increased pressure and lubricant 
viscosity. The approaching surfaces attempt to squeeze out the intervening 
fluid; this is, however, resisted by viscous forces and the film thickness is 
maintained, preventing solid-to-solid contact (Walker et al., 1968). 
Unsworth (1991) believed fluid film lubrication to be of great importance in 
diarthroidial joints. However, the activity of such lubrication mechanisms 
within synovial joints has been disputed by Ateshian (2009). 
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Figure 1.10 Fluid film lubrication. Schematic representations of fluid film 
lubrication mechanisms. A: Fluid film lubrication showing two surfaces or 
articular cartilage separated by a thin film of viscous synovial fluid lubricant. 
B: Hydrodynamic lubrication, fluid is forced into wedge-shaped gap by 
viscous forces during motion. C: Elastohydrodynamic lubrication, where 
deformation of the surface occurs and film is maintained due to viscous 
forces. D: Squeeze film lubrication force in the normal direction causes 
opposing surfaces to come together and pressurise fluid which is 
maintained by viscous forces.  
 
1.3.2.2 Boundary lubrication 
Boundary lubrication occurs when the fluid film thickness becomes very 
reduced resulting in increased asperity contact between two solid surfaces 
(Walker et al., 1968). This encompasses boosted lubrication, mixed 
lubrication, and boundary lubrication. 
MOTION 
MOTION 
A B 
C D 
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Boosted lubrication was first proposed by Walker et al. (1968) whereby 
pressure from load causes water and other small molecules from synovial 
fluid to enter the porous cartilage tissue. High molecular weight 
glycoproteins such as HA, for instance, are too large to be forced into the 
tissue so become highly concentrated at the surface, thus the resulting 
lubricating film is highly viscous (Walker et al., 1968). 
Prior to the full use of boundary lubrication there is a stage of mixed 
lubrication (Figure 1.11 A), during which the majority of the surface is 
lubricated by fluid film mechanisms, however some points of contact 
between asperities on the surface use boundary lubrication.  
During boundary lubrication (Figure 1.11 B) the fluid film is negligible so the 
surfaces touch; however, they are protected by boundary lubricants, which 
in the synovial joint are GAGs such as HA and, to a lesser extent, 
phospholipids. These molecules bind to the surface and prevent direct 
contact between the surfaces, instead sliding occurs between GAG 
molecules within the boundary lubricant layers. These GAG layers are 
replenished by the synovial fluid, ensuring they remain (Walker et al., 
1968). 
 
Figure 1.11 Boundary lubrication. Schematic representation of boundary 
lubrication regimes. Articular cartilage lined with a layer of boundary 
lubricants (blue line). A: Mixed lubrication where the fluid film is 
discontinuous, and boundary lubrication occurs at asperities which touch. 
B: Boundary lubrication where all the load is carried on the solid surface 
which is protected by a layer of boundary lubricants. 
 
A B 
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1.3.2.3 Biphasic lubrication 
The biphasic mechanism of lubrication is possibly the most important in 
articular cartilage, it describes how initial load is supported by the interstitial 
water or fluid phase of the cartilage tissue, then load is gradually passed to 
the solid phase as water content of the tissue depletes. This lubricating 
mechanism can maintain low friction under extreme loading conditions in 
the absence of surface lubricant (Forster & Fisher, 1996). 
The solid phase of cartilage denotes the collagen matrix and associated 
proteoglycans. The collagenous network has great tensile stiffness, 
however, poor compressive stiffness due to its fibrillar morphology, it has 
negligible charge. The proteoglycan component of the ECM, conversely, 
has many fixed negatively charged groups, which allow repulsion between 
molecules and therefore, considerable expansion of the volume which they 
occupy.  However, proteoglycans are entrapped within the collagen 
network, which prevents them expanding to their full potential, also, the 
high concentration of free counterions within the interstitial fluid phase 
results in high Donnan osmotic pressure, slight external mechanic or ionic 
environment alterations lead to the loss or gain of water (Mow et al., 1984). 
The architecture of the collagen matrix and the hydrophilic nature of the 
proteoglycans results in a micro-porous tissue. With increased 
compression, the tissue becomes less permeable based on its 
physiochemical composition. The permeability of the tissue to fluid 
movement and the equilibrium of swelling force from ionic interactions with 
collagen network tensile strength are directly affected by the volume of 
interstitial water (and the hyaluronic acid content). This pressurised 
interstitial water is capable of supporting the load (Katta et al., 2008; Mow 
et al., 1984). 
Under compression, the forced flow of water from the tissue results in 
higher organic material concentration, and increased charge density. When 
charge density, collagen tension and applied load are balanced, a new 
equilibrium compressive stiffness is reached. Proteoglycan molecules 
interact with the collagen network to provide the tissue with shear strength. 
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So, in the solid phase, flow independent behaviours arise, where cross-
linking between collagen fibres in the network and also interactions with 
this network and proteoglycan aggregates provide strength to resist 
deformation (Mow et al., 1984). 
With significant fluid flow (under load) the frictional drag causes flow-
dependant viscoelastic effects such as creep and stress relaxation. The 
collagen network provides resistance to tensile stress while the 
proteoglycans provide compressive stress resistance; there is also diffuse 
resistance as fluid flows through the ECM (Mow et al., 1984). 
Under compression, fixed charge density increases which leads to reduced 
permeability. Compaction of the solid matrix under compression results in 
increased drag forces against the fluid flowing through, therefore a further 
reduction in permeability. Permeability is also dependent on the viscosity of 
the fluid (Mow et al., 1984). 
The coefficient of friction is lower when load is carried by the fluid phase as 
compared to the solid phase.  The biphasic lubrication mechanism is 
successful over long periods of load bearing. When movement occurs, the 
water content of the previously loaded tissue is replenished as the load is 
transferred to a different contact area of the cartilage surface. Continued 
movement of the load allows for the fluid phase to continue bearing the 
load at a lower coefficient of friction than if the solid phase was allowed to 
bear the load (Forster & Fisher, 1999; Forster & Fisher, 1996). 
It has been noted that alterations of the counterion concentrations within 
the interstitial fluid can have major effects on the interaction of 
proteoglycans, which would have severe effects on the compressive 
resistance of the tissue, it has therefore been suggested that this ionic 
phase may be highly crucial in cartilage mechanics, so a triphasic model 
has been proposed by Lai et al. (1991). 
Above the superficial tangential zone of articular cartilage there is a surface 
amorphous layer (SAL) comprised of sulphated sugars, glycoproteins and 
lipids. This layer is suggested to also be biphasic in nature and play a role 
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in friction reduction during shock loads, to prevent damage to the 
underlying bulk of cartilage (Katta et al., 2008). 
 
1.4  Osteoarthritis 
Osteoarthritis is the most common disorder affecting joints (Herrero-
Beaumont et al., 2009). The progressive, degenerative disease causes 
degradation of articular cartilage which becomes more severe over time, as 
cartilage is unable to repair itself. More recently OA has been highlighted 
as a disease of the whole joint, not merely the cartilage and underlying 
bone (Felson, 2009). OA can result in great pain and morbidity for sufferers 
and can be debilitating at later stages, when the whole joint fails (Felson, 
2009).  
 
1.4.1 Epidemiology 
OA has a major impact globally, with an estimated 26.9 million adults aged 
25 or over in the USA presenting with the disease in some joint (Lawrence 
et al., 2008). In the United Kingdom 8.5 million people are estimated to be 
living with osteoarthritis, and this number is predicted to double by 2030 
(OANation2012). There is also a gender difference in OA prevalence, with 
more cases reported in women than men (Gabriel & Michaud, 2009). 
Arthritis Research UK report statistics that 1.8 % of males and 3.0 % of 
females consulting with their general practitioner per year are presenting 
with OA of any body part. Extrapolated, this would total 435,500 males and 
769,000 females presenting with OA each year 
(www.arthritisresearchuk.org). Although it is possible to detect OA in x-rays 
by observing joint space narrowing, it is unethical to x-ray patients who do 
not present with symptoms, so estimates are restricted to those with 
symptomatic painful OA, and the percentage of the population with 
unsymptomatic OA is unknown. Along with increasing age and female sex, 
obesity is a major risk factor associated with OA (Gabriel & Michaud, 2009) 
so it would appear that with the increasing life expectancy of the 
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population, and increased incidence of obesity, OA can only become more 
prevalent unless effective treatments can be found, Felson & Zhang (1998) 
have proposed a doubling in prevalence from 2000 to 2020. 
OA is a major economic burden, the most recent figures report around 
58,952 primary hip replacements and 62,150 primary knee replacements 
were performed in the UK in 2006/2007, at a cost of around £430 million 
and £460 million respectively (www.arthritisresearchuk.org). In the USA, 
musculoskeletal procedures (predominantly knee arthroplasty and hip 
replacements) cost $31.5 billion in 2005. More recently it has been 
suggested that OA in the USA has a direct cost of $81 billion per year 
(Lützner et al., 2009). However, it is not just costs from hospital procedures 
and care, but loss of wages through inability of sufferers to work; estimated 
as indirect costs of $47 billion in the USA (Lützner et al., 2009). Clearly OA 
poses a major economic burden to the population as well as causing great 
morbidity in the many sufferers, therefore reduction in the incidence of OA 
is imperative (Gabriel & Michaud, 2009). 
 
1.4.2 Pathogenesis 
There are classically thought to be two forms of OA, primary and 
secondary. Secondary OA is caused by well-recognised predisposing 
conditions such as anatomic abnormalities, trauma, metabolic and 
inflammatory disorders. Conversely, primary OA has no apparent triggering 
event and occurs in previously undamaged joints (Herrero-Beaumont et al., 
2009). There are many different factors which can lead to the onset of OA, 
these are outlined in Figure 1.12. Any combination of factors can lead to 
OA onset, it is likely that systemic factors predispose a person to OA, and 
the application of local biomechanical factors triggers the process of 
cartilage disruption (Felson & Zhang, 1998).  
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Figure 1.12 Osteoarthritis pathogenesis. A schematic representation of 
the pathogenesis of osteoarthritis detailing the different types of risk factors 
involved. HRT= hormone replacement therapy. Figure adapted from Felson 
& Zhang (1998).  
 
Osteoarthritic cartilage is altered from a normally silvery/white, firm tissue 
to become yellow, pitted, soft, uneven and fissured. This condition 
progressively spreads across an articular surface. Degradation of articular 
cartilage can occur through mechanical wear processes; however there 
can also be a molecular basis to cartilage degeneration (Martel-Pelletier et 
al., 2008).  
The subchondral bone undergoes areas of necrosis and resorption, which 
appear as cysts. The tissue undergoes sclerosis where new bone is laid 
down in areas under stress. Marginal osteophytes arise at the joint 
periphery, composed of a centre of new bone with a surface layer of 
cartilage containing a mixture of hyaline and fibrocartilage (Altman, 1987). 
At the clinical stage of OA there is also inflammation of the synovial 
membrane. Failure results from an inability of chondrocytes to balance this 
progressive degradation with the synthesis of new matrix. When synovial 
inflammation occurs the production of inflammatory mediators regulates 
chondrocyte homeostasis, favouring catabolic activities resulting in matrix 
loss (Martel-Pelletier et al., 2008).  
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Cartilage matrix is turned over throughout life and many cellular factors 
regulate cartilage homeostasis, balancing anabolic and catabolic activities, 
however disruption of this balance can lead to increased catabolism and 
therefore degradation of the tissue (Martel-Pelletier et al., 2008).  
One of the key anabolic factors in cartilage homeostasis is transforming 
growth factor β (TGF-β) which is thought to play a proactive role in 
regulating cell proliferation and ECM synthesis. The growth factor functions 
to increase proteoglycan synthesis  and to inhibit interleukin 1β (IL-1β) 
mediated proteoglycan synthesis suppression. It also acts to inhibit 
production of matrix metalloproteinase 9 (MMP-9) and MMP-1, molecules 
which are involved in ECM destruction. TGF-β is also able to induce MMP-
13 and the aggrecanase ADAMTS-4 (a disintegrin and a metalloprotease 
with thrombospondin motifs-4) allowing macromolecular turnover in normal 
cartilage. (Martel-Pelletier et al., 2008). TGF- β is usually present at low 
levels in healthy joints, but levels are increased in OA cartilage. Other 
anabolic factors include bone morphogenic proteins (BMPs), cartilage-
derived morphogenic proteins (CDMPs), insulin-like growth factors (IGFs) 
connective tissue growth factor (CTGF), hepatocyte growth factor (HGF) 
and fibroblast growth factor (FGF). These factors, combined, work to 
stimulate matrix deposition, cell proliferation and inhibit catabolic activity 
(Martel-Pelletier et al., 2008).  
Of greater interest are the catabolic factors, many of which appear to have 
increased production or function in OA cartilage, which may act as 
catalysts or amplifiers of OA development. These include proteases, in 
particular matrix metalloproteinases (MMPs). MMPs are classified into 
groups: collagenases (MMP-1, -8 and -13 which degrade specific collagen 
molecules), stromelysins (MMP-3 and -11 which degrade proteoglycans, 
fibronectin, elastin and laminins), gelatinases (MMP-9 and -2 which 
degrade collagen types IV and V along with denatured collagen and 
gelatine), and adamalysin (ADAMTS-5 which has aggrecanase activity). 
These MMPs have all been shown to be uniquely expressed or 
upregulated in OA cartilage.  Other proteases involved in OA development 
include certain serine and thiol proteases (Martel-Pelletier et al., 2008).  
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Inflammatory factors also play a key role in the catabolism of cartilage, the 
proinflammatory cytokine IL-1β is thought to be the most important factor 
responsible for the catabolic processes in OA. It forms a positive 
amplification loop in chondrocytes leading to increased production of itself, 
proteases, cytokines and other inflammatory factors. It is also able to inhibit 
antagonists of such enzymes and inhibit synthesis of ECM constituents 
(Daheshia & Yao, 2008). Other proinflammatory factors involved in OA 
development include tumour necrosis factor alpha (TNF-α) (Goldring, 
1999), oncostatin M (OSM) (Hui et al., 2003), leukaemia inhibitory factor 
(LIF) (Lotz et al., 1992), IL-17, IL-18 (Martel-Pelletier et al., 2008), nitric 
oxide (NO) (Vuolteenaho et al., 2007), eicostanoids (prostaglandins and 
leukotrines) and also protease-activated receptors (PARs) (Martel-Pelletier 
et al., 2008). 
There are a number of factors other than proteases and inflammatory 
molecules which have catabolic activity in cartilage which are upregulated 
in OA including fibronectin fragments (Homandberg et al., 1998), leptin 
(Teichtahl et al., 2005) and neuropeptides (Martel-Pelletier et al., 2008). 
OA was historically thought to be a disease of the cartilage, but more 
recent evidence indicates that it is a disease of the whole joint. The 
initiating lesion resulting in osteoarthritis may arise in many different tissues 
of the joint. McGonagle et al. (2010) discuss a site specific pathogenic 
classification of OA in which the disease can arise from cartilage, 
ligaments, meniscus, synovium, bone or a combination of many of these 
tissues (Halstead et al., 2010). They suggest that injury or disregulation of 
these tissues could progress to whole joint effects resulting in OA, and with 
improved magnetic resonance imaging (MRI) technology, these initial 
tissue lesions can be detected earlier, before clinical onset of OA.  
 
1.4.3 Articular cartilage defects 
Many cases of OA stem from an initially minor cartilage defect; these can 
be caused by acute injury to the joint, or from osteochondral pathology, 
such as osteonecrosis or osteochondritis dissecans. Due to the poor ability 
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of cartilage to heal, these small defects progressively deteriorate under 
regular joint loading and articulation, and advance to clinical OA (Chaing & 
Jiang, 2009). Not only do these lesions pose a risk of deterioration to OA, 
but are troublesome in themselves, often causing pain, swelling and 
mechanical symptoms such as locking of the joint, reducing the quality of 
life for patients (Minas & Nehrer, 1997). An estimated 10,000 patients in 
the UK each year suffer knee cartilage damage warranting repair (NICE 
TA89, 2008). 
To prevent onset of OA and reduce symptoms, it is possible to repair these 
defects. There are various approaches, although these depend on the 
severity and position of the defect (Schindler, 2011). Cartilage defects can 
be graded by severity, highlighting cartilage properties, as well as the size, 
shape and depth of lesions. There are many systems for categorising 
cartilage defects; two different approaches were developed by Outerbridge 
(1961) and Bauer & Jackson (1988). The latter is useful in a more 
descriptive sense, allowing for association with recent trauma (grades I-IV) 
or lesions undergoing a degenerative process (grades V & VI), as it defines 
fracture pattern. However, the Outerbridge system is most useful to 
delineate a symptomatic focal area suitable for repair as it is concerned 
with depth of the lesion (Minas & Nehrer, 1997).  More recently, the ICRS 
grading system has been widely used (Figure 1.13). 
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Figure 1.13 ICRS cartilage grading system. Normal (grade 0): healthy 
cartilage, grade 1: the cartilage has a soft spot or blisters, grade 2: minor 
tears visible in the cartilage, grade 3: lesions have deep crevices (more 
than 50% of cartilage layer), grade 4: the cartilage tear exposes the 
underlying (subchronal) bone. 
 
It has been suggested that cartilage defects can result in increased 
cartilage breakdown, leading to a decrease in cartilage volume resulting in 
decreased joint space, and breakdown of collagen type II fibres (Ding et al., 
2005). Due to the link between cartilage defects and development of early 
OA, it is proposed that repair of these defects can prevent further cartilage 
degradation and progression to OA. 
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1.5  Current approaches to defect repair 
Current treatments aim to restore the integrity of the joint surface and allow 
a full range of motion with the absence of pain. These treatments include; 
lavage and debridement, marrow stimulation techniques, 
perichondral/periosteal grafts, mosaicplasty and autologous chondrocyte 
implantation (Minas & Nehrer, 1997). When determining which of these 
procedures to use, it is important to take into account the location and 
severity of cartilage damage, the patient’s characteristics and risk factors 
(Figure 1.14; Lützner et al., 2009; Schindler, 2011). Many of these 
techniques can be performed in the knee, but are inappropriate in the hip 
due to difficulties in accessing the joint, although arthroscopy is becoming 
more advanced, usually, end stage total joint replacement is the only option 
for hip arthritis. 
 
Figure 1.14 Treatments for focal cartilage defects in the knee. The 
selection of a cartilage repair procedure based on location, lesion size and 
whether it is a first or second line treatment. * = treatment for young/high 
demand patient, ** = treatment with no medium-long term clinical results 
available to date. Figure from Schindler (2011). 
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1.5.1 Lavage & debridement 
The aim of lavage is to remove loose articular debris and inflammatory 
mediators from the joint space through arthroscopy, therefore reducing 
inflammatory synovitis and pain and improving function (Minas & Nehrer, 
1997, Lützner et al., 2009). Debridement is often performed alongside 
lavage to provide advanced benefit, with the intention of improving 
mechanical conditions by removing loose bodies, hypertrophied synovium 
and, in the knee, torn meniscal fragments, and often removing flaps and 
shaving fibrillated cartilage (Lützner et al., 2009). 
Following a  randomised six month controlled trial, lavage and tidal 
irrigation of the knee were found have an equal effect on pain relief to 
corticosteroid injection into the joint space. The effect was more prolonged 
with lavage and tidal irrigation, lasting up to 6 months in 64 % patients 
compared to only 29 % of patients receiving corticosteroid injection (Arden 
et al., 2008). Hubbard (1996) compared the effects of lavage alone to the 
use of combined debridement and lavage, and found more effective pain 
relief and sustained results when both techniques were used  (Hubbard, 
1996). Beneficially, lavage and debridement are cheap procedures which 
are relatively simple to perform. 
However, many studies have suggested that the pain relief from 
debridement is no greater than that from lavage alone (Chang et al., 1993) 
and no greater than can be achieved with a placebo (Moseley et al., 2002). 
Kirkley et al. (2008) found no significant benefit of arthroscopic surgery 
over optimised physical and medical therapy alone. This view however is 
still controversial, and the treatment may be beneficial in a small number of 
patients with specific lesion types. Furthermore, the application of this 
treatment does not replace lost tissue and has not been shown to defer 
progression into OA (Lützner et al., 2009). 
 
1.5.2 Marrow stimulation techniques 
The aim of bone marrow stimulation is to cause bleeding into the joint 
space from the subchondral bone resulting in fibrin clot formation in the 
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defect. This is followed by migration of undifferentiated mesenchymal stem 
cells to the lesion where they form fibrocartillagenous tissue to fill the full 
thickness cartilage defect (Minas & Nehrer, 1997; Lützner et al., 2009, 
Schindler, 2011). Techniques used to penetrate the subchondral bone are 
drilling, microfracturing and abrasion arthroplasty. Of these microfracturing 
is most commonly used as it is easiest to perform (Figure 1.15). Firstly 
debridement is used to remove unstable cartilage from the rim of the 
lesion, and then holes are made 2-4 mm deep and 3-4 mm apart in the 
centre of the defect. Rehabilitation involves passive motion and partial 
weight bearing for 6-8 weeks (Minas & Nehrer, 1997; Lützner et al., 2009). 
 
Figure 1.15 Microfracture procedure. Firstly debridement is used to 
define the edge of the defect, holes are made in the bone to stimulate 
bleeding, a fibrin clot forms in the defect which overtime forms repair 
fibrocartilage. Figure from Schindler (2011). 
 
Steadman et al. (2003) found that microfracture marrow stimulation greatly 
reduced pain and improved knee function for a minimum of 7 years in 
patients under the age of 45 (Steadman et al., 2003). Bae et al. (2013) 
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reported that 67.9 % of patients who underwent microfracture surgery did 
not require further treatment for cartilage pathologies at 10 year follow up. 
However, this repair technique produces fibrocartilage which has inferior 
biomechanical properties and durability compared to the original hyaline 
cartilage (Steinwachs et al., 2008; Lützner et al., 2009). It is unlikely, 
therefore, to be a curative measure or prevent disease progression 
(Lützner et al., 2009) 
Autologous matrix induced chondrogenesis (AMCI® Geistlich Pharma) has 
been developed to produce more consistent results from microfracture 
procedures. A cell free collagen matrix is secured into the defect to provide 
an environment for mesenchymal stem cells and aid chondrogenesis. The 
success of AMIC® has been reported for the repair of osteochondral 
lesions of the knee in a two year follow up study (Gille et al., 2013) 
Furthermore, the technique (alongside the use of autologous bone grafting) 
has been reported to be successful at 24 month follow up for the repair of 
osteochondral lesions of the ankle joint (Valderrabano et al., 2013). The 
long term clinical benefits of this procedure are currently unknown. 
 
1.5.3 Perichondrial/periosteal grafting 
The key problem with marrow stimulation techniques is that they produce 
an inferior fibrocartilaginous repair tissue. It has been shown that 
autogenous rib perichondrium, when grafted onto a cartilage defect which 
had undergone debridement, produced a repair tissue which resembled 
hyaline cartilage. Autogenous periosteal grafts have also been performed 
and produce hyaline-like repair cartilage (O’Driscoll et al., 1988). Therefore 
perichondrial/periosteal grafting is possibly a superior alternative to 
microfacture (Minas & Nehrer, 1997). A study conducted by Homminga et 
al. (1990) in 25 patients under the age of 45 with 30 chondral lesions used 
periostium grafts from the rib and anchored them to cartilage lesions of the 
knee using fibrin glue. They found a mean increase in knee function when 
questioning patients on the Ranawat knee scoring system, and 14 people 
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maintained that score after two years. In 28 cases, the defect was 
completely filled with hyaline cartilage (Homminga et al., 1990).  
Bouwmeester et al. (2002) performed a retrospective analysis of two 
studies comparing patients receiving perichondrial grafting and those 
receiving subchondral drilling. The success rate of perichondrial grafting 
was 78% (three grafts failed) compared to a surprisingly high 100% 
success rate of subchondral drilling. No long term advantage of having a 
hyaline-like repair tissue compared to fibrocartillage was found within the 
10 year scope of the study. Grafting has to be performed via an ‘open’ 
procedure, whereas microfracture techniques are performed 
arthroscopically, which is preferable. Furthermore there was a degree of 
calcification of the grafts (Bouwmeester et al., 2002). Perichondral grafting 
is now more commonly performed as part of autologous chondrocyte 
implantation procedures (Section 1.5.5; Chaing & Jiang, 2009). 
 
1.5.4 Osteochondral autografts/allografts (mosaicplasty) 
During autologous osteochondral transplantation (Figure 1.16), pins of 
cartilage attached to subchondral bone, which contain metabolically active 
chondrocytes, are taken from non-load-bearing areas of the affected joint 
and like periosteal/chondrial grafting are fixed to the site of chondral 
defects. Osteochondral grafts are thought to have greater stability along 
with the benefit of producing hyaline cartilage repair tissue (Minas & 
Nehrer, 1997). Koulalis et al. (2004) performed osteochondral autografts in 
knee joints of 18 patients with a follow-up time of 27 months. All showed 
defect coverage 12 months postoperatively and all cases had osseous 
integration, although there was some indication of donor site morbidity in 
11 patients which decreased over time. This is a good approach to defect 
repair; however the factor of donor site morbidity is a disadvantage 
(Koulalis et al., 2004).  
Solheim et al. (2010 and 2013) performed mosaicplasty surgeries on 69 
patients (mean age 33) and recorded Lysholm score and visual analogue 
scale (VAS; 0=no pain; 100=worst possible pain) of pain. At 12 month 
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follow up the mean Lysholm score and VAS of pain improved from 48 and 
62, respectively, at the time of surgery to 81 and 24, respectively.  
However, at mid-term (5-9 years) follow up pain levels were observed to 
have increased and mean scores of 68 and 32 were reported, respectively 
(Solheim et al., 2010). At long-term (10-14 years) follow up, mean pain 
scores were still improved from baseline, at 72 and 27 respectively. 
However an unsatisfactory Lysholm score of < 64 was reported in 40 % of 
patients. Although, the outcome was found to be improved in a specific 
demographic of patients (males under 40 years old)  with small (< 3 cm2) 
initial defects (Solnheim et al., 2013). It is therefore necessary to accurately 
select recipients for mosaicplasty to improve long term clinical success. 
 
Figure 1.16 Mosaicplasty procedure. The use of autologous 
osteochondral pins taken from non-load-bearing joint surfaces to repair 
lesions in load bearing regions. Figure from www.kneejointsurgery.com. 
 
To overcome the issues with donor site morbidity, osteochondral allografts, 
which still contain metabolically active chondrocytes, have been used. As 
they are allogeneic, rather than taken from donor sites, grafts of a much 
larger size are able to be produced. The grafts are anueral and avascular 
and so were thought to be immuneprivileged, making them ideal for 
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allogenic transplantation, however, immune reactions can be evoked from 
the immersing synovial fluid (Chaing & Jiang, 2009). There are concerns 
about possible transmission of infection for allograft recipients, so further 
steps are required to sterilise grafts (LaPrade et al., 2009). Storage and 
preparation of allografts, if not used fresh, is troublesome, as chondrocytes 
die during the process (Chaing & Jiang, 2009). 
 
1.5.5 Autologous chondrocyte implantation (ACI) 
ACI is a technique developed in the late 1900s whereby articular cartilage 
is harvested from a patient and the chondrocytes from which are expanded 
in vitro. These expanded, autologous chondrocytes are then reimplanted 
into chondral defects of the same patient, beneath a perichondrial patch 
(Chaing & Jiang, 2009). Grande (1989) initially performed this procedure 
on rabbits and found improved defect healing and decreased synovitis in 
joints in which chondrocytes had been implanted compared to controls 
where just the perichondrial flap had been attached. The repair cartilage 
was hyaline-like, and cell labelling revealed that the implanted cells were 
present in and responsible for production of the repair cartilage. A follow-up 
study by Minas (2001) looked at the capacity of ACI to repair cartilage 
defects in the human knee. In a sample of 169 patients a 87% success rate 
was found. Moradi et al. (2012) found a substantial improvement in all 
clinical outcome parameters at up to 14 years post-operatively, with 
complete defect filling in 52 % of patients as observed by MRI. 
Despite having a relatively high success rate and producing a mechanically 
and biologically superior hyaline-like repair tissue with a non-immunogenic 
graft, there are disadvantages to this procedure. The treatment involves an 
open technique, as opposed to arthroscopic which results in a more 
prolonged recovery period for patients (Minas, 2001). Also, the procedure 
is technically demanding, with multiple stages, so differences in surgical 
skill may well correlate to altered outcomes of the treatment (Grande et al., 
1989). 
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A variation of ACI, matrix assisted chondrocyte Implantation (MACI®; 
Genzyme, Cambrige, MA), has been in clinical use for a number of years. 
Similarly to AMCI®, this procedure uses a collagen matrix onto which the 
autologous chondrocytes are cultured prior to implantation into the defect. 
Beneficially, use of MACI enables the procedure to be performed 
arthroscopically, as harvest of periosteum is not required (Getgood et al., 
2009). Good clinical mid-term results have been reported with this 
approach (Kon et al., 2009). 
 
1.6  Current tissue engineering approaches 
As current surgical interventions for osteochondral defect repair have 
shown variable outcomes, there is need for the development of a 
biologically and biomechanically superior repair biomaterial which will avoid 
the use of autologous tissue and circumvent donor site morbidity. Tissue 
engineered approaches are currently undergoing research and 
development to fulfil this clinical niche. 
There are three key components in tissue engineering, cells which 
characterise the tissue type, biomaterial scaffolds which provide a habitat 
for the cells and chemical, mechanical or biological environmental factors 
which determine cell behaviour (Chaing & Jiang, 2009). 
Cells can be can be used in regenerative medicine associated with a 
scaffold, or injected directly, without a scaffold. Often these cells are 
extracted from donor tissue and either expanded or implanted directly into 
the host. These cells can be allogeneic (from another human) but most 
preferably autologous, from the individual themselves, as these will be 
immunocompatible. Enough cells may not be available from a tissue 
biopsy, or cells extracted may not be easily expanded, in these 
circumstances, stem cells are an alternative source. Stem cells can be 
embryonic, foetal-related tissue (amniotic fluid or placenta) or adult stem 
cells derived from bone marrow, skin etc. (Atala, 2007). The growth of 
research in the field of stem cell biology has opened up new possible cell 
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sources including pluripotent stem cell lines created by somatic cell nuclear 
transfer (Wakayama et al., 2001), and induced pluripotent stem cells 
(Takahashi et al., 2007), which may be of use in the future. Often scaffolds 
can be implanted without cells, to allow native cell in growth in vivo (Atala, 
2007).  
Biomaterials used to form a scaffold need to be tailored to the tissue being 
engineered, to mimic the biological and mechanical characteristics of the 
natural ECM. The scaffold should ideally be biodegradable and 
bioresorbable. These materials can be natural decellularised ECM, 
naturally derived materials formed in vitro or synthetic polymers. 
Beneficially, natural materials can be recognised biologically and thus 
avoid rejection, however polymers have the ability to be reproduced on a 
large scale, and the properties of strength, degradation and the 
microstructure can be easily controlled (Atala, 2007). 
Cartilage is a complex tissue and as such there have been a number of 
different approaches taken to engineer the tissue for use in articular 
cartilage defect repair. These approaches include synthetic polymer and 
natural biomaterial scaffolds.  
 
1.6.1 Synthetic scaffolds 
Synthetic polymers are used in research to engineer many different tissue 
types as they are easy to manufacture and their specific properties can be 
accurately controlled to mimic the natural ECM. However, the 
biomechanical properties of such materials are inferior to natural cartilage 
(Atala, 2007). Some examples of polymers which have been used as 
cartilage scaffolds are shown in Table 1.3. A single material can be used, 
but more commonly they are used in combination to provide better physical 
characteristics.  
Problems encountered with synthetic polymers include low GAG content of 
repair tissue and inconsistent subchondral bone reformation (Chu et al., 
1996). van Susante et al. (1998) found that the repair cartilage formed with 
hydroxyapatite scaffolds was inferior fibrocartilage. Scaffolds are designed 
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to biodegrade, so if cell seeding, retention or metabolism is not sufficient, 
the ECM will not be replicated by resident cells before the scaffold 
degrades and the implant will fail. The use of copolymers allows control of 
degradation rate (Frenkel & DiCesare, 2004). Other problems have been 
found with integration of successful polymer hydrogels with the existing 
cartilage, composites of polyvinyl alcohol (PVA) gels with nano-
hydroxyapatite allowed for better integration with host tissues (Pan & 
Xiong, 2009).  
Recently, nanofabrication technology has been used to produce an 
anisotropic cartilage repair biomaterial. The electrospinning of poly (ɛ-
caprolactone) (PCL) fibres enabled tangential surface alignement and 
random orientation in the rest of the material, increased fibre diameter was 
included in the base of the material to mimic natural cartilage zonal 
microstructure with promising in vitro results (McCullen et al., 2012).  
Some synthetic scaffolds have begun to undergo testing in clinical trials 
such as Trufit® plug (Smith&Nephew, Andover, USA) and BioMatrix® 
Cartilage Repair Device (Arthrex, Karlsfeld Germany). 
Synthetic biomaterial Reference 
Polylactic acid (PLA) 
 Chu et al., 1996   
Giurea et al., 2003  
Polyglycolic acid (PGA) 
Liu et al., 2002  
Schaefer et al., 2002 
PLA-PGA copolymer Cohen et al., 2003 
Poly(ethylene glycol) diacrylate (PEGDA) Kim et al., 2003 
Hydroxyapetite 
van Susante et al., 1998 
Pan & Xiong., 2009 
Polycaprolactone (PCL) McCullen et al., 2013 
Polyvinyl alchohol (PVA) Pan & Xiong, 2009 
Table 1.3 Synthetic biomaterials. Synthetic biomaterials used as 
scaffolds in cartilage tissue engineering for repair of osteochondral defects. 
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1.6.2 Natural scaffolds 
Natural biomaterials have the advantage of biological recognition, however, 
they are more difficult to use than synthetic polymers, resulting in scaffolds 
which are less reproducible (Atala, 2007). Collagen for example, has great 
advantages as a biomaterial for cartilage production, as it is the main ECM 
component of the natural tissue, and has specific RGD sequences which 
allow cell adhesion and  phenotype retention (Atala, 2007).  Fibrin is also a 
logical candidate, as the clots which form during the natural cartilage repair 
process are fibrin based (Frenkel & DiCesare, 2004). Some of the natural 
biomaterials which have been used in the production of cartilage scaffolds 
are shown in Table 1.4. As with synthetic polymers, these materials can be 
used in isolation, or in combination with a number or other materials to 
produce the optimum properties to function as a scaffold.  
Natural biomaterial Reference 
Collagen 
Wakitani et al., 1994  
Frenkel et al., 1997 
Collagen-GAG-calcium phosphate Getgood et al., 2012 
Fibrin 
Hendrickson et al., 1994 
Kreuz et al., 2009 
Gelatin Chang et al., 2004 
Hyaluronan 
Butnariu-Ephrat et al., 1996 
Grigolo et al., 2001    
Dausse et al., 2003 
Agarose and alginate 
Marijnissen et al., 2002 
Dausse et al., 2003 
Bacterial cellulose Müller et al., 2006 
Chitosan Hoemann et al., 2005 
Gellan Gum Oliveira et al., 2010 
Table 1.4 Natural biomaterials. Natural biomaterials which have been 
used as scaffolds for cartilage tissue engineering. 
 
Good results have been seen in terms of hyaline-like cartilage repair tissue 
formation in animal studies, however as with synthetic materials, there 
were problems with scaffold integration into the existing tissue, and also 
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with the thickness of the resulting tissue, being thinner than the 
surrounding cartilage. In many cases repair tissues were biologically and 
mechanically inferior to natural cartilage. It is however, suggested that 
despite the promising functionality of some biological scaffold materials, 
there are still concerns with batch variation, and the potential for pathogen 
transfer, especially bovine spongiform encephalopathy from prions within 
bovine collagen sources (Frenkel & DiCesare, 2004).  
 
1.6.3 Natural acellular scaffolds 
As discussed previously, the architecture of the cartilage ECM is essential 
for its load bearing and lubrication functions. Therefore, using a simplistic 
homogenous scaffold may not be sufficient to recreate the biological and 
mechanical properties of natural cartilage (Chaing & Jiang, 2009). An 
approach taken in the engineering of other tissues has been to use natural 
acellular ECM scaffolds. These collagen rich matrices are produced by 
chemical, enzymatic and mechanical manipulation of natural tissues 
resulting in the removal of resident cells. These scaffolds slowly degrade 
once implanted and ingrowing or transplanted cells secrete ECM proteins 
to slowly replace and remodel the scaffold (Atala, 2007). Acellular scaffolds 
also have the benefit of being biocompatible, biodegradable and 
bioresorbable as they are natural materials. Additionally, acellular tissue 
matrices can be bioactive, retaining cell attachment motifs, growth factors 
and other biological cues (Hofmann & Garcia-Fuentes, 2011). 
Work is currently underway in developing acellular porcine bladder for use 
in tissue engineering (Bolland et al., 2007), along with meniscus (Stapleton 
et al., 2008), other acellular matrices have been developed for tendon (Lee, 
2008), heart valves (Korossis et al., 2002), blood vessels (Cronklin et al., 
2002), skin (Chen et al., 2004), nerves (Kim et al., 2004) and small 
intestinal submucosa (Badylak et al., 1999) amongst others.  
Decellularised small intestinal submucosa (SIS) has been used clinically for 
over a decade to repair tissues such as skin, muscle and tendon (eg. 
Restore™, DePuy Orthopaedics; Surgisis®, Cook Biotech Inc). Although 
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the application of decellularised SIS for osteochondral repair has not been 
reported . 
1.6.3.1 Immunogenicity of tissue transplants 
If allogeneic or xenogeneic tissue engineered biomaterials are to be of use 
clinically, it is necessary to understand the immunological response to such 
materials upon implantation, to avoid the rejection of tissue engineered 
implants.  
1.6.3.1.1 Immunological response to allografts 
The extracellular matrix components of biological tissues such as collagens 
and proteoglycans are conserved between individuals and across species, 
so are not recognised as foreign upon transplantation. However, human 
leukocyte-associated (HLA) proteins are present on the cell membrane of 
every nucleated cell and are encoded for by highly polymorphic set of 
major histocompatibility complex (MHC) genes. Each individual has six sets 
of MHC I and six sets of MHC II genes, three from each parent, which are 
expressed co-dominantly. The histocompatibility proteins expressed are 
therefore unique to each individual (excluding monozygotic twins, who 
share the same genetic material). It is the presence of these 
histocompatibility proteins on the surface of cells which enables 
identification and distinction between “self” and “non-self”, and therefore 
poses a barrier in transplantation of allogeneic and xenogeneic tissues. 
The role of the MHC molecules is to present foreign antigens, such as 
epitopes from cytoplasmic or internalised pathogens. The presentation of a 
foreign antigen elicits a cell mediated immune response, however, as the 
MHC molecules are specific to each individual, allogeneic “non-self” MHC 
molecules will also be recognised as foreign, without presenting an 
antigen. Initial acute rejection of transplants can occur through direct 
recognition of allogeneic MHC Class II proteins presented on the surface of 
antigen presenting cells (APC’s) by CD4+ Helper T- cells (Figure 1.17). 
The binding of T-cell receptor to allogeneic MHC Class II, followed by 
binding of co-stimulatory cell surface molecules results in the formation of 
an immunological synapse which activates the CD4+ T-cell. Once 
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activated, the CD4+ T-cell produces interluken-2 (IL-2) which is able to 
stimulate CD8+ T-cells. CD8+ T-cells have a receptor which binds MHC 
Class I on all nucleated cells. Once CD4+ and CD8+ T-cells are activated 
they undergo clonal expansion, to rapidly produce many more T-cells 
reactive against the specific MHC molecule shape recognised as “non-
self”. Clonal expansion produces both memory and effector cells. Effector 
CD4+ T-cells release cytokines which stimulate APC’s to kill foreign cells, 
for example Interferon-γ (IFN-γ) release stimulates macrophages to destroy 
foreign cells via the production of oxygen radicals and enzymes. Effector 
CD8+ T-cells are themselves able to kill the cell presenting allogeneic MHC 
Class I which they have bound. Destruction of transplanted cells results in 
the tissue becoming necrotic and dying. Memory T-cells are long lived cells 
which reside in the body to rapidly expand if the same foreign MHC 
molecules are presented again in the future, resulting in a much more rapid 
response (Janeway, et al., 2005, Knight & Ingham, 2006).  
 
Figure 1.17 Direct antigen recognition. Helper T-cells recognise 
allogeneic MHC Class II on allogeneic antigen APC and release IL-2 to 
stimulate cytotoxic T-cells which then recognise allogeneic MHC Class I. 
Th cell = CD4+ Helper T-cell, Tc = CD8+ Cytotoxic T-cell. Figure adapted 
from Knight and Ingham (2006). 
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In addition to the mechanism of recognising allogeneic MHC molecules 
described above, MHC molecules shed by cells of the transplant tissue can 
be picked up by antigen presenting cells, and epitopes derived from the 
MHC molecule presented, leading to a cell mediated immune response. 
Cytotoxic CD8+ T-cells can then respond to MHC Class I molecules 
presented on all allogeneic cells (Figure 1.18; Janeway, et al., 2005, Knight 
& Ingham, 2006). 
 
Figure 1.18 Indirect antigen recognition. MHC fragments are shed by 
allogeneic cells, these are then taken up and epitopes presented on MHC 
Class II by APCs. Helper T-cells recognise allogeneic MHC epitopes 
release IL-2 to stimulate cytotoxic T-cells which then recognise allogeneic 
MHC Class I. Th cell = CD4+ Helper T-cell, Tc = CD8+ Cytotoxic T-cell.  
Figure adapted from Knight and Ingham (2006). 
 
1.6.3.1.2 Immunological response to xenografts 
Although xenogeneic cells will elicit immune rejection via the response 
described for allogeneic cells, they primarily induce hyper-acute rejection. 
Cells of xenogenic tissues possess a cell surface sugar, galactose α1-3 
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galactose (α-gal), which is present in all mammals except for humans and 
old world monkeys (Galili et al., 1987). Humans have a high titre of 
antibodies against a sugar epitope present on bacteria in the human gut 
which is similar in shape to α-gal. Upon transplantation of xenogeneic cells 
expressing α-gal, antibodies rapidly bind to the epitope on endothelial cells 
of blood vessels, activating the complement cascade leading to 
inflammation and blood clotting, the vessels become blocked which results 
in hypoxia and death of the transplant tissue (Janeway, et al., 2005, Knight 
& Ingham, 2006). 
By removing whole cells, membranes and cytoplasmic proteins from 
allogeneic or xenogeneic tissues, only the nonimmunogenic ECM proteins 
will remain. The tissue will retain its biological/biochemical structure and 
function yet will not elicit an immune response upon implantation. 
1.6.3.1.3 Macrophage response to decellularised tissues 
Macrophages are large mononuclear cells of the immune system which 
have been reported to be “classically activated” or “alternatively activated”. 
More recently macrophage phenotype has been shown to be a continuum 
between the two forms (Mills et al., 2000). Classically activated or M1 
macrophages are aligned with the Th1 CD4+ T-cell response. The 
secretion of IFN- γ by T-cells or the presence of TNFα or bacterial 
lipopolysaccharide (LPS) activate macrophages with enhanced 
microbicidal capacity and increased proinflammatory cytokine secretion. 
Alternatively activated, M2 macrophages are aligned with the Th2 CD4+ T-
cell response. The secretion of IL-4 and IL-13 by T-cells activate 
macrophages with a role in the immune response to parasites, but also in 
allergy, wound healing, and tissue remodelling (Cassetta et al., 2011).  
Brown et al. (2009) identified a change in macrophage polarisation in 
response to transplanted tissues with or without a cellular component. In 
vivo, cellular xenografts were infiltrated by M1 type macrophages which 
resulted in a proinflammatory response and scar tissue formation, whereas 
acellular xenografts and allografts were infiltrated with M2 polarised 
macrophages which resulted in constructive tissue remodelling.  
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Furthermore, Kean et al. (2012) have reported an association between 
decellularisation efficacy and macrophage polarisation, with ineffective 
removal of cell debris (despite histological confirmation of whole cell 
removal) resulting in a higher M1:M2 ratio. 
It is therefore, not only important to ensure the full removal of cells to avoid 
eliciting an immune response and graft rejection, but it is necessary to 
ensure effective removal of cellular debris, to tailor the tissue remodelling 
response from macrophages. 
1.6.3.2 Natural acellular (osteo)chondral scaffolds 
With the success of natural acellular scaffold materials for the repair of 
other tissues, it is possible that the most optimal treatment for articular 
cartilage repair is to use decellularised xenogeneic or allogeneic 
(osteo)chondral tissues. These constructs would ideally be structurally, 
biologically and mechanically relevant to natural articular cartilage. 
Acellular natural materials would also be biocompatible, biodegradable and 
bioresorbable. Removal of the existing allogeneic/xenogeneic cells would 
allow the construct to be immunocompatible. A limited number of 
approaches for natural cartilage tissue decellularisation are currently 
undergoing research and development (Benders et al., 2013). 
1.6.3.2.1  Decellularisation of homogenised cartilage matrix 
Yang et al. (2008) developed a method whereby human cadaveric cartilage 
was physically shattered in PBS containing protease inhibitors and then 
centrifuged to produce microfilaments. Treatment with triton X-100 (1 % v/v 
in hypotonic tris-HCl)  and hypotonic solution, nucleases and extensive 
phosphate buffered saline (PBS) washes resulted in decellularised 
cartilage microfilaments. 
Yang et al. (2010) developed a method whereby bovine cartilage was 
lyophilised and ground to a powder prior to decellularisation with trypsin, 
nucleases, hypotonic buffer and triton X-100 (1 % v/v in PBS) in the 
presence of protease inhibitors and antimicrobial agents, again followed by 
extensive PBS washes. 
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In both instances, the acellular cartilage matrix was then freeze dried into 
moulds and cross linked to produce a biomaterial. Scaffolds produced from 
decellularised homogenised cartilage have the benefit of retaining bioactive 
cues for cell growth and are also more customisable; however, they lack 
the 3D architecture and structure of native cartilage and therefore have 
reduced biomechanical function 
1.6.3.2.2 Decellularisation of cell derived matrix 
Elder et al. (2009) cultured week old calf chondrocytes in agarose to 
produce a 3D disc shaped cell-derived cartilage ECM. They then 
investigated the efficacy of different detergents to remove the cells from the 
construct. Discs were treated with a PBS decellularisation solution 
containing nucleases, protease inhibitors and antibiotics and either sodium 
dodecyl sulphate (SDS; 1% and 2% w/v), tributyl phosphate (TnBP; 2% 
w/v) or triton X-100 2% (v/v) then washed in PBS. 
Although decellularised cell-derived-ECM scaffolds have no issues 
regarding biocompatibility, the need to culture cells renders the process 
time consuming and this approach requires cell harvesting from the patient, 
increasing the number of invasive procedures performed and potentially 
causing donor site morbidity. The 3D structure and composition of the cell 
derived matrix is currently not comparable to natural cartilage tissues. 
1.6.3.2.3 Decellularisation of native cartilage 
Elder et al. (2010) developed a decellularisation protocol (based on earlier 
work; Elder et al., 2009) for 4 week old calf distal femur articular cartilage 
with the intention of producing a facet joint cartilage repair biomaterial. The 
short protocol included one freeze/thaw cycle followed by the use of 2 % 
SDS (w/v) in PBS with deoxyribonuclease (DNase), ribonuclease (RNase), 
ethylenediaminetetraacetic acid (EDTA) and penicillin/ streptomycin/ 
fungizone, then a final wash step in PBS. Different durations of SDS 
incubation were investigated. Incubation for 2 hours had no detrimental 
effects on cartilage GAG content or biomechanics, however no significant 
reduction in DNA content was seen and whole cell nuclei were still present, 
although the number was reduced. Incubation of cartilage for 8 hours in 
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SDS enabled the removal of all whole cell nuclei, however the DNA content 
was still 3861 ng.mg-1, only a 40 % reduction from fresh. In addition, 
increased duration of SDS wash incubations led to loss of GAGs and a 
reduction in biomechanical properties. With > 50 ng.mg-1 DNA remaining, 
the treated cartilage did not meet the criteria set by Crapo et al. (2011) to 
be defined as a decellularised matrix. The poor DNA reduction with this 
protocol was likely due to the initial high cellularity seen in the immature 
source tissue and also potential inhibition of nucleases through 
inappropriate application conditions. Nucleases require the presence of 
magnesium to perform nucleotide cleavage and would be denatured by 
SDS within the buffer. 
Schwarz et al. (2012) aimed to develop a porous collagen matrix from 
natural cartilage tissues, including meniscus and nasal septum cartilage 
from porcine and human source tissue. As such they did not make an 
attempt to retain the natural proteoglycan structure and biomechanical 
properties of the tissues. Cartilages were successfully decellularised using 
a protocol involving osmotic cell lysis with distilled water, following which 
sodium hydroxide (> pH 12) was used to inactivate pathogens, denature 
DNA/RNA and remove cellular debris. Samples were defatted in 70 % (v/v) 
ethanol and GAGs and other non-collagenous proteins were denatured and 
removed using a guanidine hydrochloride (1 M) solution containing sodium 
acetate (0.05N). Cartilages were finally sterilised using hydrogen peroxide 
(5% v/v). This produced a highly porous collagen scaffold, devoid of GAGs, 
which would encourage rapid cell infiltration. This protocol was not 
intended for articular cartilage decellularisation, and the produced matrix 
would not provide an acceptable repair material. 
The decellularisation of intact native cartilage tissues has the potential to 
produce an ECM with bioactive cues, the natural biological, biochemical 
and biomechanical composition and structure. However, the clinical 
relevance/success of such products may be limited, as such approaches 
do not provide a subchondral bone component for integration and stability 
of a cartilage repair biomaterial upon implantation.  
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1.6.3.2.4 Decellularisation of osteochondral tissues 
Here it is proposed that the decellularisation of osteochondral xenogeneic 
tissues may provide the best osteochondral lesion repair graft material. The 
addition of a bony component to the overlying cartilage layer may improve 
integration of the graft to the natural joint to avoid problems associated with 
graft loosening. Using a xenogeneic donor allows for a larger range of graft 
sizes, as many treatments such as mosicplasty are limited by available 
graft sizes and donor site morbidity. Another benefit of the proposed 
biomaterial would be the ‘off the shelf’ availability, with no reliance on donor 
human tissue, allowing greater ease of use and convenience during 
surgery. Acellular osteochondral pins could easily be adopted into current 
surgical procedure for mosaicplasty. 
Preliminary work has been performed to determine the capacity for 
decellularising natural xenogeneic tissues to use as an osteochondral graft. 
Kheir et al. (2011) investigated the use of a decellularisation protocol 
developed by Booth et al (2002) to develop an acellular porcine scaffold. 
Osteochondral tissues were subject to four cycles of freeze thaw (the final 
two in hypotonic solution) and then incubated through 6 cycles of 24 h in 
hypotonic solution followed by 24 h in 0.1 % (w/v) SDS in hypotonic 
solution, both containing aprotinin and EDTA at 45 °C with agitation. Blocks 
were than treated with nuclease and sterilised using 0.1 % Peracetic acid 
(PAA; v/v). The process was completed by 2 x 30 min PBS washes and a 
short 24 h final PBS wash. This technique enabled complete 
decellularisation with no detectable remnants of cellular debris or the α-gal 
epitope, but still with retention of original collagen content. However there 
were severely depleted levels of GAGs within the tissue and the collagen 
fibres seemed to be disrupted, appearing more loosely packed. The 
decellularisation process had the effect of massively decreasing the 
compressive stiffness of the tissue in mechanical studies, with the resulting 
matrix being inappropriate as a graft material.  
This previous work has outlined the possibility of using acellular xenogenic 
scaffolds, however it highlighted various issues which need to be 
addressed. The loss of GAGs and collagen disruption seen when full 
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decellularisation was achieved, led to the loss of the biomechanical 
properties of cartilage. The initial starting material for decellularisation may 
not have been optimal, Kheir et al. (2011) used porcine osteochondral 
tissues extracted from 4 month old pigs. Characterisation of osteochondral 
pins from various species of different ages may determine which material 
has properties most similar to that of human cartilage and may indicate 
more robust materials which will be least affected by harsh decellularisation 
protocols. Materials with higher levels of GAGs and more defined structure 
initially may show less disruption. 
The decellularisation protocol used previously employed EDTA as a 
proteinase inhibitor, however, this also acts to decalcify the bony 
component of osteochondral pins. Removal of EDTA from the process may 
retain the structural stability of decellularised pins. Previous studies have 
highlighted problems with detergents removing GAGs from the tissue. 
Altering the concentration of detergents may reduce the effect of 
decellularisation protocols on GAG content. Fewer wash cycles or reduced 
cycle times may also act to retain GAGs, but adversely may not adequately 
remove cellular components. Taking into account these possible 
alterations, a more effective protocol for osteochondral decellularisation 
may be developed. 
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1.7 Aim & Objectives 
 
Hypothesis 
It is hypothesised that a biocompatible xenogeneic osteochondral matrix can 
be developed with the structure and function of native tissue ECM for use in 
osteochondral lesion repair. 
 
Aim  
The aim of this project is to develop a natural decellularised xenogeneic 
osteochondral biomaterial with similar biological, biochemical and 
biomechanical properties to natural articular cartilage for use in articular 
cartilage defect repair. 
 
Objectives 
 To determine the optimal starting material for decellulartisation by 
assessing the biological, biochemical and biomechanical 
characteristics of osteochondral tissues taken from hips and knees of 
bovine, porcine and ovine animals. 
 To optimise the protocol for decellularisation xenogeneic 
osteochondral tissues. 
 To determine the biological and biochemical and biomechanical 
characteristics of the acellular osteochondral tissues by histological, 
immunohistochemical and quantitative methods 
 To investigate the regenerative capacity of the biomaterial in terms of 
cytotoxicity and biocompatibility. 
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Chapter 2  
Materials and Methods 
2.1 Materials 
2.1.1 Equipment 
The equipment used and equipment suppliers are listed in appendix A Table 
1. 
 
2.1.2 Chemicals 
The chemicals/reagents used and chemical suppliers are listed in appendix 
A Table 2 
 
2.1.3 Consumables 
The consumables and plastic ware used and suppliers are listed in appendix 
A Table 3 and appendix A Table 4 respectively. 
 
2.1.4 Cells 
The cells used in this study and suppliers are listed in Table 2.1. 
Cells Type Species Supplier 
3T3 Cells Fibroblasts Murine European collection of cell cultures 
BHK Fibroblasts Hamster Health Protection Agency 
Table 2.1 Cells used throughout the study. 
 
2.1.5 Glassware 
Glassware (beakers and bottles [100 ml, 1,000 ml and 2,000 ml]) were 
cleaned by immersion in a 1% (v/v) solution of phosphate-free detergent 
(Neutracon®, Decon Laboratories Ltd) overnight. Following this, glassware 
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was rinsed in tap water, and a final rinse in distilled water to remove any 
residual detergent. Glassware was then dried and sterilised (180 °C for 4 h, 
as required) by dry heat. 
 
2.1.6 General stock solutions 
2.1.6.1 Phosphate buffered saline (PBS) 
One PBS tablet was dissolved in 100 ml distilled water. The pH was 
adjusted to pH 7.2 -7.4.   
2.1.6.2 Baby hamster kidney (BHK) cell culture medium 
Glasgow’s minimal essential media (GMEM) was used with 5 % (v/v) foetal 
bovine serum (FBS), 2.5 % (v/v) tryptone phosphate broth (TPB), 1 mM L-
glutamine, 100 U.ml-1 penicillin and 100 U.ml-1 streptomycin. 
2.1.6.3 3T3 cell line culture medium 
Dulbecco’s modified Eagle’s medium (DMEM) was used with 10 % (v/v) 
FBS, 2 mM L-glutamine, 100 U.ml-1 penicillin and 100 U.ml-1 streptomycin. 
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2.2 Methods 
2.2.1 General methods 
2.2.1.1 Measurement of pH 
The pH of solutions was measured using a Jenway 3020 pH meter. The pH 
meter was firstly calibrated using solutions of pH 4, 7 and 10 made from 
buffer tablets dissolved in deionised water. The pH of solutions was 
measured using temperature compensation. For pH adjustment of solutions, 
1M hydrochloric acid or 1M sodium hydroxide was added drop-wise with 
stirring. 
2.2.1.2 Microscopy 
Bright-field microscopy was carried out using an Olympus BX40 microscope. 
In order to use polarized-light microscopy, a polarizer and analyser were 
incorporated in the usual bright-field set up. Fluorescence microscopy was 
carried out with the fluorescent vertical illuminator (BX51-RFA) and 
appropriate filters using the same microscope. Cells in tissue culture plates 
were viewed using an inverted microscope (Olympus IX71) set up for phase 
contrast microscopy. Images were captured using an attached Olympus 
digital camera controlled through Cell^B software (image capture and 
digitalisation). 
2.2.1.3 Sterilisation 
Solutions and equipment were sterilised using one of three procedures 
 Dry heat sterilisation – Items suitable for dry heat sterilisation were 
placed in a hot air oven for 4 h at 180 °C. 
 Moist heat sterilisation – Items which were not suitable for dry heat 
sterilisation were sterilised in an autoclave for 20 min at 121 °C at a 
pressure of 103 kPa. 
 Filter sterilisation – Solutions which were not suitable for heat 
sterilisation were filtered using 0.2 µm pore sized filters using a 
disposable syringe in a class II safety cabinet. 
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2.2.2 Tissue acquisition 
2.2.2.1 Dissection equipment 
The dissection equipment used and suppliers are listed in Table 2.2 and 
shown in Figure 2.1. 
Equipment Size/model Supplier 
Bench top Clamp - Irwin 
Corer (serrated drill attachment) 9 mm diameter University of Leeds 
Corer (serrated) 9 mm diameter University of Leeds 
Corer (smooth) 9 mm diameter University of Leeds 
Hand drill - Bosch 
Hand saw - - 
Rat toothed forceps 125 mm length Fisher Scientific Ltd 
Scalpel handle Size 4 Scientific Laboratory Supplies Ltd 
Straight fine point forceps 115 mm length Fisher Scientific Ltd 
Straight scissors with fine point 125 mm length Fisher Scientific Ltd 
Table 2.2 Dissection equipment used throughout the study. 
 
 
Figure 2.1 Dissection equipment. A – Hand held power drill. B – Metal 
File. C – Smooth corer. D – Serrated corer. E – Serrated corer drill 
attachment. F – Scalpel. G – Hack saw. H – Clamping apparatus to hold 
large limbs in place. I – Bench top vice for holding smaller limbs in place. 
 
2.2.2.2 Dissection 
Porcine, ovine and bovine legs were supplied by local abattoirs, usually 
within 24 h of slaughter (bovine legs within 96 h). Pigs were aged ~ 6 
months, sheep  8-12 months and > 4 yr and cows ~ 18 months. Joints were 
used fresh, or stored at 4 °C overnight for dissection the following day.  
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Porcine and ovine legs were dissected as shown in  Figure 2.2. Excess 
flesh was removed from the skeletal structures to allow easier access and 
maneuverability. Joints were exposed by cutting the surrounding tissue and 
extracapsular ligaments, then the joint capsule was excised. All ligaments 
were severed and the menisci removed from the knee so that all joint 
surfaces were exposed. Any exposed cartilage surfaces were kept hydrated 
throughout by covering in PBS soaked tissue. Bovine legs were supplied 
without the acetabulum and with the meat already removed, so only excision 
of the patella and menisci was required. 
 
Figure 2.2 Dissection of porcine legs. A – Whole porcine Leg. B – Incision 
made laterally to the knee. C – Enlargement of incision site, parallel to 
femur. D – Full removal of flesh. E – Incision made into joint cavity between 
patella and grove on the lateral side. F – Collateral ligaments severed. G – 
Severing of cruciate ligaments. H – All knee surfaces exposed. I – Incision 
made to medial side of the hip joint capsule. J – Teres ligament severed. K – 
Incision to joint capsule extended following the labrum. L – Femoral head 
and acetabulum fully exposed. 
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2.2.2.3 Pin extraction 
Osteochondral pins 9 mm in diameter and ~12 mm deep were extracted 
from cartilage surfaces of the acetabulum, femoral head, femoral groove, 
medial and lateral condyles and the medial and lateral tibial plateau. The 
side of each joint was removed with a hacksaw to ease pin extraction. The 
pins were initially marked out then a power drill with a specialist corer drill bit 
was used to cut into the subchondral bone. A handheld corer was then used 
to loosen the pin and extract it from the joint. Images showing the procedure 
for the bovine femoral groove are shown in Figure 2.3. 
 
 
Figure 2.3 Extraction of osteochondral pins. A – Intact bovine femoral 
groove. B – Edge of groove removed for ease of extraction. C – Position of 
extraction marked out with smooth corer. D – indentations made with 
serrated corer to allow drill attachment to grip. E – Cores drilled out. F – Pins 
fully extracted. 
 
2.2.2.4 Storage 
Pins were rinsed in PBS before being placed in plastic storage pots on PBS 
moistened filter paper and kept at -20 °C for up to 3 months. 
 
2.2.3 Basic histological techniques 
2.2.3.1 Fixation 
Osteochondral pins were placed in a universal with 15 ml 10 % (v/v) neutral 
buffered formalin (NBF) for 48 hours to achieve complete fixation prior to 
decalcification. 
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2.2.3.2 Decalcification 
2.2.3.2.1 Decalcification solution (12.5 % (w/v) EDTA) 
Ethylenediaminetetraacetic acid (EDTA; 250 g) and NaOH (25 g) were 
dissolved in 1.75 L distilled water. The pH was adjusted to 7.0 using 6 M HCl 
or 6 M NaOH if necessary. 
2.2.3.2.2 Decalcification procedure 
Bone was decalcified using 25 ml 12.5 % (w/v) EDTA for 2 weeks (or until 
bone was soft enough to be sectioned) at 45 °C with agitation. 
Decalcification solution was changed every 2-3 days.  
2.2.3.3 Paraffin wax embedding 
Osteochondral pins were bisected as described in Figure 2.4 before being 
placed in plastic cassettes (Histocette®) and cycled in the Leica TP 120 
automated tissue processor. Tissues were processed by immersion in 70 % 
(v/v) ethanol for 1 h followed by 1 h in 90 % (v/v) ethanol. Tissues were then 
immersed in absolute ethanol for 2 h 20 min, 3 h 20 min then 4 h 20 min. 
Immersion in xylene followed for cycles of 1 h, 1 h 30 min and 2 h. Tissues 
were then embedded with molten paraffin wax for 1 h 30 min then 2 h. 
Tissue cassettes were taken from the automated processor, tissues 
removed and orientated cut-surface-down in moulds. Samples were covered 
in molten wax, left to set overnight at room temperature, after which, excess 
wax was trimmed away. 
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Figure 2.4 Orientation of osteochondral pins for histology. Pins were 
bisected before being placed in histology cassettes, then the cut surface was 
laid face down when moulded in wax, so that sections could be cut from the 
cartilage surface through the osteochondral face. 
 
2.2.3.4 Sectioning and slide preparation 
Wax embedded tissues were sectioned on a microtome (Leica RM2125RTF) 
to a thickness of 6 μm, sections were taken from the cartilage surface 
through the bone as shown in Figure 2.4, to avoid dragging of bone 
fragments through the cartilage. Using forceps and a brush, sections were 
carefully placed in a water bath at 40 °C. The wax sections were then 
transferred onto Superfrost Plus slides and placed directly onto a hotplate at 
45 °C to bake on and dry. 
2.2.3.5 Dewaxing and rehydration 
Sections were dewaxed in xylene for 10 min, then in fresh xylene for another 
10 min. Sections were then dehydrated in 3 successive immersions in 100% 
(v/v) ethanol for 3 min, 2 min then 2 min followed by immersion in 70% (v/v) 
ethanol for 2 min. Slides were then placed under running tap water for 3 min 
to rehydrate the sections.   
2.2.3.6 Dehydration and mounting 
Stained sections were dehydrated by immersion in 70% (v/v) ethanol for 5 
sec, followed by successive washes in 100% ethanol for 1 min, 2 min and 3 
min. Sections were then immersed twice in xylene for 10 min each time. 
Cover slips were mounted to slides using a drop of DPX mountant, avoiding 
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bubbles. Slides were left to dry in a fume hood for a minimum of 4 h before 
visualizing using microscopy. 
 
2.2.4 Histological staining methods 
2.2.4.1 Haematoxylin and eosin staining 
Haematoxylin and eosin (H&E) was used to stain cell nuclei and general 
tissue architecture. Once paraffin embedded tissue sections had been 
dewaxed and rehydrated (Section 2.2.3.5) slides were immersed in pre-
made haematoxylin (Mayer’s) for 1 min, rinsed under running tap water until 
the water ran clear then immersed in eosin for 3 min. Slides were then 
dehydrated and mounted (Section 2.2.3.6). 
2.2.4.2 Sirius red/ Miller’s staining 
Reagents: 
 5 % (w/v) potassium   15 g potassium permanganate 
permanganate   300 ml distilled water 
 1 % (w/v) oxalic acid  1 g oxalic acid 
100 ml distilled water 
 Weigert’s haematoxylin  1 part solution A 
1 part solution B 
 0.1 % (w/v)Sirius Red  0.1 g Sirius red 
     100 ml saturated piric acid solution 
Sirius red stains collagen fibers, while Miller’s stains for elastin fibers. 
Following dewaxing and rehydration sections were immersed in potassium 
permanganate for 5 min then rinsed using distilled water. Sections were 
immersed in oxalic acid for 2 min then distilled water for 1 min then 4 min. 
Sections were then dehydrated in 70 % (v/v) ethanol for one min then 95 % 
(v/v) ethanol for one minute before being immersed in Millers stain for 1 h. 
Sections were rinsed in 70 % (v/v) ethanol until clear, immersed in 95 % 
(v/v) ethanol for 1 minute  then rinsed in running tap water for 2 min. 
Sections were immersed in Weigert’s haematoxylin for 10 min then rinsed in 
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running tap water for 1 min then distilled water for 30 sec. Sections were 
immersed in Sirius red for 1 h, rinsed in distilled water and blotted dry before 
being dehydrated and mounted (Section 2.2.3.6). Sections were viewed 
using polarized light microscopy. 
2.2.4.3 Alcian blue staining 
Alcian blue was used to stain cartilage proteoglycans, a counter stain of 
periodic acid and Schiff’s reagent (PAS) was used to stain other structures 
and nuclei were stained with haematoxylin (Gills III). Following dewaxing and 
rehydration sections were immersed in pre-made 1 % (w/v) alcian blue for 
15 min. Sections were rinsed in distilled water then immersed in pre-made 
periodic acid for 5 min. Sections were again rinsed (three times) in distilled 
water before immersion in Schiff’s reagent for 15 min. Sections were cleared 
in running tap water for 5 min before being immersed in haematoxylin for 90 
sec. Sections were returned to running tap water to clear before being 
dehydrated and mounted (Section 2.2.3.6). 
2.2.4.4 Van Gieson staining 
Reagents: 
 1.0 % (v/v) Acid alcohol  2 ml hydrochloric acid (37 %, v/v) 
200 ml 70 % (v/v) ethanol 
Van Gieson stains for collagen fibres, nuclei are stained with haematoxylin. 
Following dewaxing and rehydration sections were immersed in Weigert’s 
haematoxylin for 15 min, then running tap water for 15 min. Sections were 
then differentiated in acid alcohol for 2 min and cleared in running tap water 
for 3 min before being immersed in van Gieson stain for 3 min. Each section 
was blotted dry before being dehydrated and mounted. 
2.2.4.5 Safranin O/ fast green staining 
Reagents: 
 0.1 % (w/v) Safranin O  0.1 g safranin O 
     100 ml distilled water 
 0.02 % (w/v) Fast green  0.02 g fast green 
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100 ml distilled water 
 1.0 % (v/v) acetic acid  3 ml glacial acetic acid 
300 ml distilled water 
Safranin O stains proteoglycans while fast green stains collagen, nuclei are 
stained with Weigert’s haematoxylin. Following dewaxing and rehydration, 
sections were immersed in Weigert’s haematoxylin for 3 min then running 
tap water for 10 min. Sections were differentiated in 1 % (v/v) acid alcohol 
for 1 min then rinsed for 3 min in running tap water. Sections were immersed 
in fast green for 5 min before being rinsed in acetic acid for 10-15 sec. 
sections are immersed in safranin O for 4 min before being dehydrated and 
mounted.  
2.2.4.6 DAPI staining 
Reagents: 
 Sodium hydrogen    4.2 g sodium hydrogen carbonate 
carbonate buffer (1 M, pH 9.0) 500 ml distilled water 
 2.5 % (w/v) DABCO  (pH 9.0) 2.5 g 1,4-diazobicyclo-(2, 2, 2)- 
octane (DABCO) 
100 ml 1 M sodium hydrogen 
carbonate buffer 
 DABCO:glycerol mountant  10 ml 2.5 % (w/v) DABCO 
     90 ml glycerol 
 Dye Buffer (pH 7.4)   1.211 g Trizma base  
0.3724 g EDTA  
0.0058 g sodium chloride 
1 L distilled water 
 DAPI dye solution   10 mg DAPI 
10 ml nuclease free water 
 DAPI working solution (pH 7.4) 20 µl DAPI dye solution 
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200 ml dye buffer 
4’,6-diamidino-2-phenylindole (DAPI) binds DNA which enables cell nuclei 
and DNA remnants to be visualised. Following dewaxing and rehydration, 
sections were immersed in DAPI working solution for 10 min in the dark. 
Sections were then washed 3 times for 10 min each in PBS in the dark 
before being mounted in DABCO:glycerol. Sections were kept in the dark 
until visualised using an upright fluorescent microscope and a DAPI filter.  
 
2.2.5 Tissue culture 
Cells were cultured in cell culture medium (Section 2.1.6). All cell culture 
work was performed aseptically in a class II safety cabinet. Cultures were 
incubated at 37 °C in 5 % CO2 (v/v) in air. Before use, all culture medias and 
additives were equilibrated to 37 °C. 
2.2.5.1 Resurrection and maintenance of cells 
Following removal from liquid nitrogen storage, cells were thawed in a 37 °C 
water bath. Thawed cell stock (2 ml) was added to a T75 cell culture flask 
containing 13 ml of the appropriate, pre-warmed cell culture medium. Flasks 
were incubated for at least 18 h at 37 °C in 5 % CO2 (v/v) in air to allow cells 
to attach to the culture plastic. Culture medium was changed every 2-3 days 
until cells were confluent and could be passaged. 
2.2.5.2 Cell passaging 
Cell culture medium was aspirated and the monolayer gently washed two 
times with 10 ml PBS without calcium or magnesium. Trypsin/EDTA (1.5 ml) 
was added to the flask and incubated for 5 min at 37 °C in 5 % CO2 (v/v) in 
air. Flasks were gently tapped to detach cells and 10 ml culture medium was 
added to suspend cells and inhibit trypsin activity. The cell suspension was 
then centrifuged for 10 min at 150 g. The supernatant was carefully 
aspirated from the cell pellet, which was then resuspended in 5 ml culture 
medium. Following a count of viable cells (Section 2.2.5.3), the appropriate 
cell density was seeded into a fresh flask with culture medium and the 
medium replaced every 2-3 days until confluent and ready for passage 
again.  
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2.2.5.3 Cell viability 
In order to test the viability of cells, trypan blue was added to cell 
suspensions before counting. Trypan blue is able to enter dead cells due to 
a loss of membrane potential, so live cells microscopically appeared 
transparent while dead cells appeared blue and could therefore be excluded 
from cell counts. 
To perform a cell count, 20 µl cell suspension was added to 20 µl trypan blue 
and added to an Improved Neubauer counting chamber. Viable cells were 
counted in n number of grids which resulted in a cell count of between 100-
300 cells. The total number of cells per ml suspension was calculated as 
follows:  
                     
                      
 
                     
Where n = number of grids used in count and  
And Dilution factor = correction required due to dilution of cell suspension in 
trypan blue (in this case Dilution factor = 2) 
2.2.5.4 Cell cryopreservation 
Cells were harvested from flasks and a cell count performed as detailed 
previously (Section 2.2.5.2 and 2.2.5.3). Cells were resuspended at 106.ml-1 
in cryopreservation medium (DMEM containing 20 % (v/v) FBS and 10 % 
(v/v) filter sterilised dimethyl sulphoxide (DMSO)). Cell aliquots (1 ml) were 
put in cryovials and placed into cryofreezing pots containing isopropanol. 
Pots were frozen at -80 °C for 12 – 24 h following which vials were 
transferred to liquid nitrogen for long term storage.  
 
2.2.6 Statistical analysis 
2.2.6.1 Confidence limits 
Numerical data was analysed using Microsoft Excel (version 2007, 
Microsoft) and presented as the mean (n≥3) ± 95 % confidence level (CL). 
The 95% confidence intervals (α = 0.05) were calculated using the 
descriptive statistics part of the data analysis package in Microsoft Excel.  
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x =  Individual value 
n = Sample number  
∑ = Sum of 
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2.2.6.2 Statistical analysis 
The student’s t-test was used to compare groups of two means or a  one-
way analysis of variance (ANOVA) was used when comparing the means of 
more than two groups. Individual differences between group means were 
identified by calculating the minimum significant difference (MSD) at p = 0.05 
using the T-method, or T’-method when comparing groups of unequal 
sample size (Sokal & Rohlf, 1995). 
Q = Critical value 
α = p = 0.05 
k = number of groups 
v = degrees of freedom (n-1) 
       [   ]     
 
2.2.6.3 Arcsin transformation 
Where data is presented as a percentage or proportion, values were 
transformed to arcsin to allow accurate calculation of 95 % CL and statistical 
analysis. Following analysis, values were transformed back for presentation. 
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2.2.6.4 Linear regression analysis 
When interpolation of results was required, a linear regression analysis was 
performed on standard curves.  
          
                        
                                          
 
 
 
- 69 - 
Chapter 3  
Characterisation of porcine, bovine and ovine 
osteochondral tissues 
3.1 Introduction 
To provide successful long-term cartilage lesion repair, a biomaterial should 
closely mimic the function of natural articular cartilage. As discussed in 
Chapter 1, the composition and structure of cartilage is essential for the load 
bearing, low friction function of the tissue. The glycosaminoglycans (GAGs) 
within the cartilage matrix create a Donan osmotic pressure, reducing fluid 
flow within the tissue under loading, providing the compressive strength of 
cartilage, and reducing friction between solid phase components of the 
matrix. The collagen fibres provide tensile strength for the tissue (Mow et al., 
2005, Roughly, 2006). Variations in the biochemical composition and 
biological structure alter the function of articular cartilage.  
Here, it is proposed that the use of an acellular osteochondral biomaterial 
will enable successful repair of osteochondral lesions. Procedures to 
decellularise tissues are performed with the aim of producing an 
immunocompatible scaffold which retains the original tissue function, so the 
properties of any source material should be retained in the final scaffold. 
Cartilage biology, biochemical composition and biomechanical function 
(Athanasiou et al., 1991) varies between species and joint regions (Rogers 
et al., 2006). Before developing a decellularisation protocol it was sensible to 
assess the potential tissue sources currently available and to identify which 
species/joint region has properties most similar to that of human cartilage. 
Furthermore, assessment of composition will allow any cartilages with high 
GAG content to be identified, as sulphated proteoglycan concentration is 
known to be diminished following decellularisation using SDS (Stapleton et 
al., 2008; Elder et al., 2010; Kier et al., 2011; Crapo et al., 2011; Benders et 
al., 2013).  
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To achieve good clinical outcomes in osteochondral repair with an acellular 
xenogeneic scaffold it was therefore necessary to characterise and 
understand the biochemical composition, biological structure and 
biomechanical function of any potential source materials and chose a tissue 
with properties desirable in the decellularised scaffold. 
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3.2 Aims and objectives 
Aims: 
The aim of the study presented in this chapter was to characterise 
osteochondral tissues from various joint regions and species. The intention 
was to determine the most suitable material for use in the development of a 
decellularisation process. 
Objectives: 
 To qualitatively assess the osteochondral tissues using histology, 
looking at the general histoarchitecture, GAG distribution and to 
measure cellularity and cartilage thickness. 
 To quantify biochemical components of the cartilage, including 
sulphated proteoglycan, collagen and water content. 
 To characterise biomechanical properties of cartilage, measuring the 
percentage deformation and cartilage thickness, then to determine 
cartilage permeability and equilibrium elastic modulus using a finite 
element method. 
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3.3 Biological methods 
Osteochondral pins were collected from the acetabulum, femoral head, 
femoral groove, medial and lateral condyles and medial and lateral tibial 
plateau as described in Section 2.2.2. Porcine (~6 month old), bovine (~18 
month), ovine (~1 yr and >4 yr) and human cadaveric tissues were 
characterised. Acetabular tissues were not available from cows, so were not 
characterised in this study. 
 
3.3.1 Histological evaluation of osteochondral tissues 
The general histological methods used in this study can be found in Section 
2.2.3. 
 
3.3.2 Cell count 
Sections were stained with H&E and the resulting images were analysed 
using Image-Pro Plus software (Media Cybernetics). For each image n=6, 
500 µm2 regions were manually selected to sample cells from all three 
cartilage zones (two regions of superficial cartilage, two of middle zone 
cartilage and two of deep zone cartilage). All cells which fell in that defined 
region were counted manually. The mean number of cells was calculated for 
each image. Images from n=5 animals were counted for each joint region. 
The mean number of cells for each species and joint region and the 95 % CL 
were calculated.  
 
3.3.3 Thickness measurement 
Image-Pro Plus software (Media Cybernetics) was used to measure the 
thickness of cartilage from all animals, using images of sections stained with 
alcian blue. Measurements (n=6) were made through the depth of the 
cartilage at even intervals across the image, the cartilage-bone interface was 
defined as when the blue stain colour finished and became red/pink staining. 
Again, the mean thickness of each image was calculated, then the mean of 
n=5 animals determined plus 95 % CL for that species/ joint region. 
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3.4 Biochemical methods 
3.4.1 Sample preparation 
3.4.1.1 Lyophilisation 
Cartilage tissue was cut away from the subchondral bone and macerated. 
Samples were weighed three times and a mean wet weight calculated. 
Samples were placed in a freeze dryer (Thermo, Savant ModulyoD) at -50 
°C, 0.15 – 0.2 mbar, and the weight measured every 24 h until constant (48 - 
72 h). 
3.4.1.2 Papain digestion 
For sulphated proteoglycan quantification, macerated, freeze-dried tissues 
were digested using papain.  
 Digestion buffer (pH 6.0)  0.788 g L-cystine hydrochloride 
1.8612 g EDTA 
1 L PBS 
 Digestion solution   1250 U papain 
25 ml digestion buffer 
Papain digestion solution (5 ml) was added to 10 – 20 mg (dry weight) 
lyophilised cartilage in a bijou and incubated in a water bath at 60 °C for 36 – 
48 h, until fully digested. 
3.4.1.3 Acid hydrolysis 
For quantification of hydroxyproline residues, cartilage was macerated, 
lyophilised and hydrolysed in hydrochloric acid. Tissues (15 mg) were placed 
in polypropylene universals and 5 ml 6 M hydrochloric was added. Samples 
were incubated in a block heater at 120 °C for 8 - 16 h as verified in Figure 
3.1, before being neutralised with 6 M sodium hydroxide. 
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Figure 3.1 Hydroxyproline concentration after varying durations of acid 
hydrolysis. Data is displayed as the mean (n=3) ± 95 % CL. * Represents a 
significant difference from 16 h, one-way ANOVA (p< 0.05). 
 
3.4.2 Water content 
The percentage water content of tissue was determined by weighing before 
and after lyophilisation (Section 3.4.1.1). The water weight was calculated 
from the dry and wet weights and was then presented as percentage of 
tissue wet weight. 
 
3.4.3 GAG quantification 
Quantification of GAGs (sulphated/carboxylated proteoglycans) in tissues is 
possible by colorimetric analysis, using a method first developed by 
Farndale et al. (1982). Under acidic conditions the cationic dye 1,9- 
dimethylemethylene blue (DMB) undergoes metachromatic changes upon 
binding with carboxyl or sulphate groups of GAG chains, this can then be 
measured spectrophotometrically.  
Reagents: 
 Phosphate buffer (pH 6.8)  137 ml sodium di-hydrogen 
orthophosphate (0.1M) 
63 ml di-sodium hydrogen  
orthophosphate (0.1M) 
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 DMB dye (pH 3.0)   16 mg DMB 
5 ml ethanol 
2 ml formic acid 
2 g sodium formate 
Make up to 1 L with distilled water 
Method: 
Tissues were lyophilised and papain digested (Sections 3.4.11 & 3.4.1.2). 
Standard calibration solutions of dermatan sulphate were made up in 
phosphate buffer at 0, 3.125, 6.25, 12.5, 25, 50, 100, 150 and 200 µg.ml-1. 
Test samples were neat, or diluted 1:10, 1:25, 1:50, 1:100, 1:250, 1:500, 
1:1000 in phosphate buffer, a dilution of 1:50 was found to be optimal.  Each 
standard and sample (40 µl) were added to a clear,  96 well flat bottomed 
plate in triplicate, to which 250 µl DMB dye was added. Plates were gently 
shaken for 2 min on a plate shaker before the optical density of each well 
was read at 525 nm using a micro plate spectrophotometer. A standard 
curve was plotted of the absorbance of the dermatan sulphate standards vs 
concentration, linear regression analysis was performed (Section 2.2.6.4) to 
interpolate the GAG concentration of test samples based on their 
absorbance. Dilution factors were then accounted for, and the concentration 
of GAG was determined for tissue dry weight.  
 
3.4.4 Hydroxyproline quantification 
Hydroxyproline residues are a major constituent of collagen, and are unique 
to this protein in articular cartilage. Hydroxyproline residues can be oxidised 
to pyrroles which produce a red chromophore with p-
dimethylaminobenzaldehyde, this can then be measured colorimetrically. 
This method is based on that of Edwards & O’Brien (1980). The 
hydroxyproline levels can then be used to calculate collagen content. 
Reagents: 
 Hydroxyproline buffer (pH 6.2) 13.3 g citric acid 
3.2 ml glacial acetic acid 
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      32 g sodium acetate 3 hydrate 
      9.1 g sodium hydroxide 
      80 ml propan-1-ol 
      Made up to 400 ml with distilled 
      water 
 Chloramine T   1.41 g Chloramine T 
100 ml distilled water 
 Ehrlich’s reagent   7.5 g p-dimethylbenzaldehyde 
30 ml propan-1-ol 
13 ml 62 % (v/v) perchloric acid 
Made up to 50 ml with distilled 
water 
Method: 
Samples were lyophilised and acid hydrolysed (Section 3.4.1.1 & 3.4.1.3). 
Standard concentrations of trans-4-hydroxy-L-proline were made up in 
hydroxyproline buffer at 0, 2, 4, 6, 8, 10, 15, 20, 25 & 30 µg.ml-1. Test 
solutions were neat and diluted 1:5, 1:10, 1:25, 1:50, 1:100 in assay buffer, a 
dilution of 1:10 was found to be optimal. Standard and test solutions (50 µl) 
were added to a clear, flat bottomed 96 well plate in triplicate. Chloramine T 
(100 µl) was added to each well and the plate shaken gently for 5 min to 
oxidise the hydroxyproline residues. Ehrlich’s reagent (100 µl) was then 
added to each well and the plate incubated in a water bath at 60 °C for 45 
min. The optical density of each well was then measured at 570 nm using a 
micro plate spectrophotometer. A standard curve was produced of 
absorbance vs. concentration, from which the hydroxyproline concentration 
of test samples could be interpolated. Neutralisation and dilution factors 
were accounted for and the hydroxyproline concentration was determined for 
cartilage dry weight. 
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3.5 Biomechanical methods 
3.5.1 Creep indentation 
In order to assess the time dependent biomechanical behaviour of articular 
cartilage, osteochondral pins underwent creep indentation. The equipment 
used is shown in Figure 3.2. Pins were secured in a collet, mounted in a 
sample holder  and submerged in PBS to maintain cartilage hydration 
(Figure 3.3). An impermeable, stainless steel, hemispherical indenter (3 mm 
diameter) was used to indent the cartilage with a load of 0.82 N over 1 h. 
The indenter was positioned ~ 1 mm above the cartilage surface and the 
lowering of the indenter shaft was controlled via a silicone oil filled dashpot, 
to reduce the speed of impact, the full load was applied within 0.2 sec. The 
displacement of the indenter was measured using a linear variable 
differential transducer (LVDT; RDP D5-200H, Electrosence, PA, USA) and 
the resistance force measured using a piezo-electric force transformer (Part 
No. 060-1896-02, Electrosence, PA, USA). LabView 8 software (National 
Instruments, TX, USA) was used to collect and store data produced by the 
force transducer and LVDT.  
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Figure 3.2 Indentation apparatus. The equipment used to perform creep 
indentation testing to determine deformation of osteochondral pins.  
 
 
 
Figure 3.3 Sample holder and indenters. A – collet, collet holder and 
sample bath, B – Pin held in place, C – hemispherical and needle indenters 
used during testing. 
A B C 
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3.5.1.1 Calibration† 
Calibration was required to convert the voltage outputs of the LVDT and 
force transducer into millimetres and Newtons respectively. Standard steel 
slip gauges were used to calibrate the LVDT, the voltage was recorded for 
each height increase following the addition of slip gauges. Voltage was 
plotted against slip gauge height and the linear trend line calculated, the 
equation of which was used as a calibration factor (Figure 3.4). 
 
Figure 3.4 LVDT calibration. Calibration of LVDT from the indentation 
apparatus using standard height slip gauges to determine factor to convert 
output voltage to displacement. 
 
To calibrate the force transducer, the voltage was recorded over incremental 
increases of known mass. This again, was plotted as a graph and the 
equation of the trend line used to convert voltage to Newtons (Figure 3.5). 
                                            
† Work performed by Abdellatif Abdelgaied 
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Figure 3.5 Load cell calibration. Calibration of the load cell from the 
indentation apparatus using standard known masses to determine the factor 
to convert output voltage to load. 
 
3.5.2 Needle indentation  
The thickness of cartilage was measured in order to normalise deformation 
data for each osteochondral pin so that the percentage deformation could be 
presented and the material properties could be derived. Cartilage thickness 
was assessed using needle indentation. An Instron material testing machine 
(Instron 3365, Bucks, UK) was used for this purpose (Figure 3.6). 
Osteochondral pins were secured in a PBS bath as described in Section 
3.5.1, a needle attached to the instron arm was manually positioned ~1 mm 
above the cartilage surface. During testing the arm was controlled via a PC 
graphic user interface and lowered at a rate of 4.5 mm.min-1. The resistance 
to motion was measured using a 500 N load cell.  
Cartilage thickness was defined as the distance between the increase in 
resistance from initial needle contact with the surface and the steep increase 
in resistance from needle contacting the much stiffer bone (Figure 3.7). Each 
pin was indented 6 times and the mean thickness calculated.  
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Figure 3.6 Instron material testing machine. Equipment used to indent 
osteochondral pins with a needle indenter to determine cartilage thickness. 
 
 
Figure 3.7 Needle indentation graph interpretation. This schematic 
shows how cartilage thickness was determined from needle indentation. 
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3.5.3 Finite element method for derivation of material properties 
Cartilage deformation curves generated in Section 3.5.1 along with cartilage 
thicknesses measured in Section 3.5.2 were used to derive the permeability 
and equilibrium elastic modulus of cartilage. An axisymmetric biphasic 
poroelastic finite element (FE) model (ABAQUS, version 6.9-1 Dassault 
Systemes, Suresnes Cedex, France) created and published by Pawaskar et 
al. (2010, 2011) was used for the derivation of these properties (Figure 3.8). 
 
Figure 3.8 Finite element model of an osteochondral pin. This schematic 
shows the axis of symmetry, and the imposed fluid flow restrictions. 
Cartilage was modelled as a poroelastic material and meshed using four-
node bilinear displacement and pore pressure axisymmetric elements 
(CAX4P), cartilage was assigned the water content  value calculated in 
section 3.4.2 and a Poisson’s ratio of zero was assumed. Bone was meshed 
using four-node bilinear elastic axisymmetric elements (CAX4), A Poisson’s 
ratio of zero and was assigned and elastic modulus of 17 GPa (Pawaskar, 
2010). 
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The FE model mimicked the method for collecting experimental data 
(Section 3.5.1), the load was increased from 0 – 0.82 N over 2 sec through 
the indenter and was applied for 3600 sec in total. A deformation/time graph 
was produced by the FE model based on the material properties (equilibrium 
elastic modulus and permeability) set. The closeness of fit between the final 
30 % of the FE generated and experimental curves was assessed using 
MATLAB (version 7.4, MathWorks Inc, Boston, MA, USA; Figure 3.9). The 
input material properties were incrementally changed to minimise squared 
error, an R2 value greater than 0.6 was accepted as significant for biological 
tissues. The material properties input into the FE model which gave the 
highest R2 were taken as the equilibrium elastic modulus and permeability 
for that cartilage. 
 
Figure 3.9 Experimental and modelled cartilage displacement curves. 
The FE modelled curve was fitted to the deformation curve produced by 
experimental data to reach the highest possible agreement by altering the 
input material properties. 
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3.6 Results 
3.6.1 Macro scale observations 
Upon dissection, physical differences were observed between species. The 
length of the femurs from femoral head to the front of the condyles was ~ 20 
cm in both pigs and sheep; however this was double in cows, ~ 40 cm 
(Figure 3.7). This size difference was reflected in the size of the joints; the 
bovine femoral head measured ~ 8 cm from the terres ligament to femoral 
neck, while the porcine was ~ 4 cm and ovine only ~ 2 cm. This pattern in 
joint size was seen for both the hip and knee. Cartilage generally appeared 
white, glossy and healthy with exception of ovine (> 4 yr) cartilage which had 
a yellowed appearance in most cases. Upon drilling, the bone of porcine and 
young ovine was notably softer than that of bovine and older ovine samples. 
Old ovine bone, despite being hard, was also found to be quite brittle when 
cores were extracted from the joints. 
 
 
Figure 3.10 Dissected femurs. a) porcine, b) bovine, c) ovine ~ 1 yr and d) 
ovine > 4 yr. 
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3.6.2 Histological evaluation of cartilage 
3.6.2.1 H&E 
H&E staining of osteochondral sections from each species showed 
characteristic cell orientation (Figure 3.11), with smaller flattened cells at the 
superficial zone becoming rounder and more randomly distributed in the 
middle zone and then forming linear columns perpendicular to the cartilage 
surface in the deep zone. This characteristic cell organisation was less 
pronounced in porcine (a) and young ovine (c) cartilage and cells in the deep 
zone showed a more hypertrophic appearance. 
 
Figure 3.11 H&E staining of cartilage from the medial condyle. a) 
porcine, b) bovine, c) ovine ~1 yr, d) ovine > 4 years. Size bars are 500 µm. 
 
3.6.2.2 Alcian blue 
Alcian blue staining of osteochondral sections from each species showed 
characteristic proteoglycan distribution (Figure 3.12). All cartilage tissues 
showed strong alcian blue staining in the middle and deep zones, while the 
superficial zones and deep calcified cartilage and bone showed reduced 
a b 
c d 
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alcian blue staining, highlighted by the presence of pink periodic acid-Schiff 
counterstaining.  
 
Figure 3.12 Alcian blue and periodic acid-Schiff staining of cartilage 
from the medial condyle. a) porcine, b) bovine, c) ovine ~1 yr, d) ovine > 4 
years. Size bars are 500 µm. 
 
3.6.3 Cell count 
From the images of H&E stained sections a cell count was performed to 
identify cell density of cartilage from the different species and joint areas. 
Cartilage from the younger animals (pig and young sheep) tended to have 
the highest concentration of cells and cartilage from old sheep was least 
cellular, this trend was significant in a number of joint regions (Figure 3.13). 
Within species, cartilage from the porcine tibial plateau had a significantly 
higher cell concentration that cartilage from the femoral groove, unlike 
bovine tibial plateau cartilage, which was significantly less cellular than all 
other joint regions except for the femoral head. Old ovine cartilage from the 
acetabulum and medial tibia had significantly fewer cells than other joint 
regions. No significant difference was seen in young ovine cartilage 
cellularity across joint regions (p<0.05 ANOVA).   
a b 
c d 
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Figure 3.13 Cellularity of cartilage from various joint regions of the pig, 
cow and sheep. Data is expressed as the mean (n=5) ± 95 % confidence 
limits. Data for a given tissue site was analysed by one-way analysis of 
variance and individual means compared by the T-method. * indicates 
p<0.05. 
 
3.6.4 Cartilage thickness measurement 
Thickness of cartilage for each species was measured from digital images of 
the stained sections (Figure 3.14). Ovine cartilage tended to be thinner than 
porcine and bovine cartilage, significantly so in a number of joint regions.  
Porcine tibial cartilage was significantly thinner than that of the groove and 
medial condyle, young ovine femoral head cartilage was significantly thinner 
than that of the medial tibia, no significant difference between joint areas 
was seen in bovine or old ovine (p<0.05 ANOVA). There was a trend toward 
cartilage of the condyles and femoral groove being thicker than other joint 
regions. 
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Figure 3.14 Thickness of cartilage from various joint regions of the pig 
cow and sheep. Data is expressed as the mean (n=5) ± 95 % confidence 
limits. Data for a given tissue site was analysed by one-way analysis of 
variance and individual means compared by the T-method .  * indicates 
p<0.05. 
 
3.6.5 Water content 
The water content of cartilage did not vary significantly between any species 
except for bovine lateral tibial cartilage which had a significantly higher water 
content than cartilage from the lateral tibia of older sheep (Figure 3.15). 
Significant intra-species water content variation was only seen in bovine 
cartilage, with that from both sides of the tibia having a significantly higher 
water content than bovine femoral head and medial groove cartilage, 
cartilage from the lateral tibia also had significantly higher water content than 
from the bovine femoral head (p<0.05 ANOVA). All cartilages had a water 
content between 70 - 82 %. 
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Figure 3.15 Water content of cartilage from various joint regions of the 
pig cow and sheep. Data was subject to arcsin transformation prior to 
calculation of the 95% confidence limits and analysis of variance. Data is 
expressed as the back transformed mean (n=5) ± 95 % confidence limits. 
Data for a given tissue site was arcsine transformed then analysed by one-
way analysis of variance and individual means compared by the T-method .  
* indicates p<0.05.   
 
3.6.6 GAG quantification 
The GAG content of porcine cartilage was significantly higher than that of 
other species in a number of joint regions (Figure 3.16), cartilage from old 
sheep tended to have the lowest GAG concentration. There was a trend 
seen  across the joint regions, similar to that seen for cartilage thickness, 
with femoral knee (groove & condylar) cartilage having higher concentrations 
of GAGs compared to other joint regions. In the pig, cartilage of the groove 
and both condyles had a significantly higher GAG content than that of the 
medial side of the tibial plateau, only the medial condyle and groove showed 
higher concentration than the lateral side. Cartilage from the medial condyle 
of the older sheep had a significantly higher GAG content than that of the 
acetabulum, groove and tibia. Cartilage of the bovine lateral condyle had 
significantly fewer GAGs than the medial tibia (p<0.05 ANOVA). 
 
- 90 - 
 
Figure 3.16 GAG content of cartilage from various joint regions of the 
pig cow and sheep. Data is expressed as the mean (n=5) ± 95 % 
confidence limits. Data for a given tissue site was analysed by one-way 
analysis of variance and individual means compared by the T-method .  * 
indicates p<0.05. 
 
3.6.7 Hydroxyproline quantification 
Quantification of hydroxyproline content (relative to collagen content) 
showed there was an inverse relationship to GAG content (Figure 3.17). 
Porcine cartilage had the highest GAG content in most regions, and had the 
lowest hydroxyproline content, whereas old ovine cartilage had low GAG 
content, but had highest hydroxyproline content. Cartilage of the porcine 
lateral condyle had significantly lower hydroxyproline content than that of the 
medial condyle, there were no other significant differences within species 
(p<0.05 ANOVA). 
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Figure 3.17  Hydroxyproline content of cartilage from various joint 
regions of the pig cow and sheep. Data is expressed as the mean (n=5) ± 
95 % confidence limits. Data for a given tissue site was analysed by one-
way analysis of variance and individual means compared by the T-method .  
* indicates p<0.05.   
 
3.6.8 Percentage deformation 
The mechanical properties of cartilage from the different species and joint 
regions are shown in Figure 3.18 and Table 3.1, detailing the percentage 
deformation of cartilage after one hour, the permeability, elastic equilibrium 
modulus and thickness of each tissue. Properties could not be determined 
for ovine groove cartilage as the joints were too small to collect suitable pins.  
Cartilage of the hip (femoral head and acetabulum) tended to have a lower 
percentage deformation than that of the tibial plateau and lateral condyles. 
Porcine tibial cartilage showed significantly greater percentage deformation 
than all other joint areas. Bovine lateral condyle and lateral tibial cartilage 
had significantly higher percentage deformation than that of the femoral 
head and medial condyle and tibia. Cartilage from the young ovine 
acetabulum deformed significantly less than that of the femoral head. 
Acetabular cartilage from the older sheep had a significantly lower 
percentage deformation than cartilage from the lateral condyle and tibial 
plateau, and acetabular cartilage from young sheep and pigs.  
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Figure 3.18 Percentage deformation of cartilage from various joint 
regions of the pig cow and sheep. Data was subject to arcsin 
transformation prior to calculation of the 95% confidence limits and analysis 
of variance. Data is expressed as the back transformed mean (ovine 8-12 
months, acetabulum and groove n=5; all other n=6) ± 95 % confidence 
limits. Data for a given tissue site was arcsine transformed then analysed by 
one-way analysis of variance and individual means compared by the T-
method .  * indicates p<0.05.  a) From Taylor et al. (2011), b) from McLure et 
al. (2012), all other data from the present study. 
 
3.6.9 Equilibrium elastic modulus, permeability and thickness 
The equilibrium elastic modulus was generally lowest for  porcine cartilage, 
increasing in bovine then young ovine cartilage, with old ovine having a 
much higher equilibrium elastic modulus than the other species. A trend was 
seen across the joint regions in all species, with cartilage of the tibial plateau 
having a lower elastic modulus than the femoral knee and hip.  
Permeability showed an inverse relationship with equilibrium elastic 
modulus. Old ovine cartilage was the least permeable tissue and porcine 
tended to be most permeable. Permeability was highest in the tibial plateau 
and cartilage of the hip had the lowest permeability. 
 Equilibrium elastic 
modulus Porcine Bovine Ovine (8-12 month) Ovine (> 4 years) 
(MPa) Mean R
2
 Mean R
2
 Mean R
2
 Mean R
2
 
Acetabulum 1.30 0.99 - - 1.69 0.98 4.32 0.91 
Femoral head 
a
1.13
 
0.97 
a
1.59 0.91 1.22 0.94 
a
2.52 0.95 
Groove 1.04 0.93 0.86 0.94 - - - - 
Medial condyle 
b
0.74 0.63 
b
1.17 0.80 1.31 0.99 
b
2.04 0.89 
Lateral condyle 
b
0.66 0.67 
b
0.81 0.81 1.42 0.98 
b
2.02 0.86 
Medial tibia 
b
0.88 0.86 
b
0.85 0.73 0.95 0.99 
b
2.02 0.87 
Lateral tibia 
b
0.70 0.86 
b
0.81 0.85 1.19 1.00 
b
1.96 0.82 
         Permeability, k Porcine Bovine  Ovine (8-12 month) Ovine (> 4 years) 
x10
-16
 (m4/Ns) Mean R
2
 Mean R
2
 Mean R
2
 Mean R
2
 
Acetabulum 3.04 0.99 - - 1.12 0.98 0.37 0.91 
Femoral head 5.70 0.97 1.78 0.91 2.99 0.94 0.76 0.95 
Groove 4.49 0.93 6.33 0.94 - - - - 
Medial condyle 7.18 0.63 4.49 0.80 2.91 0.99 1.64 0.89 
Lateral condyle 6.77 0.67 5.45 0.81 2.73 0.98 1.59 0.86 
Medial tibia 8.09 0.86 4.52 0.73 3.67 0.99 1.30 0.87 
Lateral tibia 10.29 0.86 5.75 0.85 2.87 1.00 1.37 0.82 
         
Table 3.1a Material properties of cartilage from various joint regions of the pig, cow and sheep. 
  
 Thickness Porcine Bovine  Ovine (8-12 month) Ovine (> 4 years) 
(mm) Mean 95% CL Mean 95% CL Mean 95% CL Mean 95% CL 
Acetabulum 1.12 0.15 - - 0.85 0.12 1.06 0.45 
Femoral head 1.22 0.05 1.32 0.13 0.48 0.07 0.52 0.10 
Groove 1.70 0.53 1.36 0.10 - - - - 
Medial condyle 2.23 0.20 1.28 0.17 0.87 0.12 0.71 0.24 
Lateral condyle 2.08 0.23 0.93 0.15 0.80 0.22 0.55 0.18 
Medial tibia 0.87 0.15 1.70 0.36 0.76 0.23 0.61 0.24 
Lateral tibia 0.82 0.08 1.02 0.21 0.70 0.28 0.59 0.27 
Table 3.1b Material properties of cartilage from various joint regions of the pig, cow and sheep. 
Thickness data is expressed as the mean (ovine 8-12 months, acetabulum and groove n=5; all other n=6) ± 95 % confidence limits, 
Elastic equilibrium modulus and permeability data was modelled on mean deformation data and R2 values for modelled and 
experimental deformation curve agreement are presented. a) from Taylor et al. (2011), b) from McLure et al. (2012), all other data 
from the present study.  
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3.7 Discussion  
A xenogeneic source material for decellularisation should have properties as 
similar as possible to those of human osteochondral tissues to improve the 
chances of clinical success. Additionally a higher GAG content in source 
materials compared to that of human cartilage may be beneficial, as GAGs 
are depleted following decellularisation with SDS which can result in 
diminished mechanical properties (Stapleton et al., 2008; Elder et al., 2010; 
Kier et al., 2011; Crapo et al., 2011; Benders et al., 2013).  The work in this 
chapter looked at the biological, biochemical and biomechanical properties 
of different osteochondral tissues. Porcine, bovine and ovine  osteochondral 
tissues from various regions of the hip and knee were assessed to 
determine the most suitable source material for the development of a 
decellularisation protocol.  
Initial macroscopic observations of cartilage from the different species 
showed that old ovine cartilage (>4 years) had a yellowed appearance seen 
in older cartilage tissues (Altman, 1987), usually attributed to the presence of 
advanced glycation end products (Bank et al., 1998). These non-enzymatic 
crosslinks affect the mechanical properties of tissues,  increasing the 
stiffness (Bank et al., 1998; Verzijl et al., 2002). Yellowed, aged ovine 
cartilage would make and inferior substitute for healthy young cartilage in 
vivo. Joint size may impact on the usefulness of species as donors of 
osteochondral tissues, as a greater number of osteochondral samples can 
be harvested from a bovine joint compared to a porcine joint, and even more 
so than a small ovine joint. When drilling, the apparent softness of porcine 
and to some extent younger ovine bone highlighted the skeletal immaturity 
of these tissues.  
H&E staining of cartilage tissues showed varying extents of cell organisation, 
the highly ordered cell orientation seen in bovine and old ovine cartilage was 
indicative of mature tissues, while the lack of organisation and the increased 
presence of hypertrophic chondrocytes showed the relative immaturity of 
porcine and young ovine cartilages. As in humans, the cellularity of animal 
cartilage decreased with age (Stockwell, 1976), with older sheep (>4 years) 
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having fewest cells and pigs (6 months) having the most. Porcine cartilage 
cellularity varied according the thickness of the cartilage from the different 
joint regions, so cartilage from the groove, which was significantly thicker 
than that from the tibia, also had significantly fewer cells. Thicker cartilage 
has been reported to have lower cell density than thin cartilage (Stockwell 
1971). A source material with fewer cells would be preferable for 
decellularisation. 
Cartilage thickness has been reported to increase as body weight increases 
(Stockwell, 1971). This was not necessarily supported by the work in the 
current chapter. Sheep, with a lower body mass than pigs or cows did have 
thinner cartilage, however, bovine cartilage was thinner than porcine, despite 
cows having greater body mass.  Julkunen et al. (2009) showed that 
cartilage thickness varies with skeletal maturity, that immature animals have 
thick cartilage and that cartilage thickness decreases with maturity. This was 
supported here by the comparison of two age groups of sheep, with the 
mature ovine cartilage tending to be thinner than that of sheep around 1 year 
of age. In all species, cartilage of the groove and condyles tended to be 
thicker than that of the hip and tibia, this trend was also seen when 
comparing the thickness of cartilage from the same joint regions in humans 
(Athanasiou et al., 1991; Shepherd & Seedhom, 1999a; Thambya et al., 
2006). Simon et al. (1973) identified a relationship between cartilage 
thickness and joint congruity, with more congruent joints such as the hip 
having thinner cartilage than that of less congruent joints such as the knee. 
Human cartilage, on average, tended to be thicker than that of any of the 
species studied for a given joint region. Shepherd & Seedhom (1999a) 
report the thickness of human femoral head cartilage to range between 1.08-
2.40 mm whereas ovine cartilage was only ~ 0.68 mm in this area, porcine 
1.14 mm and bovine 1.53 mm. Cartilage from the human femoral groove 
ranged between 1.76-2.59 mm, ovine cartilage was again much thinner; 0.86 
mm in young sheep and 0.63 mm in old sheep. Cartilage from the porcine 
groove was 2.04 mm and bovine 1.52 mm, within or approaching the range 
of human cartilage thickness. The relative thickness of human cartilage 
probably reflects the increased loads placed on human knee cartilage due to 
the bipedal posture, as discussed by Stockwell (1971). For an acellular 
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xenogenic osteochondral graft to integrate and function well when implanted 
in a human joint, it is likely that a graft with similar thickness to the 
surrounding host cartilage would be best, therefore porcine and bovine 
tissues have preferred cartilage thickness for this purpose.  
The GAG content of cartilage from each species was assessed qualitatively 
with alcian blue staining of tissue sections and quantitatively using a 
colourimetric assay with DMB dye. Qualitatively, all species showed 
characteristic zonal distribution of sulphated proteoglycans. Only staining of 
old ovine cartilage showed a distinct tidemark below which acidic mucins 
were not found, suggesting that this tissue was fully mature. Quantitatively, 
porcine cartilage had the highest GAG concentration, likely due to the young 
age of the tissue, as the concentration of proteoglycans is reportedly higher 
in immature cartilage, and decreases with age (Roughley & White, 1980). It 
has been suggested that age related reductions in cartilage GAG 
concentration are due to changes in chondrocyte activity; aggrecan and link 
protein synthesis decreases with maturity (Bolton et al., 1999). Except for 
cartilage of the medial condyle, there was no significant difference in the 
GAG content of bovine and ovine cartilage. A continuing trend showed 
cartilage of the groove and condyles having higher GAG content than other 
joint regions. The relationship in these joint areas of increased GAG content 
alongside increased thickness has been observed when tissues undergo 
increased loading or activity (Kiviranta et al., 1987). However, forces acting 
on the healthy knee are reportedly lower than those of the hip (Paul, 1976). 
This trend across the joint regions may again be due to the congruence of 
the joints, affecting the contact area and therefore stresses. Increased load 
on a very local scale may cause specific remodelling at that site, to increase 
thickness and GAG concentration so to decrease contact pressure. 
Information on human cartilage GAG content is limited in the literature. 
Various figures have been quoted for the GAG concentration of cartilage 
from the femoral head, Vilim & Krajickova (1991) quote 54.7 and 38.6 mg.g-1 
GAG per wet weight cartilage from two donors, while Hollander et al. (1991) 
reported values ranging between 25 – 40 μg.mg-1 wet weight. In the current 
study, porcine femoral head cartilage was 78 ± 30 µg.mg-1, bovine was 68 ± 
8 μg.mg-1, young ovine was 45 ± 18 μg.mg-1 and old ovine was 62 ± 16 
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μg.mg-1, all higher than values reported for human cartilage. GAG content 
was reported to be between 5-10 % total cartilage mass, as described for 
human cartilage by Mow et al. (2005). All species have a relatively high GAG 
content compared to human cartilage, however, as loss of GAGs is a 
limitation in decellularisation processes with SDS (Stapleton et al., 2008; 
Elder et al., 2010; Kier et al., 2011; Crapo et al., 2011; Benders et al., 2013), 
porcine cartilage, with the highest GAG content would be preferred.  
The hydroxyproline content of cartilage from different species showed an 
inverse relationship with GAG content. Porcine cartilage had highest GAG 
content, but also had lowest hydroxyproline content. Muir et al. (1970) found 
great variation in human cartilage collagen content between individuals and 
joint regions, no correlation between collagen content and age was seen. 
The present study only quantitatively assessed collagen content of articular 
cartilage and did not investigate collagen fibre alignment or the ratios of 
different collagens present within the cartilage. Although collagen content 
appeared constant across species and joint regions there may be qualitative 
differences which have not been identified here.  
Water content of the cartilages from different species and joint areas did not 
vary significantly on the whole, only significant differences were seen with 
bovine tibial cartilage. The water content of human cartilage varies between 
68-85 % (Mow et al., 2005), the water content of cartilage from all joint 
regions and species lies within this range. Any species would therefore 
make an acceptable starting material, in terms of cartilage water content, 
however this parameter may differ once the tissue has undergone 
decellularisation.  
Percentage deformation of cartilage appeared to vary with joint region, 
cartilage of the tibia tended to have higher deformation than the hip, this was 
reflected in the equilibrium elastic modulus derived for each type of tissue, 
with tibial cartilage showing a lower modulus. Tibial cartilage, with low GAG 
content, had higher permeability. As proteoglycans are responsible for 
restriction of fluid flow through the tissue, increased fluid flow results in 
reduced load supported by the fluid phase so tissues showed greater 
deformation. The relationship between material properties and 
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biological/biochemical composition was most pronounced in the bovine 
knee; cartilage of the medial condyle and medial tibia was thicker and had 
higher GAG content than its lateral counterpart, cartilage of the medial side 
of each joint also showed lower permeability, and stiffer equilibrium elastic 
modulus (lower percentage deformation). 
Porcine cartilage was least stiff, and cartilage from old sheep was most stiff. 
Despite young ovine cartilage having higher GAG content, old ovine 
cartilage was stiffer, bovine cartilage was also stiffer than porcine cartilage, 
again despite the GAG content of porcine cartilage being higher. This is 
possibly due to the quality of the GAGs within these younger tissues. 
Cartilages from these more skeletally mature animals may have more 
effective proteoglycan structures which are more adequately immobilized 
within the cartilage matrix resulting in lower permeability and stiffer cartilage. 
As mentioned previously, old ovine cartilage had a yellowed appearance 
indicative of the presence of advanced glycation end products, the increased 
crosslinking of the collagen matrix results in a stiffer cartilage , which may 
explain the reduced deformation and increased equilibrium elastic modulus 
of old ovine cartilage (Bank et al., 1998; Verzijl et al., 2002). Old ovine 
cartilage being stiffer than bovine may be an effect of yet further maturity in 
GAG structures or an effect of ovine cartilage being much thinner than 
bovine. In this study, thinner cartilage tended to have a stiffer equilibrium 
elastic modulus. The equilibrium elastic modulus of bovine lateral condyle 
cartilage was similar to the equilibrium aggregate modulus quoted for human 
(0.70 MPa) and bovine (0.89 MPa) previously (Athanasiou et al., 1991; Mow 
et al., 2005). Porcine cartilage also had a similar elastic modulus, but was 
lower; this was possibly as a result of having softer subchondral bone. Old 
ovine cartilage had a much higher elastic modulus, so may be too stiff to 
replace human cartilage. Cartilage from all species was less permeable than 
values reported for human cartilage (Mow et al., 2005; Athanasiou et al., 
1991).  
Many of the differences seen in cartilage properties in the current chapter 
appear to be as a result of animal age and therefore skeletal maturity. The 
age of the species considered in this study was restricted by the availability 
of animals bred from the food chain for human consumption. Not only should 
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the specific parameters of each cartilage be considered here, but the 
potential pros and cons of using a skeletally mature versus a more 
biologically active immature tissue as a osteochondral scaffold as the 
regenerative capacity may differ. 
The characterisation of cartilage from different species and joint areas was 
carried out with the aim of identifying a source material for decellularisation 
with properties as similar as possible to those of human cartilage. Porcine 
cartilage from 6 month old animals was the thickest of all cartilages studied, 
however was not as thick as human. The GAG content of porcine cartilage 
was high, however cartilage was highly cellular and did not have a fully 
defined structure due to the immaturity of the tissue. Bovine cartilage from 
18 month old animals, conversely, was mature. The GAG content of bovine 
cartilage was lower than that found for porcine cartilage, but still within the 
range of human tissues. Bovine cartilage was also relatively thick. Both 
porcine and bovine cartilages had an equilibrium elastic moduli similar to the 
equilibrium aggregate modulus reported for human cartilage. Ovine cartilage 
from both age ranges was very thin, young ovine cartilage was not fully 
mature with high cell density and less well defined structural organisation. 
Ovine cartilages had lower GAG content than porcine.  
Based on the parameters characterised in this chapter, osteochondral 
tissues from the porcine medial condyle and bovine medial groove were 
identified as the most suitable source materials for development of an 
osteochondral decellularisation protocol. 
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Chapter 4  
Development of a protocol for the 
decellularisation of bovine osteochondral 
tissues 
4.1 Introduction 
Surgical repair techniques for osteochondral lesions have shown varying 
degrees of efficacy, producing fibrocartilaginous repair tissue in the case of 
microfracture (Steinwachs et al., 2008; Lützner et al., 2009), or in the case of 
procedures such as autologous chondrocyte implantation (ACI) or 
mosaicplasty producing more hyaline-like repair materials but with varying 
degrees of donor site morbidity (Chaing & Xiong, 2009; Minas et al., 2001; 
Koulalis et al., 2004).  Tissue engineering approaches have focused upon 
production of synthetic or natural scaffold materials, which avoid issues with 
donor site morbidity, but are unable to produce a hyaline-like repair tissue 
with the same composition, structure and function of natural articular 
cartilage (Frenkel & di Cesare, 2004). 
Decellularisation of xenogeneic tissues has the potential to produce a 
natural extracellular matrix (ECM) scaffold, with the same biological, 
biochemical and biomechanical characteristics of natural tissue, and does 
not require tissue harvesting from a host donor site. Ideally, the 
decellularisation process will remove all immunogenic proteins and avoid 
issues of immunological rejection upon implantation (Crapo et al., 2011).  
As discussed in Chapter 1, the ECM plays a key role in the function of 
articular cartilage as a low friction, load distributing tissue. In addition, it is 
understood that the molecularly diverse natural ECM is biologically active, 
having involvement in chemotaxis, cell mitogenesis (Bornstein & Sage, 
2002) and differentiation and promoting tissue homeostasis.  These 
attributes are thought to stem from the specific microarchitecture, surface 
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topology and composition of the ECM (Crapo et al., 2011). This interactivity 
with cells may facilitate the recellularisation and regeneration of acellular 
ECM more effectively than synthetic or artificially arranged natural material 
scaffolds, potentially resulting in improved clinical outcomes.   
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4.2 Decellularisation of natural tissues 
There are many different methods which can be employed to decellularise 
tissues including chemical, enzymatic and physical techniques which can be 
used to varying extents depending on the type of tissue being treated. An 
acellular tissue, as defined by Crapo et al. (2011), should meet the following 
criteria: 
 <50 dsDNA per ECM dry weight 
 <200 bp DNA fragment length 
 Lack of visible nuclear material in tissue sections stained with DAPI or 
H&E  
Most decellularisation processes use a combination of chemical, enzymatic 
and physical methods to achieve adequate decellularisation of natural 
tissues. Each of these approaches is discussed below. 
 
4.2.1 Chemical methods 
4.2.1.1 Acids and bases 
Acids and bases can hydrolyse biomolecules, this enables solubilisation of 
cellular membranes and removal of nucleic acids. Peracetic acid (PAA) has 
been successfully used at low concentrations (0.1 % v/v in 4% v/v ethanol)  
as a decellularisation agent for a number of thin tissues, including porcine 
small intestinal submucosa (SIS) and layers of the urinary bladder with 
minimal effect on the ECM structure (Freytes et al., 2004; Gilbert et al., 
2008). Higher concentrations of PAA (5 % v/v) have, however, been shown 
to greatly alter the ECM structure (Wu et al., 2011). Concomitantly with 
decellularisation, PAA is a sterilant since it can penetrate microorganisms 
and generate oxygen free radicals which oxidise microbial proteins (Pruss et 
al., 1999). Other acids such as hydrochloric acid and sulphuric acid and 
bases such as NaOH (Schwartz et al., 2012) are also able to disrupt cellular 
membranes and decellularise matrices, but have been shown to dissociate 
GAGs from the tissue. Applying lime (a mixture of calcium hydroxide, soda 
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ash and sodium sulphate) to porcine dermis lea to severely reduced 
biomechanical and structural properties (Reing et al., 2010). 
4.2.1.2 Hypotonic and hypertonic solutions 
Hypertonic saline solutions have been shown to dissociate DNA from 
proteins (Cox & Emili, 2006) while hypotonic solutions induce cell swelling 
and bursting by osmosis. These solutions are also used to aid washout of 
cellular debris, however further chemical or enzymatic treatments are likely 
required to fully remove DNA and cellular debris. 
4.2.1.3 Detergents 
Detergents are amphipathic molecules comprising of a hydrophilic head 
group and a hydrophobic tail. In aqueous solution, these molecules 
spontaneously form micelles (Seddon et al., 2004). Detergents disrupt 
cellular membranes by inserting into lipid bi-layers. At concentrations above 
the critical micelle concentration detergents form micelles containing native 
lipids and encapsulating membrane proteins which can then be washed from 
the tissue. 
4.2.1.3.1 Ionic detergents 
Ionic detergents have a hydrophilic head with either a negative or positive 
net charge. Ionic detergents are extremely effective in the solubilisation of 
membrane proteins but are almost always denaturing to some extent 
through the disruption of protein-protein interactions (Seddon et al., 2004). 
SDS (Figure 4.1) is an anionic detergent commonly used in decellularisation 
processes (Booth et al., 2002, Stapleton et al., 2008, Kheir et al., 2011) 
 
Figure 4.1 Molecular structure of sodium dodecyl sulphate (SDS). 
Adapted from Seddon (2004). 
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The use of ionic detergents  such as SDS and sodium deoxycholate (SDC) 
has been shown to be more effective than the use of non-ionic or zwitterionic 
detergents for tissue decellularisation (Booth et al., 2002). However, ionic 
detergents have been shown to disrupt matrix proteins, with tissues showing 
a loss of GAGs and collagen damage when ionic detergents, such as SDS 
have been used at high concentrations (1.0 – 2.0 % w/v; Samouillan et al., 
2000; Elder et al., 2010). These effects may, in part, have been the result of 
matrix metalloproteinase activity following release of cellular proteases 
during cell membrane disruption and cell lysis. These deleterious effects 
have been minimised by using low detergent concentrations (SDS, 0.1 % 
w/v; SDC 0.5 % w/v ) and protease inhibitors (Booth et al., 2002). 
4.2.1.3.2 Non-ionic detergents 
Non-ionic detergents have uncharged hydrophilic head groups and have 
minimal effects on protein-protein interactions, so do not have a deleterious 
effect on the protein components of the ECM (Seddon et al., 2004). Triton X-
100 is one of the most widely used non-ionic detergents for decellularisation 
treatments (Courtman et al., 1995; Vavken et al., 2009). 
 
Figure 4.2 Molecular structure of triton X-100. Adapted from Seddon 
(2004). 
 
The effects of Triton X-100 as a decellularisation agent have been shown to 
be variable and dependent on exposure time and tissue type. 
Decellularisation of porcine heart valves with Triton X-100 (1 % v/v) with 0.2 
mg.ml
-1
 
DNase and 20 μg.ml-1
 
RNase for 24 h at 37 ºC was successful, 
however this lead to a near complete loss of GAG as well as reduction of 
laminin and fibronetin ( Grauss et al., 2005). Conversely, Woods & Gratzer 
(2005) did not see deleterious effects upon GAG or collagen content of ACL-
bone tissues following decellularisation with 1% (v/v) Triton X-100 in 
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combination with hypotonic and nuclease treatment, however full cell removal 
was not achieved. 
4.2.1.3.3 Zwitterionic detergents 
Zwitterionic detergents possess both a negative and positive charge at 
different regions of the molecule. As such, they display properties of both 
ionic and non-ionic detergents, having greater effect on disrupting protein-
protein interactions than non-ionic detergents.  
 
Figure 4.3 Molecular structure of CHAPS. Figure adapted from Seddon 
(2004). 
One of the most commonly used zwitterionic detergents for the 
decellularisation of tissues is  3-[(3-cholamidopropyl)dimethylammonio]-1-
propanesulfonate (CHAPS). Du et al. (2010) found that decellularisation of 
porcine corneas with 0.5 % and 1.0 % (w/v) CHAPS for 36 h histologically  
had little effect in removing cells and cellular debris, and destroyed tissue 
histoarchitecture.  Booth et al. (2002) found no histological differences in the 
biochemical components of porcine aortic tissue following 72 h incubation 
with CHAPS (0.5 % w/v), however decellularisation was not achieved with 
this detergent. 
 
4.2.2 Enzymatic methods 
Enzymes such as nucleases, collagenase, lipase and α-galactosidase have 
been used as part of decellularisation procedures alongside other agents to 
provide higher specificity for removal of undesirable constituents (Gilbert et 
al., 2006; Crapo et al., 2011). Only trypsin has been used on its own as a 
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successful decellularisation technique. Cebotari et al. (2002) treated human 
aortic and pulmonary heart valves with a solution of trypsin/EDTA  
(containing 0.5 % w/v trypsin and 0.2 % w/v EDTA) in PBS (1:10 ratio) for 48 
h at 37 °C. Complete decellularisation was reported with preservation of 
ECM. Conversely, Grauss et al. (2005) used 0.5 % (w/v) trypsin and 0.05 % 
(w/v) EDTA in the presence of DNase, RNase and gentamycin for 17 h at 37 
°C to decellularise porcine aortic valves and found that pyknotic cell nuclei 
remained and that significant damage to the elastin and collagen fibres had 
been sustained, along with a moderate reduction in GAG content seen 
histologically.  
Nucleases are commonly used to cleave nucleic acids and enable the more 
effective wash out of nuclear material from tissues. The successful use of 
nucleases to reduce tissue DNA content following detergent treatment has 
been reported for a number of tissues, including heart valves, tendon, 
meniscus and osteochondral tissues without adverse effect on tissue ECM 
(Booth et al., 2002; Ingram et al., 2007; Stapleton et al., 2008; Kheir et al., 
2011).   
Treatment of xenogeneic tissues with α-galactosidase can be required as 
part of a decellularisation bioprocess to specifically remove galactose α1-3 
galactose (α-gal), a xenogeneic cell membrane protein which leads to 
hyperacute rejection of xenografts (Stapleton et al., 2011). 
 
4.2.3 Physical methods 
A number of physical methods can be employed in combination with 
chemical and enzymatic methods to decellularise tissues. These include 
freezing, the application of direct pressure, agitation and sonication (Gilbert 
et al., 2006, Crapo et al., 2011). Freezing is commonly used and has been 
included in processes for cartilage (Kheir et al., 2011) and meniscus 
(Stapleton et al., 2008) decellularisation, amongst other tissues. Freezing 
produces ice crystals within the cells, which disrupt membranes, resulting in 
cell lysis. The formation of crystals within the ECM also acts to increase 
tissue permeability, improving perfusion of subsequent solutions through 
tissues and enhancing the wash out of cellular debris. Freeze-thawing has, 
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however, been linked to the denaturation of proteins (Cao et al., 2003), 
which may result in adverse effects on the biomechanical performance of the 
tissues. As ice crystal size is affected by freezing rate, it is important to 
select the correct temperature at which to freeze tissues so as to balance 
damage to the matrix against cell lysis (Gilbert et al., 2006).  
Funamoto et al. (2010) have reported successful decellularisation of porcine 
aortic blood vessels using high-hydrostatic pressure. Vessels were sealed in 
a bag containing PBS and placed in a cold isostatic pressurization machine. 
An atmospheric pressure of 980 MPa was gradually applied (at a rate at 
which the starting temperature was maintained) then sustained for 10 min, 
following which vessels were washed in PBS for 14 days. At high pressures, 
the temperature at which water freezes is increased, so temperature and 
magnitude of pressure needs to be carefully optimised. The rate of pressure 
increase/decrease should also be monitored, as drastic changes in pressure 
alter the temperature. The temperature of the pressurisation chamber was 
maintained above 30 °C at 980 MPa, to prevent ice crystal formation and 
avoid deleterious effects on the tissue ECM. No histological damage was 
seen in tissues pressurised at 30  °C, however those decellularised using a 
starting temperature of 10 °C showed damage to the collagen fibre network 
following formation of ice crystals as a result of high pressure. Both 
conditions resulted in reduction of the mechanical properties of the tissue 
compared to native vessels. 
In combination with chemical or enzymatic treatment, mechanical scraping 
has been employed to remove epithelial layers from basement membranes 
such as the amniotic membrane. However, results have been inconsistent 
and often lead to damage of the basement membrane (Hopkinson et al., 
2008).  
Agitation and sonication can be employed to increase the penetration of 
enzymatic and chemical decellularisation solutions and therefore improve 
cell lysis and wash out of cell debris. Orbital shakers, magnetic stirrers and 
low profile rollers have been used to agitate solutions and the tissues within 
them (Gilbert et al., 2006). The rate of agitation can affect the wash out of 
DNA from a tissue, and can vary depending on the size and density of the 
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tissue to be decellularised. Increasing agitation rate has been reported to 
increase DNA wash out, but adversely can also increase the wash out of 
ECM components, so needs to be optimised for each tissue type (Crapo et 
al., 2011). Sonication has been employed in decellularisation bioprocesses 
to increase the permeability of dense tissues and improve recellularisation 
(Ingram et al., 2007). However, optimisation of sonication frequency and 
duration is necessary to avoid excess structural damage to the tissue. 
- 110 - 
4.3 Aims and objectives 
Aims: 
The aim of the research described in this chapter was to develop a process 
using low concentration SDS plus proteinase inhibitors to decellularise 
bovine osteochondral pins obtained from the medial femoral groove. 
Objectives: 
 To develop a protocol to remove cells and cellular debris from bovine 
osteochondral pins while retaining the natural histoarchitecture, 
biochemical composition and biomechanical function of the native 
osteochondral tissues. 
 To characterise the resultant decellularised ECM and compare to 
native tissue using: 
o Histological characterisation to identify the presence/lack of 
cells and to observe any changes in the histoarchitecture of the 
tissue. 
o DNA quantification to determine the reduction in DNA 
compared to native tissue following decellularisation 
o Determination of the GAG and collagen content of 
decellularised scaffolds 
o Determination of the mechanical properties of cartilage 
following decellularisation. 
 To characterise immunohistochemically the distribution of collagen 
type VI and COMP in the native and decellularised bovine 
osteochondral matrix. 
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4.4 Methods 
4.4.1 Decellularisation solutions 
4.4.1.1 PBS 
A solution of PBS was produced as described in Section 2.1.7.1. When 
required, PBS was solution was sterilised by moist heat, as described in 
Section 2.2.1.3. Solution was stored at room temperature for up to 1 month. 
4.4.1.2 PBS with aprotinin (10 KIU.ml-1 aprotinin) 
A solution of PBS was produced as described in Section 2.1.7.1. When 
required, the  solution was sterilised by moist heat, as described in Section 
2.2.1.3. Solution was stored at room temperature and used within 1 month. 
Just prior to use, 1 ml aprotinin (10,000 KIU.ml-1) was added to 1 L PBS.  
4.4.1.3 Hypotonic buffer (10 mM Tris, 10 KIU.ml-1 aprotonin) 
Trisma base (1.21 g) was dissolved in 990 ml distilled water. The pH was 
adjusted to 8.0 – 8.2 using 6 M HCl and the volume made up to 1 L. When 
necessary, the  solution was sterilised by moist heat, as described in Section 
2.2.1.3. Solution was stored at room temperature for up to 1 month. Just 
prior to use, 1 ml aprotinin (10,000 KIU.ml-1) was added. 
4.4.1.4 SDS in hypotonic buffer (0.1 % w/v SDS, 10 mM Tris, 10 KIU.ml-1 
aprotonin) 
SDS (10 g) was dissolved in 100 ml distilled water to produce an SDS 
solution. SDS solution (10 ml) was added to 990 ml hypotonic solution. 
When necessary, the  solution was sterilised by moist heat, as described in 
section 2.2.1.3. Solution was stored at 4 °C and used within 1 week. Just 
prior to use, 1 ml aprotinin (10,000 KIU.ml-1) was added.  
4.4.1.5 Nuclease solution (50 mM Tris, 10 mM MgCl2, 50 U.ml
-1 DNAase, 
1U.ml-1 RNAase) 
Trisma base (6.1 g) and magnesium chloride (MgCl2; 2 g) were dissolved in 
80 ml distilled water. The pH was adjusted to 7.5 – 7.7 using 6 M HCl. The 
volume was then made up to 990 ml using distilled water. At this stage, 
when required, the  solution was sterilised by moist heat, as described in 
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Section 2.2.1.3. Just prior to use, 5 ml DNase (10,000 U.ml-1) and 10 ml 
RNase (100 U.ml-1) were added. Solution was used within 10 min of 
preparation. 
4.4.1.6 Peracetic acid solution (0.1 % v/v) 
Peracetic acid (PAA; 1.57 ml) was added to 500 ml distilled water and 
adjusted to pH 7.2 – 7.5 using 6 M NaOH. Solution was used within 1 h of 
preparation. 
4.4.1.7 EDTA solution (12.5 % w/v) 
EDTA solution was produced as described in Section 2.2.3.2.1, and if 
necessary was sterilised by moist heat as described in Section 2.2.1.3. 
Solution was stored at room temperature and used within 6 months of 
preparation. Just prior to use 1 ml aprotinin (10,000 KIU.ml-1) was added to 1 
L EDTA solution.  
 
4.4.2 Decellularisation processes  
Decellularisation methods using low concentration 0.1 % (w/v) SDS plus 
proteinase inhibitors were developed based on the initial process described 
by Booth et al. (2002) and adapted following methods developed by 
Stapleton et al. (2008) and Kheir et al. (2011). Osteochondral pins (9 mm 
diameter, 10 – 12 mm deep) were placed 4 – 5 per 150 ml pot into which 
125 ml of each solution was added. All incubations were carried out at 42 ± 
2 °C except the nuclease treatment which was performed at 37 ± 1 °C and 
the PAA treatment which was performed at 27 ± 1 °C. All solutions were pre-
warmed to the appropriate temperature. Agitation on an orbital shaker at 240 
rpm was carried out during each incubation excluding the nuclease step, 
which was agitated at 80 rpm, pots were laid horizontally on the shaker. 
4.4.2.1 dCELL 1 (basic decellularisation) 
Osteochondral pins were harvested from the bovine medial femoral groove, 
as described in Section 2.2.2 and stored at – 20 °C on PBS moistened filter 
paper. Pins (3 – 5 pins per pot from n=3 animals) were thawed at room 
temperature (RT) for 1 - 2 h or until fully defrosted and then re-frozen on 
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PBS moistened filter paper at -20 °C for 3 h. Pins were again thawed at RT 
for 1 – 2 h or until fully defrosted before hypotonic buffer was added and pins 
were frozen at -80 °C. Pins were thawed at 45 °C in a water bath for 1 - 2 h 
or until fully defrosted before 1 further cycle of freeze/ thaw in hypotonic 
solution was completed. Pins were washed for 3 x 10 min in PBS with 
aprotinin before being incubated in hypotonic buffer for 16 h. An incubation 
in SDS in hypotonic solution then followed for 24 h. Pins were washed for 3 
x 10 min in PBS with aprotinin and incubated in nuclease solution for 3 h. 
Pins were then washed for 3 x 10 min in PBS without aprotinin and 
incubated in PAA solution for 3 h. A final set of 3 x 10 min PBS without 
aprotinin washes were performed and the pins were stored frozen at -20 °C 
or used immediately for analysis. 
4.4.2.2 dCELL 2 (extended PBS wash) 
This process was exactly the same as that described in Section 4.4.2.1 with 
the addition of a 48 - 60 h extended final PBS wash. 
4.4.2.3 dCELL 2 (hypotonic) 
This process differed from dCELL 2 described in Section 4.4.2.2 only in that 
all four freeze/thaw cycles were conducted in hypotonic buffer containing 10  
KUI.ml-1 aprotinin. 
4.4.2.4 dCELL 2 (distilled water) 
This process differed from dCELL 2 described in Section 4.4.2.2 only in that 
all freeze/thaw cycles were conducted in distilled water containing 10  
KUI.ml-1 aprotinin. 
4.4.2.5 dCELL 2 (+ ultrasonication) 
This processed followed the same method outlined in Section 4.4.2.2 
however, prior to the initial freezing, pins were ultrasonicated. The technique 
was based on work by Ingram et al. (2007) and Stapleton  (2008b). Each 
osteochondral pin was placed in a custom wire mesh holder and positioned 
under an ultrasonic probe in a bath of ice cold PBS. Each sample was 
sonicated at 70 watts for 15 min with 6 second pulses. 
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4.4.2.6 dCELL 3 (water pik) 
Water pik treatment of the subchondral bone was added to the dCELL 2 
method described in Section 4.4.2.2. Following the first thaw, blood clots and 
marrow from the subchondral bone were removed using a water pik (Figure 
4.4). A thin jet of PBS (200 - 400 ml per pin) was applied directly to the bone 
to force out marrow components.  
 
 
Figure 4.4 Water pik. PBS (stored in the reservoir)  was pumped through 
the nozzle and forced into a thin jet when directed through the tip. The 
intensity of the jet can be controlled using the dial.  
 
4.4.2.7 dCELL 3 (hirudin) 
A 16 h incubation in the anticoagulant enzyme hirudin (1 U.ml-1 in PBS with 
10 KUI.ml-1 aprotinin) at RT was added to the process described in Section 
4.4.2.6 before treatment with the water pik. 
4.4.2.8 dCELL 3 (hirudin applied to the bone only) 
Rather than incubating the entire osteochondral pins in hirudin solution (1 
U.ml-1 in PBS with 10 KUI.ml-1 aprotinin), as described in Section 4.4.2.7, 
pins were placed in 6 well plates and 8 ml hirudin solution was added to 
each well (Figure 4.5). The lid of each plate was lined with PBS moistened 
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tissue paper to maintain a moist environment for the exposed cartilage. 
Plates were incubated at 37 °C on an orbital shaker at 80 rpm for 18 h. 
 
 
Figure 4.5 Anticoagulant application to bony region of osteochondral 
pins. Pins were placed in a 6 well plate with the bony component 
submerged in an anticoagulant solution. 
 
4.4.2.9 dCELL 3 (monosodium citrate applied to the bone only) 
As an alternative to the hirudin used in Section 4.4.2.8, the bone component 
was incubated in a 0.4 % (w/v) solution of monosodium citrate. Sodium 
hydrogen carbonate (NaHCO3; 1.98 g) and citric acid (C6H8O7; 3.92 g) were 
dissolved in 1 L distilled water and pH adjusted to 7.0. Plates were incubated 
at 37 °C on an orbital shaker at 80 rpm for 18 h. 
4.4.2.10 dCELL 3 (PBS) 
The same method was followed as in Section 4.4.2.7, however the hirudin 
solution was substituted for PBS and the incubation was completed at RT. 
4.4.2.11 dCELL 4 (PBS at 45 °C) 
This followed the method outlined in Section 4.4.2.10 however the 
incubation in PBS prior to the water pik treatment was carried out at 45 °C 
rather than RT. 
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4.4.2.12 dCELL 4 (+ extra nuclease) 
In this process, an additional nuclease treatment was added to the protocol 
outlined in Section 4.4.2.11. Following the first 3 h incubation in nuclease 
solution, pins were washed for 3 x 10 min in PBS without aprotinin before 
being subject to a second nuclease treatment for a further 3 h incubation. 
4.4.2.13 dCELL 4 (+ decalcification) 
The process described in Section 4.4.2.11 was adjusted to include a 
decalcification step. Following water pik treatment, pins were decalcified in 
12.5 % (w/v) EDTA for 1, 2, 4, 8 or 12 days with incubation at 45 °C and 
agitation at 240 rpm. Incubation for 4 days was selected for further process 
development. 
4.4.2.14 dCELL 5 (+ hypotonic/SDS cycle) 
The dCELL 4 process described in Section 4.4.2.11 was adapted to include 
a further cycle of washing with hypotonic buffer and SDS in hypotonic buffer. 
Following the first 24 h incubation in SDS solution, pins were incubated in 
hypotonic buffer for 24 h and again in SDS in hypotonic buffer for 24 h 
before continuing with PBS washes, nuclease and PAA treatments. 
 
4.4.3 Histological characterisation 
Histological characterisation of fresh and decellularised osteochondral 
tissues was carried out as described in Section 2.2.3. H&E, DAPI and alcian 
blue stains were performed. 
 
4.4.4 DNA quantification 
4.4.4.1 Tissue lyophilisation 
Tissues were freeze dried prior to digestion as described in Section 3.4.1.1. 
Cartilage was removed from the bone using a scalpel and macerated prior to 
freeze drying. 
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4.4.4.2 Cartilage digestion using proteinase K 
Tissues were digested using solutions provided in the QIAGEN DNeasy 
blood and tissue kit using a method based on the manufactures’ instructions. 
Briefly, lyophilised native cartilage tissue (25 g wet weight) was placed in a 
sterile 2 ml eppendorf tube. Digestion buffer ATL (180 µl) and proteinase K 
(20 µl) were pre-mixed then added to the tissue. Digests were vortexed 
briefly then incubated at 56 °C for 16 h with agitation at 80 rpm. 
Lyophilised decellularised cartilage tissue (~250 g wet weight) was digested 
as above, but using 360 µl buffer ATL with 40 µl proteinase K. If digestion 
was not complete after 18 h, a further 180 µl ATL and 20 µl proteinase K 
were added and incubation continued until digestion was complete. 
4.4.4.3 Cartilage DNA purification 
Once digestions were complete, DNeasy spin columns were used to extract 
and purify DNA from the digests. The manufacturers’ instructions were 
followed for native tissue. For decellularised tissue digests, the volumes of 
ethanol and buffer AL were doubled when precipitating DNA, as the digest 
volume was doubled. Columns were rinsed and then the isolated DNA was 
eluted from the membrane using 200 µl buffer AE. Elution was repeated a 
second time into the same eppendorf to ensure that all of the DNA was 
recovered. 
4.4.4.4 DNA quantification 
Purified DNA was quantified using a nanodrop nanospectrophotometer. 
Samples and standards (2 µl) were pipetted onto the pedestal and their 
absorbance measured at 260 nm. Absorbance was normalised to a blank of 
AE buffer.  A standard curve was produced using known concentrations of 
calf thymus DNA to calibrate the nanodrop spectrophotometer.  
 
4.4.5 Biochemical characterisation 
The GAG, hydroxyproline and water content of fresh and decellularised 
tissues was determined using methods described in Section 3.4. 
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4.4.6 Biomechanical characterisation 
The percentage deformation of decellularised cartilage was determined 
using the indentation methods described in Sections 3.5.1 and 3.5.2.  
 
4.4.7 Immunohistochemical labelling 
4.4.7.1 Reagents 
 Hydrogen peroxide solution  20 ml hydrogen peroxide (30 % v/v) 
(3 % v/v)    180 ml PBS 
 Tris buffer (2 M, pH 7.6)  242.26 g Trizma base 
758 ml distilled water 
 Sodium chloride solution (3M)    175.32 g sodium chloride 
1 L distilled water 
 Tris buffered saline (TBS)  25 ml Tris buffer (2 M) 
50 ml sodium chloride solution (3 
M) 
925 ml distilled water 
 TBS containing 0.05 % (w/v)  500 µl Tween 20 
Tween 20 (TBS-T)   1 L TBS 
 Bovine serum albumin   2.5 g BSA 
(BSA; 5 % w/v)   500 ml PBS 
 Antibody diluent   6 ml Sodium azide (1 % w/v) 
300 µl BSA (5 % w/v) 
54 ml TBS 
1 L distilled water 
 
4.4.7.2 Sample preparation 
Fresh and decellularised tissues (n=3) were fixed in 10 % (v/v) NBF, 
decalcified, wax embedded, sectioned and transferred onto slides as 
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described in Sections 2.2.3.1 – 2.2.3.4, sections were then dewaxed and 
rehydrated as described in Section 2.2.3.5. 
4.4.7.3 Antigen retrieval 
As tissues had been NBF fixed, antigen retrieval was performed to re-
expose tissue epitopes for antigen binding. Following dewaxing and 
rehydration, each section was circled using a hydrophobic marker and 
proteinase K solution applied drop wise until sections were fully covered. 
Sections were incubated at room temperature for 20 min. 
4.4.7.4 Antibodies 
All antibodies were diluted to optimised working concentration in antibody 
diluent.  
 
Antigen Supplier Product 
code 
Isotype Stock 
concentration 
Dilution/ Working 
concentration 
Collagen 
Type VI 
AbD 
Serotech 
AHP2049 IgG 1.0 mg.ml-1 1 in 500 
2.0 mg.L-1 
COMP AbCam ab74524 IgG 0.4 mg.ml-1 1 in 80 
5.5 mg.L-1 
IgG AbCam ab27478 - 0.2 mg.ml-1 - 
Table 4.1 Antibodies. Antibodies and isotype controls used during 
immunohistochemical analysis of native and decellularised bovine 
osteochondral tissues 
 
4.4.7.5 Labelling of tissue sections using monoclonal antibodies 
Following antigen retrieval (Section 6.3.1.3) sections were immersed in 
hydrogen peroxide (3 %, v/v) in PBS for 10 min at room temperature to block 
endogenous peroxidase activity, and then washed for 3 min in running tap 
water. Sections were briefly washed with TBS on a plate rocker. To block 
non-specific background staining, dual endogenous enzyme block (25 µl) 
from the Ultra vision kit was added and sections were incubated for 10 
minutes, followed by two ten min washes in TBS on a plate rocker. The 
primary antibody (Table 6.1) was then applied at working concentration and 
incubated at room temperature for 1 h. Sections were then washed twice for 
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10 min in TBS-T, then twice for 10 min in TBS on a plate rocker. Labelled 
polymer-HRP (20 µl) from the Ultra vision kit was then added to each section 
and incubated for 30 min in the dark at room temperature. Sections were 
again washed twice for 10 min in TBS-T, then twice for 10 min in TBS on a 
plate rocker. Excess buffer was tapped off before substrate chromogen (20 
µl liquid 3,3-diaminobenzidine (DAB) chromagen plus 1 ml substrate buffer) 
was added to each section and incubated at room temperature for 10 min. 
Sections were rinsed four times in distilled water before being immersed in 
haematoxylin (Mayer’s) for 10 sec. Sections were washed for 3 min in 
running tap water before being dehydrated and mounted in DPX mountant, 
as described in Section 2.2.3.6. To verify specific antibody binding, an 
isotype control was performed on native and decellularised tissue sections 
using IgG in place of the primary antibody at the same concentration as the 
primary antibody had been used. An antibody-free negative control was also 
included, in which sections were incubated in antibody diluent alone in place 
of the primary and secondary antibody. Once dry, sections were viewed 
using normal light microscopy. 
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4.5 Results 
Initial attempts to decellularise bovine osteochondral tissues were not 
successful and this led to numerous alterations to the process which are 
documented below. 
Images of sections of native bovine osteochondral tissue and tissue subject 
to various decellularisation protocols stained with H&E, DAPI or alcian 
blue/PAS are presented in Figures 4.6, 4.7 and 4.8 respectively. DNA, GAG  
and hydroxyproline content of native bovine cartilage and tissues subject to 
various decellularisation protocols are presented in Figures 4.9, 4.10 and 
4.11 respectively. The percentage deformation of native osteochondral 
tissues and tissues subject to various decellularisation protocols is 
presented in Figure 4.12. 
 
4.5.1 Native tissue 
Native bovine medial groove osteochondral sections stained with H&E 
(Figure 4.6 a) showed characteristic cartilage architecture and cell 
organisation, cells were present throughout the depth of the cartilage tissue 
and were situated in chondrons. At the superficial layer, cells were smaller 
and more randomly orientated, in the mid and deep zones linear columns of 
cells aligned perpendicularly to the cartilage-bone interface were seen. 
There was a darker stained layer at the cartilage surface indicating a 
healthy, smooth articulating surface. Pink eosin staining become more 
intense in the bone and the intratrabecular spaces of the bone could be 
seen, small, round osteocytes were nestled in lacunae within the bone 
tissue. Bone marrow was also present within the subchondral bone with a 
high cell density. This organisation of cells and extent of cellularisation could 
also be seen in DAPI stained sections (Figure 4.7 a). Staining with alcian 
blue showed more intense blue GAG staining in the middle zone and slightly 
less staining in the deep and superficial zones. There was an absence of 
GAGs in the bone (Figure 4.8 a). Native cartilage contained 261.1 ± 29.3 
µg.mg-1 sulphated proteoglycans per cartilage dry weight (Figure 4.10).  
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Native cartilage had a DNA content of 119 ± 36 ng.mg-1 wet weight (Figure 
4.9). 
 
4.5.2 dCELL 1 
After application of the dCELL 1 basic protocol developed by Stapleton et al. 
(2008), staining of treated tissue sections with H&E revealed that there were 
still a number of cells present in the cartilage and bone (Figure 4.6 b). In the 
superficial zone, a number of empty lacunae could be seen, which were 
slightly enlarged. The general structure of the tissue was maintained, 
marrow was present in the bone, but did not contain whole cell nuclei. DAPI 
staining confirmed a reduction in cell nuclei, but showed that a large number 
of cells remained (Figure 4.7 b). There was no significant reduction in 
cartilage DNA content compared to native tissue (Figure 4.9). There was a 
slight loss of intensity of alcian blue staining throughout the cartilage, and 
PAS staining was slightly present at the very superficial layer (Figure 4.8 b), 
indicating that loss of GAGs has occurred. The GAG content of cartilage 
following treatment with the dCELL 1 protocol was not significantly different 
from native tissue, however a reduction was noted (Figure 4.10).  
 
4.5.3 dCELL 2 
Following the introduction of an extended PBS wash to the end of the basic 
protocol, sections of osteochondral pins decellularised using the dCELL 2 
protocol as outlined in Section 4.4.2.2 showed a much greater reduction in 
cell content (Figure 4.6 c). Empty lacunae, again, appeared slightly enlarged 
and within the empty lacunae, there was light eosin staining, which may 
have indicated the collapsed collagen type VI shell, as previously reported 
by Kheir et al. (2011). These stained regions within  lacunae did not stain 
with haematoxylin or DAPI (Figure 4.7 c) so do not contain nuclear material. 
DNA quantification showed a significant reduction from native tissues 
(Figure 4.9). However, nucleated cells were still visible in the deep/calcified 
cartilage regions and in the subchondral bone. There appeared to be an 
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overall reduction in GAGs in cartilage tissues (Figure 4.8 c), which when 
quantified, was not significantly different from native tissues (Figure 4.10). 
To enhance osmotically induced cell lysis in the deep/calcified regions and 
improve decellularisation, alterations were made to dCELL 2 protocol to 
freeze/thaw entirely in hypotonic buffer or distilled water. As seen in Figure 
4.6 d & e and Figure 4.7 d & e cells were still present in the dense deep 
cartilage and bone in similar numbers to those seen following use of the 
dCELL 2 protocol. The DNA content of cartilage treated with hypotonic 
freeze/thaw did not differ significantly from native cartilage, however distilled 
water freeze/thawed tissue did show a significant reduction (Figure 4.9). 
Both protocols resulted in similar GAG reduction to that of dCELL 2 protocol 
(Figure 4.8 d & e), which when quantified, was not significantly different from 
native tissues (Figure 4.10). 
Ultrasonication was employed in an attempt to increase the permeability of 
the matrix and aid perfusion of decellularisation solutions through the deeper 
cartilage and bone. No histological changes could be seen in cartilage or 
bone structure following treatment with the sonicating probe (Figure 4.6 f). 
Similar to the freeze/thaw alterations to the dCELL 2 protocol, ultrasonication 
did not improve the removal of cells (Figure 4.7 f) nor did it have any 
additional effects on GAG retention (Figure 4.8 f and Figure 4.10) although 
DNA content was significantly reduced from that of native tissue (Figure 4.9).  
 
4.5.4 dCELL 3 
To increase decellularisation solution access to the bone and deep cartilage 
layers a water pik was used to remove bone marrow from within the 
trabecular spaces (dCELL 3 protocol). Visibly, not much marrow was 
removed following application of the water jet. Histologically, no damage to 
the cartilage or bone was seen (Figure 4.6 g), there was no additional 
adverse effects on cartilage GAGs (Figure 4.8 g and Figure 4.10), although 
cells were still visible in the tissue and within denser areas of bone (Figure 
4.7 g). The DNA content of cartilage was significantly reduced compared to 
native cartilage (Figure 4.9). 
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As bovine tissues were received 3 – 4 days post-slaughter, blood within the 
marrow had clotted, potentially making removal using the water pik difficult. 
To overcome this issue, an anticoagulant, hirudin, was applied to 
osteochondral pins to increase the efficacy of the water pik treatment. 
Marrow was more easily removed, and histolgically, there appeared to be a 
greater extent of cell removal (Figure 4.6 h and Figure 4.7 h) compared to 
use of the water pik alone. The DNA content of cartilage was significantly 
reduced compared to native cartilage (Figure 4.9).However, blue staining 
was less intense, indicating a greater loss of GAGs with use of the enzyme 
(Figure 4.8 h), however the reduced GAG content was not significantly 
different to native cartilage (Figure 4.10). 
Since application of hirudin to the cartilage had an adverse effect on GAGs, 
a different method was developed to submerge only the bony component of 
osteochondral pins into the enzyme (section 4.4.2.8), a non-enzymatic 
anticoagulant, monosodium citrate, was also used in this novel set up to 
avoid enzymatic removal/degradation of GAGs. The incubation temperature 
was increased to 37 °C to increase the rate of diffusion. This method was 
unsuccessful as there was significant loss of GAGs with hirudin treatment 
(Figure 4.8 I and Figure 4.10). Monosodium citrate did not cause as great a 
reduction in cartilage GAGs as hirudin (Figure 4.8 j & Figure 4.10). Cell 
removal was not as effective following either of these treatments as was 
seen when pins were completely submerged in hirudin (Figure 4.6 i & j and 
Figure 4.7 i & j). However, the reduction in DNA was still significant (Figure 
4.9). 
As a negative control for the anticoagulant activity of hirudin, pins were also 
incubated in PBS prior to use of the water pik. Water pik treatment was 
equally effective at removing marrow following incubation of pins in PBS as it 
was with hirudin incubation (Figure 4.6 k and Figure 4.7 k). The reduction in 
DNA content was equally acceptable (Figure 4.9). The adverse effects on 
GAGs were minimised using PBS rather than hirudin (Figure 4.8 k and 
Figure 4.10). 
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4.5.5 dCELL 4 
As bone marrow has a high lipid content, it was thought that marrow wash 
out would be more effective at a higher temperature, when marrow fats 
would be liquid rather than solid. To this end, the temperature of the pre-
water pik treatment PBS incubation was increased to 45 °C. This greatly 
improved ease and extent of marrow removal with the water pik (dCELL 4 
protocol). However no improvement in cell presence or DNA reduction in 
cartilage tissue was seen compared to incubation in PBS at room 
temperature (Figure 4.6 l, Figure 4.7 l and Figure 4.9), and a significant 
reduction in GAG content compared to native tissue was observed (Figure 
4.8 l, Figure 4.10). 
To improve DNA removal, an additional nuclease step was included in the 
dCELL 4 protocol. No improved cell removal was seen compared to the use 
of a single nuclease treatment (Figure 4.6 m and Figure 4.7 m) and again, 
GAG content was significantly lower than that of native cartilage (Figure 4.8 
m and 4.10). 
As cell retention appeared to occur in dense bony regions and calcified 
cartilage, it was thought that decalcification of the osteochondral pins might 
improve access to these regions. Cells were still visible in the deep cartilage 
regions (Figure 4.5 n and Figure 4.7 n) and cartilage DNA content did not 
differ from dCELL 4 (Figure 4.9). GAG content of EDTA treated cartilage 
was significantly lower than native tissues (Figure 4.8 n and Figure 4.10) 
 
4.5.6 dCELL 5 
To achieve full decellularisation, other processes have required repeat 
cycles of SDS and hypotonic washes (Stapleton et al., 2008; Kheir et al., 
2011), however these have resulted in greater GAG loss. Two cycles of SDS 
were incorporated into the dCELL 5 protocol, so cells were exposed to 
additional osmotic stress and membranes would be more effectively 
removed. Following decellularisation with dCELL 5 protocol, cartilage only 
contained 7 ± 6 ng.mg-1 DNA per wet weight (39 ng.mg-1 DNA per dry 
weight), a reduction of 94 % (Figure 4.9). This protocol also led to full 
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removal of whole cells from both cartilage and bone (Figure 4.6 o and Figure  
4.7 o). Empty lacunae were enlarged throughout the cartilage ECM (Figure 
4.6 o).  However, following the application of the protocol, the presence of 
GAGs within the cartilage tissue was greatly reduced (Figure 4.8 o). The 
GAG content of the acellular cartilage was significantly reduced to 2.5 ± 2.8 
µg.mg-1; a  99 % (w/w) reduction from native tissue (Figure 4.10). Previous 
protocols, despite resulting in reduced cartilage GAG content, did not have 
adverse effects on the tissue biomechanics. Following application of this 
protocol however, the severe reduction in GAGs was found to result in a 
significant increase in the percentage deformation from 30.4 (+ 7.6, - 7.1) % 
deformation of native cartilage to 48.4 (+ 20.1, - 21.2) % (Figure 4.12). The 
reduction in GAG content resulted in a significant increase in the cartilage 
collagen content as a proportion of tissue dry weight from 72.3 ± 26.5  
µg.mg-1 (native) to 146.3 ± 65.1 µg.mg-1 (dCELL 5; Figure 4.11). 
To further characterise the acellular bovine osteochondral matrix produced 
following the application of the dCELL 5 protocol, immunohistochemical 
analysis was performed to localise specific matrix proteins in native and 
decellularised tissues. Tissues were labelled with antibodies for collagen 
type VI (Figure 4.13). In native tissues, brown staining was seen throughout 
the superficial and middle zones of the cartilage, with greater intensity in the 
superficial region, little to no staining was seen in the deep zone. Intense 
staining was found localised to the cartilage chondrons around 
chondrocytes. Decellularised tissues showed very little staining, and no 
increased intensity could be seen at chondrons. Isotype and antibody free 
controls did not show any brown staining for native tissue, however slight 
brown staining was seen in the decellularised tissue isotype control. 
Images of  tissue sections labelled with antibodies against COMP care 
presented in Figure 4.14. Staining was evenly dispersed across the native 
cartilage, but was absent in the deep calcified region and was slightly 
depleted at the cartilage surface. Decellularised tissues also showed similar 
staining, however there was a more distinct loss of staining it the surface 
layer and at higher magnification (100 x) a graininess could be seen in the 
stain, which was not present in the native tissue stains. Again, isotype and 
antibody-free controls were negative for native tissue, however the isotype 
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control for decellularised tissue was positive (Figure 4.14 g), although the 
graininess seen when labelling the decellularised cartilage with antibody 
against COMP was not present in the isotype. 
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Figure 4.6 H&E stained sections of native and decellularised bovine 
osteochondral pins. a) fresh, b) dCELL 1, c) dCELL2, d) dCELL 2 with 
hypotonic freeze/thaw, e) dCELL 2 with distilled water freeze/thaw, f) dCELL 
2 with ultrasonication, g) dCELL 3, h) dCELL 3 with hirudin, i) dCELL 3 with 
hirudin applied to bone only, j) dCELL 3 with monosodium citrate, k) dCELL 
3 with PBS, l) dCELL 4, m) dCELL 4 with two nuclease washes, n) dCELL 4 
with EDTA pre-treatment, o) dCELL 5. Scale bar = 500 µm. 
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Figure 4.7 DAPI stained sections of native and decellularised bovine 
osteochondral pins. a) fresh, b) dCELL 1, c) dCELL2, d) dCELL 2 with 
hypotonic freeze/thaw, e) dCELL 2 with distilled water freeze/thaw, f) dCELL 
2 with ultrasonication, g) dCELL 3, h) dCELL 3 with hirudin, i) dCELL 3 with 
hirudin applied to bone only, j) dCELL 3 with monosodium citrate, k) dCELL 
3 with PBS, l) dCELL 4, m) dCELL 4 with two nuclease washes, n) dCELL 4 
with EDTA pre-treatment, o) dCELL 5. Scale bar = 500 µm. 
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Figure 4.8 Alcian blue stained sections of native and decellularised 
bovine osteochondral pins. a) fresh, b) dCELL 1, c) dCELL2, d) dCELL 2 
with hypotonic freeze/thaw, e) dCELL 2 with distilled water freeze/thaw, f) 
dCELL 2 with ultrasonication, g) dCELL 3, h) dCELL 3 with hirudin, i) dCELL 
3 with hirudin applied to bone only, j) dCELL 3 with monosodium citrate, k) 
dCELL 3 with PBS, l) dCELL 4, m) dCELL 4 with two nuclease washes, n) 
dCELL 4 with EDTA pre-treatment, o) dCELL 5. Scale bar = 500 µm. 
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Figure 4.9 Cartilage DNA content. Data is shown as the mean (fresh and 
dCELL 1 n=5, others n=3) ± 95 % confidence limits. * significant difference  
compared to native tissue p<0.05 (ANOVA). 
 
 
Figure 4.10 Cartilage GAG content. Data is shown as the mean (fresh and 
dCELL 1 n=5, others n=3) ± 95 % confidence limits. * significant difference  
compared to native tissue p<0.05 (ANOVA). 
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Figure 4.11 Cartilage hydroxyproline content. Data is shown as the mean 
(fresh and dCELL 1 n=5, others n=3) ± 95 % confidence limits. * significant 
difference  compared to native tissue p<0.05 (ANOVA). 
 
 
Figure 4.12 Percent deformation of cartilage. Data was subject to arcsin 
transformation prior to calculation of the 95% confidence limits and analysis 
of variance. Data is shown as the back transformed mean (fresh and dCELL 
1 n=5, others n=3) ± 95 % confidence limits. * significant p<0.05 (ANOVA). 
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Figure 4.13 Localisation of collagen type VI in native and decellularised 
bovine osteochondral tissues. a) native tissue (20 x magnification) scale 
bar = 1000 µm, b) decellularised tissue (20 x mag.) scale bar = 1000 µm, c) 
native tissue (40 x mag.) scale bar = 500 µm, d) decellularised tissue (40 x 
mag.) scale bar = 500 µm, e) native tissue (100 x mag.) scale bar = 200 µm, 
f) decellularised tissue (100 x mag.) scale bar = 200 µm. 
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Figure 4.14 Labelling of COMP in native and decellularised bovine 
osteochondral samples. a) native tissue (20 x magnification) scale bar = 
1000 µm, b) decellularised tissue (20 x mag.) scale bar = 1000 µm, c) native 
tissue (40 x mag.) scale bar = 500 µm, d) decellularised tissue (40 x mag.) 
scale bar = 500 µm, e) native tissue (100 x mag.) scale bar = 200 µm, f) 
decellularised tissue (100 x mag.) scale bar = 200 µm, g) decellularised 
tissue isotype control (100 x mag.) scale bar = 200 µm. 
a b 
c 
e 
d 
f 
g 
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4.6 Discussion 
This study aimed to produce an acellular bovine osteochondral pin for use in 
osteochondral lesion repair. The aim was to achieve complete removal of 
whole cells and cellular debris from the ECM scaffold to eliminate the 
immunogenic effects of xenogeneic cellular antigens. As the fundamental 
macromolecules of the ECM, such as collagens, are conserved throughout 
mammalian species, these matrix proteins should not evoke an immune 
response.   
A protocol for decellularisation was developed, based on previous work by 
Booth et al. (2002). Increased incubation temperatures (Stapleton et al., 
2008 and Khier et al., 2011) were required to overcome issues with dense 
matrix and high GAG concentrations of osteochondral tissues which can 
inhibit the diffusion of decellularisation solutions. Additionally, EDTA, 
incorporated as a protease inhibitor in existing protocols was initially 
removed from the process to avoid decalcification of the bony component of 
the osteochondral pins. 
Histological analysis of osteochondral tissues decellularised using the 
dCELL 5 protocol showed the full removal of whole cells and large cellular 
debris, and the DNA content of cartilage was significantly reduced to  below 
50 ng.mg-1. To achieve complete decellularisation, bone marrow first needed 
to be loosened and removed. This was achieved by incubation in PBS at 45 
°C with agitation for 18 h and then use of a water pik. Use of anticoagulants 
and lower temperatures did not prove as effective at loosening marrow. 
Removal of bone marrow enabled better diffusion of decellularisation 
solutions through the bone and up to the subchondral plate. Four cycles of 
freeze/thaw were required (two of which were in hypotonic solution) to open 
up the ECM through formation of ice crystals to improve diffusion of 
solutions through the tissue. The use of hypotonic buffer or distilled water at 
all stages did not improve the efficacy of freeze/thaw cycles and 
ultrasonication of tissues prior to decellularisation to increase diffusion was 
not advantageous.  Two applications of hypotonic buffer and low 
concentration SDS in series were required to fully remove cells from calcified 
cartilage and the subchondral bone plate, as these areas were most dense.  
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This number of SDS cycles was fewer than required in the protocol 
developed by Khier et al. (2011) for porcine tissue, likely due to the smaller 
volume of tissue being decellularised. Extensive washing in PBS following 
nuclease treatment and PAA sterilisation was required to fully remove cell 
remnants from the tissue. 
Although decellularisation was achieved, there were detrimental effects on 
the ECM. Histological analysis of the acellular matrix showed an increase in 
cartilage porosity. A reduction in GAGs was seen with alcian blue staining 
which was confirmed by sulphated proteoglycan quantification. This loss of 
GAG had an adverse effect on the mechanical properties of the tissue 
resulting in a significant increase in cartilage deformation. 
The DNA content of the bony section of the osteochondral tissue was not 
quantified, so the true extent of osteochondral decellularisation is currently 
unknown. Satisfactory digestion of the mineralised tissue could not be 
achieved following preliminary alterations to the protocol provided with the 
Qiagen kit, further work is required to quantify bone DNA. Retention of DNA 
within the bone is not thought to be problematic, as whole cell nuclei have 
been shown to be removed following histological analysis. The presence of 
DNA in the bone will not elicit an immune response, only the presence of 
cellular  membranes and proteins (Knight & Ingham, 2006). Residual DNA is 
known to result in calcification of decellularised tissues following implantation 
(Schoen & Levy, 2005), however this would not pose and issue in an already 
mineralised tissue such as bone. 
Immunohistochemical analysis of decellularised tissues showed that most 
collagen type VI was lost from the tissue. Collagen type VI is a key 
component of the cartilage ECM and is usually localised to the chondrons 
(Cremer et al., 1998) where it plays a role in chondrocyte attachment to the 
ECM (Poole et al., 1997). As cells were removed from the tissue during the 
process, it was expected that some damage to the immediate pericellular 
matrix would occur. Damage to collagen type VI following decellularisation 
was also seen by Kheir et al. (2011), where the collagen shell of the 
chondron had collapsed in. 
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COMP is a non-collagenous matrix protein which plays a role in matrix 
assembly. The protein is uniformly distributed in the interterritorial matrix, 
with slightly increased density in the deep zone and decreased density 
around the tidemark and calcified cartilage (DiCesare et al., 1995). Depletion 
of COMP has been seen in osteoarthritic cartilage (DiCesare et al., 1996), 
and is thought to be a good soluble biomarker for the disease (Saxne & 
Heinegård, 1992). Immunolabelling of tissue sections showed COMP to be 
uniformly distributed throughout native bovine cartilage, with some reduction 
in staining at the superficial zone and an absence of staining in the calcified 
cartilage. Decellularised tissues showed similar stain distribution, however 
there was a distinct boundary of stain loss at the superficial zone, and 
throughout the cartilage staining appeared grainy, suggesting some 
clumping of COMP proteins. 
Isotype controls were negative for native tissues but positive for 
decellularised tissue sections, showing non-specific binding of the secondary 
antibody. It is likely that residual SDS from the decellularisation process is 
interacting ionically with the secondary antibody, resulting in positive 
staining. 
Other studies have been conducted to decellularise bovine articular cartilage 
without the subchondral bone. Elder et al. (2010) used 2 % (w/v) SDS over a 
range of incubation times to decellularise immature calf cartilage. They 
found that minimal detrimental effects to GAG content and therefore 
mechanical function occurred at short (2 h) incubation times, however, there 
were also minimal reductions in cell and DNA content. To achieve 
decellularisation, longer incubation (8 h) with SDS was required, however 
this lead to detrimental effects on GAG content and mechanical properties, 
as also seen in this study. 
Yang et al. (2012) achieved successful decellularisation of mature bovine 
cartilage and retained GAGs, however their protocol involved freeze drying 
and homogenisation of cartilage to a powder before decellularising and re-
forming, thus completely removing the structure of the natural ECM.  
The regenerative capacity of the acellular bovine osteochondral scaffold 
developed in this study will need to be determined. The biological and 
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structural changes which have occurred following decellularisation and the 
biocompatibility of the resultant matrix need to be investigated further. As a 
number of  alterations to the protocol for the decellularisation of bovine 
tissues have been explored in the current study, with varying degrees of 
success, the efficacy of some of these initial protocols will be investigated 
using porcine tissues. It may be possible to produce a porcine ECM scaffold 
which retains more of the characteristics of native tissues than was seen for 
bovine tissues. 
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Chapter 5  
Investigation of methods for the 
decellularisation of porcine osteochondral 
tissues 
5.1 Introduction 
As introduced previously  (Chapter 1 and Chapter 4), an acellular 
xenogeneic osteochondral scaffold may provide a more effective early 
intervention treatment for osteochondral lesions. An analysis of 
osteochondral tissues from different species and joint areas in Chapter 3 
identified bovine medial groove and porcine medial condyle tissues as 
appropriate source materials for decellularisation. A protocol was developed 
for the successful decellularisation of bovine osteochondral tissues using a 
water pik to remove bone marrow followed by four cycles of freeze-thaw (two 
of which were in hypotonic buffer solution), two cycles of hypotonic buffer 
solution followed by incubation in 0.1 % (w/v) SDS, treatment with nucleases 
and sterilisation with 0.1 % (v/v) peracetic acid. In this chapter, the process 
required to decellularise porcine osteochondral tissues was investigated. 
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5.2 Aims and objectives 
Aims: 
The aim of the research in this chapter was to investigate methods using low 
concentration SDS plus proteinase inhibitors to decellularise porcine 
osteochondral pins obtained from the medial condyle. 
Objectives: 
 To develop a protocol to remove cells and cellular debris from porcine 
osteochondral pins while retaining the same natural histoarchitecture, 
biochemical composition and biomechanical function as the native 
osteochondral tissues. 
 To characterise the resultant decellularised ECM and compare to 
native tissues 
o To characterise the tissue histologically in order to identify the 
presence/lack of cells and to observe any changes in the 
histoarchitecture of the tissue. 
o To quantify the total DNA, to identify the reduction in DNA 
compared to native tissue following decellularisation 
o To characterise the tissue biochemically to assess GAG and 
collagen content of decellularised scaffolds 
o To determine the biomechanical properties in order to 
determine any changes in the mechanical properties of 
cartilage following decellularisation. 
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5.3 Methods 
5.3.1 Decellularisation solutions 
Solutions for decellularisation were produced as described in Section 4.4.1. 
Additional solutions used in this part of the study are described below. 
5.3.1.1 0.05 % (w/v) SDS in hypotonic buffer 
SDS (10g) was dissolved in 100 ml distilled water to produce a 10 % (w/v) 
SDS solution. SDS solution (5 ml) was added to 995 ml hypotonic buffer. 
When required, the solution was sterilised by autoclaving and could be 
stored at room temperature for up to 3 months. Just prior to use, 1 ml 
aprotinin (10,000 KIU.ml-1) was added to give a final concentration of 10 
KUI.ml-1. 
5.3.1.2 PBS with aprotinin and EDTA (0.1% w/v) 
A solution of PBS was produced as described in Section 2.1.7.1. EDTA (1 g) 
was dissolved in 1 L PBS and the pH adjusted to 7.2 – 7.4. When required, 
the solution was sterilised by autoclaving  and could be stored at room 
temperature for up to 3 months. Just prior to use 1 ml aprotinin (10,000 
KIU.ml-1) was added to give a final concentration of 10 KUI.ml-1. 
5.3.1.3 PBS with mannitol (1 % w/v) 
A solution of PBS was produced as described in Section 2.1.7.1. Mannitol 
(10 g) was dissolved in 1 L PBS and the pH adjusted to 7.2 – 7.4. When 
required, the solution was sterilised by autoclaving and could be stored at 
room temperature for up to 3 months. Just prior to use 1 ml aprotinin (10,000 
KIU.ml-1) was added to give a final concentration of 10 KUI.ml-1. 
5.3.1.4 PBS with mannitol (2 % w/v) 
A solution of PBS was produced as described in Section 2.1.7.1. Mannitol 
(20 g) was dissolved in 1 L PBS and the pH adjusted to 7.2 – 7.4. When 
required, the solution was sterilised by autoclaving and could be stored at 
room temperature for up to 3 months. Just prior to use 1 ml aprotinin (10,000 
KIU.ml-1) was added to give a final concentration of 10 KUI.ml-1. 
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5.3.2 Development of the decellularisation process 
Decellularisation processes developed for bovine cartilage in the previous 
chapter were used to determine the response of porcine osteochondral 
tissues to decellularisation. Porcine osteochondral pins (9 mm diameter, 10 
– 12 mm deep) were harvested from the porcine medial condyle and stored 
frozen as described in Section 2.2.2.  
5.3.2.1 dCELL 1 (basic decellularisation) 
Porcine osteochondral pins were decellularised as described in Section 
4.4.2.1. 
5.3.2.2 dCELL 3 (water pik) 
Porcine osteochondral pins were decellularised as described in Section 
4.4.2.6. 
5.3.2.3 dCELL 3 (0.05 % w/v SDS) 
Porcine osteochondral pins were decellularised as described in Section 
4.4.2.6, however a reduced concentration (0.05 % w/v) of SDS in hypotonic 
buffer was used. 
5.3.2.4 dCELL 3 (6 h 0.1 % w/vSDS) 
Porcine osteochondral pins were decellularised as described in Section 
4.4.2.6, however the 24 h 0.1 % (w/v)  SDS in hypotonic buffer wash was 
replaced with 6 h in 0.1 % (w/v) SDS followed by 18 h in PBS. 
5.3.2.5 dCELL 3 (0 % w/v SDS) 
Porcine osteochondral pins were decellularised as described in Section 
4.4.2.6, however the 24 h 0.1 % (w/v) SDS wash was replaced with 24 h in 
hypotonic buffer without SDS. 
 
5.3.3 Cartilage characterisation 
Following application of the decellularisation process detailed in Section 
5.3.2.5, the cartilage was assessed histologically using the methods detailed 
in Section 2.2.3. 
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5.3.3.1 Denatured collagen quantification 
5.3.3.1.1 Lyophilisation 
Cartilage (50 mg) was lyophilised to a constant weight as described in 
Section 3.4.1.1. 
5.3.3.1.2 α-chymotrypsin digestion 
To determine the extent of collagen denaturation, macerated, freeze-dried 
tissues were digested using α-chymotrypsin. 
 Digestion Buffer (pH 7.8)  1.21 g trizma base 
0.15 g calcium chloride 
100 ml distilled water 
 Digestion solution   100 mg α-chymotrypsin 
20 ml digestion buffer 
α-chymotrypsin digestion solution (5 ml) was added to each sample and 
incubated at 30 °C for 24 h.  
5.3.3.1.3 Acid hydrolysis of α-chymotrypsin digest supernatant 
Following digestion, each sample was centrifuged at 600 g for 10 min. The 
supernatant (4 ml) was collected in a polypropylene universal and 
hydrolysed with hydrochloric acid (6 M; 4ml) and then neutralised as 
described in Section 3.4.1.3. 
5.3.3.1.4 Hydroxyproline quantification 
The hydroxyproline residues from denatured collagen in the hydrolysed 
supernatant were quantified using the method detailed in Section 3.4.4. The 
supernatant was not diluted before assaying.  
 
5.3.4 Investigation of the cause of cartilage damage 
Osteochondral pins were harvested from the medial condyle of n=3 pigs. 
Unless otherwise stated, two pins from each individual were placed in one 
pot and three pots (n=3) were used for each condition. One pin from each 
pot was analysed. 
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5.3.4.1 Analysis of incubation temperature  
Osteochondral pins (2 pins per pot, n=3) were decellularised as described in 
Section 5.3.2.4. One group was decellularised at 40 °C and the other group 
at 45 °C. The solution temperatures were measured with a thermometer at 
the beginning and end of each wash step and the temperature inside the 
incubator measured at the end of each wash step.  
5.3.4.2 Systematic removal of  major steps of the decellularisation 
process  
Osteochondral pins (2 pins per pot, n=3) were decellularised using the 
dCELL 3 protocol as described in Section 5.3.2.2 at 42 °C. The complete 
protocol was used as a positive control for cartilage damage. Each major 
step of the protocol was systematically removed as detailed in Table 5.1 to 
identify the effect on cartilage. Incubation in PBS with aprotinin for the same 
duration was performed as a negative control. 
 
Run name +ve a b c d e f -ve 
Water pik + + + + + + + - 
dry freeze/thaw (-20°C) + - - + + + + - 
Hypotonic freeze/thaw (-80°C) + + - + + + + - 
PBS + + + + + + + PBS 
Hypotonic  + + + - + + + PBS 
SDS + + + + - + + PBS 
PBS + + + + + + + PBS 
Nuclease + + + + + + + PBS 
PBS + + + + + + + PBS 
PAA + + + + + - + PBS 
PBS + + + + + + + PBS 
PBS end wash + + + + + + - PBS 
Table 5.1 Protocols with systematic removal of major steps of the 
process. The wash steps of the decellularisation protocol are listed in order. 
Variations are labelled a-f and positive (+ve) and negative (-ve) control 
protocols are also listed. The presence of each individual step is denoted 
with (+) and if the step was omitted this is indicated with (-). 
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5.3.4.3 Matrix metalloproteinase Inhibition 
Osteochondral pins (2 pins per pot, n=3) were incubated in PBS with 
aprotinin and EDTA (0.1 % w/v) for 5 days at 42 °C with agitation. Another 
set of pins (2 pins per pot, n=3) were incubated in PBS without aprotinin or 
EDTA as a positive control. 
5.3.4.4 Analysis of solution tonicity 
5.3.4.4.1 Osmolality measurements 
The osmolality of synovial fluid (collected from the porcine knee cavity using 
a 1 ml syringe, n=3) and of PBS containing 1 % and 2 % (w/v) mannitol was 
measured. Each sample (20 µl, n=3) was measured using a micro- 
osmometer (Advanced Instruments, 3MO Plus Freezing Point Osmometer). 
5.3.4.4.2 Incubation of pins in PBS with mannitol 
Osteochondral pins (2 pins per pot, n=3) were incubated in solutions of 1 % 
and 2 % (w/v) mannitol in PBS for 5 days at 42 °C with agitation. 
5.3.4.4.3 Decellularisation of pins using PBS with mannitol 
Osteochondral pins (2 pins per pot, n=3) were decellularised following the 
dCELL 3 process detailed in Section 5.3.2.2 however PBS washes were 
carried out in 1 % or 2 % (w/v) mannitol in PBS. 
5.3.4.5 Analysis of pig skeletal maturity 
Osteochondral pins were harvested from the medial condyle of 3 month old 
(n=3) and ~ 3 year old (n=3) pigs as described in Section 2.2.2. Pins were 
decellularised (1 pin per pot) following the dCELL 3 process detailed in 
Section 5.3.2.2. 
5.3.4.6 Decellularisation with 1 vs 5 pins per pot 
Osteochondral pins were decellularised by dCELL 3  as described in Section 
5.3.2.2 with either 1 or 5 pins per pot (n=3). 
 
5.3.5 Histological characterisation 
Histological characterisation of native and decellularised osteochondral 
tissues was carried out as described in Section 2.2.3.  
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5.3.6 DNA quantification 
The DNA content of native and decellularised cartilage and bone was 
quantified as detailed in Section 4.4.4.  
 
5.3.7 Biochemical characterisation 
The GAG, hydroxyproline and water content of native and decellularised 
tissues was assessed using methods described in Section 3.4. 
 
5.3.8 Biomechanical characterisation 
The percentage deformation of decellularised cartilage was determined 
using the indentation methods described in Sections 3.5.1 and 3.5.2.  
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5.4 Results 
5.4.1 Decellularisation optimisation 
5.4.1.1 dCELL 1 
Following application of the dCELL 1 basic protocol the general tissue 
structure was maintained, however, there were still a number of cells present 
in the cartilage and bone (Figure 5.2 b and 5.3 b). Only a 77.5 % reduction in 
cartilage DNA was found (Figure 5.5). Native cartilage contained 262.1 ± 
72.9 ng.mg-1 DNA per cartilage wet weight while cartilage which had been 
subject to the dCELL 1 protocol had 58.9 ± 9.9 72.9 ng.mg-1. There was 
some loss of intensity of alcian blue staining (Figure 5.4 b) and PAS staining 
was stronger in the middle zone, suggesting loss of GAGs in this zone. 
Native cartilage contained 377.4 ± 54.2 µg.mg-1 GAG per cartilage dry 
weight while cartilage which had been subject to the dCELL 1 protocol had 
151.7 ± 105.1 µg.mg-1, a reduction of 59.8 % (Figure 5.6). This reduction in 
GAGs had a detrimental effect on the biomechanics of the tissue (Figure 
5.7), with the percentage deformation of the cartilage increasing from 22.8 
(+1.1, -1.0) % (native) to 34.7 (+7.3, -6.9) % (dCELL 1). The hydroxyproline 
content of cartilage following dCELL 1 was significantly increased from 43.6 
± 14.6 µg.mg-1 per dry weight (native) to 115.2 ± 16.4 µg.mg-1 (Figure 5.8). 
The water content of cartilage was not significantly different following the 
application of dCELL 1 (Figure 5.9). 
5.4.1.2 dCELL 3 
As application of the dCELL 1 protocol did not result in complete 
decellularisation of porcine osteochondral tissues, dCELL 3 as developed for 
bovine tissues in the previous chapter was employed. This again resulted in 
the general ECM structure being maintained (Figure 5.2 c) and following this 
protocol no whole cell nuclei could be seen (Figure 5.2 c and 5.3 c). The 
DNA content of cartilage was reduced by 98 % to 5.3 ± 0.4 ng.mg-1 cartilage 
wet weight (Figure 5.5). Images of alcian blue stained section showed a loss 
of blue intensity and increased PAS staining in the superficial and middle 
zones (Figure 5.4). The GAG content of cartilage had reduced by 60.3 % to 
149.8 ± 284.6 µg.mg-1 cartilage dry weight (Figure 5.6), however variation 
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between samples was high, with one sample only having 19.2 µg.mg-1. This 
again resulted in significantly increased percentage deformation (Figure 5.7) 
to 41.9 (+21.5, -20.0) %. The hydroxyproline content was not significantly 
different to native cartilage (Figure 5.8), however the water content had 
increased to 83.5 (+3.6, -4.0) % (Figure 5.9). 
5.4.1.3 dCELL 3 (0.05 % SDS) 
Upon completion of the dCELL 3 protocol using 0.05 % (w/v) SDS in place of 
0.1 % (w/v) SDS, following the extended PBS end wash the solutions 
containing the osteochondral pins (n=3) were cloudy, and in one of the three 
pots, cartilage had dissolved away from the bone. Another pot of pins were 
subject to the process to achieve n=3. The cartilage in the remaining pots 
appeared gelatinous and had shrivelled away from the edge of the bone 
(Figure 5.1). 
 
 
Figure 5.1 macroscopic observation of damaged pins. a) side view and 
b) top view of dCELL 3 pin (left) and dCELL 3 with 0.05% SDS pin (right). 
 
No cell nuclei were observed in the decellularised tissue (Figure 5.2 d and 
5.3 d) however the cartilage structure  was highly porous and had reduced 
alcian blue staining for GAGs (Figure 5.2 d and Figure 5.4 d). The cartilage 
DNA content of these samples was significantly reduced by 98.2 % (Figure 
5.5). The GAG content of cartilage was reduced by 82.1 % to 67.7  ± 161.7 
µg.mg-1 (Figure 5.6). The hydroxyproline content of the tissue following this 
protocol was significantly increased compared to native tissue and was 
115.2 ± 48.9 µg.mg-1 (Figure 5.8). The water content of the tissue was 
significantly increased to 84.2 ± 0.8 % compared to native tissue (Figure 
a b 
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5.9). Following measurement of deformation using a hemispherical indenter, 
this damaged cartilage did not recover, so needle indentation could not 
subsequently be performed to measure cartilage thickness. No percentage 
deformation data is therefore available for presentation. 
5.4.1.4 dCELL 3 (6 h) 
Similarly to the previous protocol using 0.05 % SDS, when samples were 
incubated in 0.1% SDS for only 6 h, cartilage damage was seen again. 
Cartilage was porous, the surface was wrinkled (Figure 5.2 e) and cartilage 
GAG content was depleted (Figure 5.4 e). No cell nuclei were present in the 
tissue (Figure 5.2 e and 5.3 e). The DNA content of this cartilage was 
significantly reduced by 90.6 % compared to native tissue. No sulphated 
proteoglycans could be detected using the DMB dye assay, there was no 
significant difference in the absorbance of the sample to that of the blank 
(ANOVA). The hydroxyproline content of the tissue was significantly 
increased compared to native tissue to 137.3 ± 59.1 µg.mg-1. The cartilage 
water content was also significantly increased to 93.8 ± 0.3 %. Again, tissue 
did not recover following indentation, so the percentage deformation of the 
cartilage could not be determined. 
5.4.1.5 dCELL 3 (0.0% SDS) 
As seen following the two previous decellularisation protocols, cartilage 
appeared shrivelled and gelatinous, the tissue volume was greatly reduced. 
The histological appearance was also as previously reported (Figure 5.2 f, 
5.3 f and 5.4 f). Since limited tissue was available, this group of damaged 
pins were used to investigate the nature of the cartilage damage by 
performing histological analysis and quantitative analysis of collagen 
damage (Section 5.4.2).  
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Figure 5.2 H&E stained sections of native and decellularised 
osteochondral pins. a) native, b) dCELL 1, c) dCELL 3, d) dCELL 3 (0.05 
% SDS), e) dCELL3 (6 h SDS) and f) dCELL 3 (0.0 % SDS).  Scale bar = 
500 µm. 
a b 
c d 
e f 
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Figure 5.3 DAPI stained sections of native and decellularised 
osteochondral pins. a) native, b) dCELL 1, c) dCELL 3, d) dCELL 3 (0.05 
% SDS), e) dCELL3 (6 h SDS) and f) dCELL 3 (0.0 % SDS). Scale bar = 500 
µm. 
a b 
c d 
e f 
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Figure 5.4 Alcian blue/PAS stained sections of native and 
decellularised osteochondral pins. a) native, b) dCELL 1, c) dCELL 3, d) 
dCELL 3 (0.05 % SDS), e) dCELL3 (6 h SDS) and f) dCELL 3 (0.0 % SDS). 
a, b, e and f scale bar = 500 µm, c and d scale bar = 1000 µm. 
 
a b 
c d 
e f 
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Figure 5.5 Cartilage DNA content. Data is shown as the mean (native and 
dCELL1 n=5, others n=3) ± 95% confidence limits. * significantly different to 
native (p<0.05 ANOVA). 
 
Figure 5.6 Cartilage GAG content. Data is shown as the mean (native and 
dCELL 1 n=5, others n=3) ± 95% confidence limits. * significantly different to 
native (p<0.05 ANOVA). 
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Figure 5.7 Percent deformation of cartilage. Data was subject to arcsin 
transformation prior to calculation of the 95% confidence limits and analysis 
of variance. Data is shown as the back transformed mean (native n=6, 
dCELL 1 and 3 n=3) ± 95% confidence limits. * significantly different to 
native (p<0.05 ANOVA). 
 
 
Figure 5.8 Cartilage hydroxyproline content. Data is shown as the mean 
(native and dCELL 1 n=5, others n=3) ± 95% confidence limits. * significantly 
different to native (p<0.05 ANOVA). 
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Figure 5.9 Cartilage water content. Data was subject to arcsin 
transformation prior to calculation of the 95% confidence limits and analysis 
of variance. Data is shown as the back transformed mean (native and 
dCELL 1 n=5, others n=3) ± 95% confidence limits. * significantly different to 
native (p<0.05 ANOVA). 
 
5.4.2 Cartilage damage characterisation 
5.4.2.1 Histological analysis 
Cartilage which was damaged following application of the dCELL 3 (0.0% 
SDS) protocol was analysed histologically to identify changes to the general 
structure. H&E stained sections (Figure 5.2 f) showed that the cartilage 
surface was much rougher than native cartilage, no cell nuclei were visible, 
and lacunae appeared enlarged. The cartilage also appeared to be generally 
thinner. The bone appeared histologically normal. Use of alcian blue (Figure 
5.4 f) and safranin O staining of cartilage sections (Figure 5.10 a & b) 
showed a severe loss of GAGs. There was no safranin O staining visible in 
the damaged cartilage and PAS staining was present throughout all layers of 
the cartilage in the damaged samples. Staining of sections with van Geison 
(Figure 5.10 c & d) and Sirius red (Figure 5.10 e & f) was performed to 
visualise collagen fibres within the cartilage ECM. Both stains showed a 
clumping of the collagen fibres into a more mesh-like network in the 
damaged samples as opposed to the evenly dispersed collagen seen in the 
native tissues. The attachment of cartilage to the underlying bone in the 
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damaged samples also appeared to be less secure, with long threads of 
collagen sparsely attaching to the underlying bone. 
 
 
Figure 5.10 Histological characterisation of cartilage damage following 
application of the dCELL 3 (0.0 % SDS) protocol. Safranin O/Fast green 
stained sections of a) native and b) damaged cartilage, van Gieson stained 
sections of c) native and d) damaged cartilage, Sirus red/Millers elastin 
stained sections of e) native and f) damaged cartilage. Scale bar = 500 µm. 
 
5.4.2.2 Denatured collagen quantification 
To determine whether collagen fibres were being denatured during the 
decellularisation processes, samples of native and treated cartilage (dCELL 
3, 0.0 % SDS) were digested with α-chymotrypsin which can only cleave 
denatured collagen. The digest was hydrolysed and the hydroxyproline 
a b 
c d 
e f 
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content quantified to determine the amount of denatured collagen in the 
tissues. There was no significant difference between the levels of denatured 
collagen in cartilage subject to the dCELL 3 (0.0 % SDS) protocol compared 
to native tissue (Figure 5.11). 
 
 
Figure 5.11 Denatured collagen content of native and damaged 
cartilage (dCELL 3, 0.0% SDS). Data is shown as the mean (n=3) ± 95% 
confidence limits. * significantly different to native (p<0.05 ANOVA).  
 
5.4.3 Investigation into cartilage damage 
To determine the cause of the cartilage damage which was occurring during 
decellularisation, key steps in the process were changed or omitted 
systematically to determine their effect on cartilage stability. 
5.4.3.1 Analysis of incubation temperature 
To better understand the temperature changes during the decellularisation 
process and how temperature could affect cartilage stability, the temperature 
of all solutions and incubators was measured when set to 45 °C which was 
used as standard and at a lower temperature of 40 °C. The incubator and 
solution temperatures recorded during dCELL 3 (6 h 0.1 % SDS) process 
are shown in Figure 5.12. The highest solution temperature reached during 
incubation at 40 °C was 43 °C, whereas solutions incubated at 45 °C 
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reached temperatures of  47.5 °C during the extended PBS end wash. At the 
end of the decellularisation process the cartilage was still attached to all pins 
decellularised at 40 °C, however the cartilage on the pins decellularised at 
45 °C had all become detached and had begun to completely dissolve in 
solution. All subsequent decellularisation processes were performed at 42 
°C to minimise any detrimental effects of high temperature on the cartilage 
structure. 
 
Figure 5.12 Incubator and solution temperatures during 
decellularisation. The solution temperature before and after incubation 
(n=1) and the incubator temperature at the end of each incubation are 
shown for incubators set at 40 °C and 45°C. 
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5.4.3.2 Systematic removal of key steps of the decellularisation 
process 
Key stages of the decellularisation process were removed to identify how the 
level of cartilage damage was affected by the presence/absence of that step, 
as described in Section 5.3.4.2. Histological assessment of tissues following 
these varied decellularisation procedures are shown in Figure 5.13. 5.14 and 
5.15. 
 
a 
b 
c 
d 
e 
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Figure 5.13 H&E stained sections (n=3) of cartilage following 
decellularisation following protocols with steps systematically 
removed. Panel a) complete decellularisation dCELL 3 process (positive 
control), b) dCELL 3 process with the dry freeze/thaw cycle (-20 °C) omitted, 
c) dCELL 3 process with the all four freeze/thaw cycles omitted, d) dCELL 3 
process with the hypotonic wash omitted, e) dCELL 3 process with the SDS 
wash omitted, f) dCELL 3 process with the PAA sterilisation step omitted, g) 
dCELL 3 process with the extended PBS end wash omitted, h) PBS only 
(negative control). Scale bar = 200 µm. 
  
f 
g 
h 
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Figure 5.14 van Gieson stained sections (n=3) of cartilage following 
decellularisation following protocols with steps systematically 
removed. Panel a) complete decellularisation dCELL 3 process (positive 
control), b) dCELL 3 process with the dry freeze/thaw cycle (-20 °C) omitted, 
c) dCELL 3 process with the all four freeze/thaw cycles omitted, d) dCELL 3 
process with the hypotonic wash omitted, e) dCELL 3 process with the SDS 
wash omitted, f) dCELL 3 process with the PAA sterilisation step omitted, g) 
dCELL 3 process with the extended PBS end wash omitted, h) PBS only 
(negative control). Scale bar = 200 µm. 
 
  
g 
h 
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Figure 5.15 Alcian blue stained sections (n=3) of cartilage following 
decellularisation following protocols with steps systematically 
removed. Panel a) complete decellularisation dCELL 3 process (positive 
control), b) dCELL 3 process with the dry freeze/thaw cycle (-20 °C) omitted, 
c) dCELL 3 process with the all four freeze/thaw cycles omitted, d) dCELL 3 
process with the hypotonic wash omitted, e) dCELL 3 process with the SDS 
wash omitted, f) dCELL 3 process with the PAA sterilisation step omitted, g) 
dCELL 3 process with the extended PBS end wash omitted, h) PBS only 
(negative control). Scale bar = 200 µm. 
 
All tissues showed signs of damage, having much larger lacunae than native 
tissue and showing a rougher cartilage surface. Clumping of the collagen 
network could be seen at the cartilage surface on most pins. Surprisingly, 
however, even the PBS negative control also showed cartilage damage. 
5.4.3.3 Matrix metalloproteinase inhibition 
Since incubation in PBS alone for 5 days at 42 °C resulted in damage to the 
cartilage, EDTA was added to the PBS plus aprotinin in order to inhibit the 
activity of matrix metalloproteinases which may have been actively 
degrading the cartilage ECM. H&E, van Gieson and alcian blue stained 
sections of pins incubated in PBS with aprotinin and EDTA are shown in 
Figure 5.16, and pins incubated in just PBS plus aprotinin (as a positive 
control) can be seen in Figure 5.17.  
Damage to cartilage was minimal in both sets, enlarged lacunae and 
roughened cartilage surface seen previously were less evident in these 
images, even in the PBS only positive control. 
g 
h 
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Figure 5.16 Osteochondral pins incubated in PBS with EDTA plus 
aprotinin for 5 days at 42 °C. Panel a) H&E stained tissue sections, scale 
bar = 500 µm, b) van Gieson stained tissue sections, scale bar = 500 µm, 
and panel c) alcian blue stained tissue sections, scale bar = 1000 µm. 
a 
b 
c 
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Figure 5.17 Osteochondral pins incubated in PBS plus aprotinin only 
for 5 days at 42 °C. Panel a) H&E stained tissue sections, scale bar = 500 
µm, b) van Gieson stained tissue sections, scale bar = 500 µm, and panel c) 
alcian blue stained tissue sections, scale bar = 1000 µm.  
 
5.4.3.4 Analysis of solution tonicity 
5.4.3.4.1 Osmolality measurements 
The osmolality of synovial fluid obtained from porcine knee joints was 
measured to determine whether PBS was at the correct tonicity for cartilage, 
as although it is isotonic to the cells, it may not be isotonic to cartilage ECM. 
The osmolality of porcine synovial fluid was found to be 329 ± 59 
mOsmol.Kg-1 and ranged between 302 - 344 mOsmol.Kg-1 (Figure 5.18). 
PBS had a lower osmolality than synovial fluid, but not significantly so.  
Mannitol was added to PBS at to different concentrations, 1 % (w/v) mannitol 
in PBS resulted in a solution with an osmolality of 352 ± 6 mOsmol.Kg-1, and 
2 % (w/v) mannitol in PBS had significantly higher osmolality than that of 
synovial fluid at 401 ± 5 mOsmol.Kg-1. 
a 
b 
c 
- 169 - 
 
Figure 5.18 Osmolality of porcine synovial fluid, PBS and PBS with 
mannitol. . Data is shown as the mean (n=3) ± 95% confidence limits. * 
significantly different to synovial fluid (p<0.05 ANOVA).  
 
5.4.3.4.2 Incubation in PBS with mannitol 
After incubating osteochondral pins in PBS with 1 % (w/v) and 2 % (w/v) 
mannitol for 5 days at 42 °C, pins were assessed histologically (Figure 5.19 
& 5.20). As previously observed (Section 5.4.3.3), there was no major 
damage visible. It was hypothesised that in the absence of agents such as 
SDS to remove the cells, the process was less harsh and occurrence of 
damage more variable. It was therefore decided to test the hypertonic wash 
solutions in the complete decellularisation process. 
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Figure 5.19 Osteochondral pins incubated in 1 % (w/v) mannitol in PBS 
for 5 days at 42 °C. Panel a) H&E stained tissue sections, scale bar = 500 
µm, b) van Gieson stained tissue sections, scale bar = 500 µm, and panel c) 
alcian blue stained tissue sections, scale bar = 1000 µm. 
 
 
a 
b 
c 
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Figure 5.20 Osteochondral pins incubated in 2 % (w/v)mannitol in PBS 
for 5 days at 42 °C. Panel a) H&E stained tissue sections, scale bar = 500 
µm, b) van Gieson stained tissue sections, scale bar = 500 µm, and panel c) 
alcian blue stained tissue sections, scale bar = 1000 µm. 
 
5.4.3.4.3 Decellularisation of pins using PBS with mannitol 
By not incorporating decellularisation steps, the cells remained in the 
cartilage when washed with PBS alone for five days at  42 °C and the cells 
may have acted to stabilise the tissue and not allow cartilage damage as 
seen in Section 5.4.3.4.2. The hypertonic mannitol in PBS solutions were 
therefore tested in place of standard PBS washes in a decellularisation 
protocol so that the effect of solution osmolality could be determined. 
Histological analysis of pins decellularised using dCELL 3 are shown in 
Figure 5.21, pins decellularised using dCELL 3 with PBS washes containing 
1 % (w/v) and 2 % (w/v) mannitol are shown in Figures 5.22 and 5.23 
respectively. All pins showed a severe reduction in GAGs and some signs of 
damage, including enlarged lacunae, however damage was not as severe as 
observed previously, and was not improved by the addition of mannitol.  
a 
b 
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Figure 5.21 Osteochondral pins decellularised with the dCELL 3 
protocol at 42 °C. Panel a) H&E stained tissue sections, scale bar = 500 
µm, b) van Gieson stained tissue sections, scale bar = 500 µm, and panel c) 
alcian blue stained tissue sections, scale bar = 1000 µm. 
a 
b 
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Figure 5.22 Osteochondral pins decellularised with the dCELL 3 
protocol using 1 % (w/v) mannitol in PBS at 42 °C. Panel a) H&E stained 
tissue sections, scale bar = 500 µm, b) van Gieson stained tissue sections, 
scale bar = 500 µm, and panel c) alcian blue stained tissue sections, scale 
bar = 1000 µm. 
a 
b 
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Figure 5.23 Osteochondral pins decellularised with the dCELL 3 
protocol using 2 % (w/v) mannitol in PBS at 42 °C. Panel a) H&E stained 
tissue sections, scale bar = 500 µm, b) van Gieson stained tissue sections, 
scale bar = 500 µm, and panel c) alcian blue stained tissue sections, scale 
bar = 1000 µm. 
 
5.4.3.5 Analysis of pig skeletal maturity 
Osteochondral pins were taken from skeletally mature pigs (2.4 -3.6 yr) and 
from immature pigs (3 months). These tissues were analysed by histology in 
their native form and following decellularisation using the dCELL 3 protocol 
at 42 °C. H&E stained sections and alcian blue stained sections of native 
and decellularised mature porcine osteochondral tissues are shown in 
Figure 5.24 and 5.25 respectively, H&E stained native and decellularised 
immature porcine osteochondral sections are shown in Figures 5.26 and 
5.27, and alcian blue stained sections are shown in Figure 5.28 and 5.29. 
Mature cartilage was notably thinner (~ 1.2 mm) than immature cartilage (~ 
5.0 mm) and had a lower cell density. The cells of mature cartilage had a 
much more defined orientation, with linear columns of cells aligning 
perpendicular to the cartilage-bone interface. The chondrons of immature 
a 
b 
c 
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cartilage often contained more than one cell, especially in the deep and 
hypertrophic regions. The subchondral bone plate of mature porcine tissues 
was well formed, dense and thick, whereas the boundary between cartilage 
and bone in immature cartilage was much less defined. Trabecular struts of 
mature bone were much thicker than those of immature bone. Cartilage from 
immature pigs also appeared to be highly vascularised, vascular tissues 
could be seen upon dissection and cross sections of vasculature were 
clearly visible in histological sections, for example Figure 5.28 a and b, 
where pink PAS stained blood vessels were observed to cross over from 
bone to cartilage. Vascular tissues have been observed in 6 month old pigs 
(Figure 5.19 b), however, no vascularisation was present in mature porcine 
cartilage. 
During decellularisation, all osteochondral pins from mature pigs remained 
intact, cartilage detached from two of the three pins from immature pigs. 
Upon histological analysis, no damage to the cartilage surface was observed 
on any of the pins, even those from which the cartilage had detached. 
Cartilage and bone from immature pigs appeared mostly decellularised, 
however cells remained in the tissues from mature pigs. 
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Figure 5.24 H&E stained sections of native and decellularised (dCELL 3 
process at 42 °C) mature porcine osteochondral tissues. a) Native (2.4 
yr)  b) decellularised (2.4 yr), c) native (3.6 yr), d) decellularised (3.6 yr), e) 
native (3.6 yr), f) decellularised (3.6 yr). Scale bar = 500 µm. 
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Figure 5.25 Alcian blue stained sections of native and decellularised 
(dCELL 3 process at 42 °C) mature porcine osteochondral tissues. a) 
Native (2.4 yr)  b) decellularised (2.4 yr), c) native (3.6 yr), d) decellularised 
(3.6 yr), e) native (3.6 yr), f) decellularised (3.6 yr). Scale bar = 500 µm. 
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Figure 5.26 H&E stained sections of native immature porcine 
osteochondral tissues. a) 73 days old, b) 74 days old and c) 77 days old. 
Scale bars = 500 µm. 
a b c 
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Figure 5.27 H&E stained sections of immature porcine osteochondral 
tissues following decellularisation with dCELL 3 process at 42 °C. a) 
73 days old, b) 74 days old and c) 77 days old. Scale bars = 500 µm. 
a b c 
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Figure 5.28 Alcian blue stained sections of native immature porcine 
osteochondral tissues. a) 73 days old, b) 74 days old and c) 77 days old. 
Scale bars = 500 µm. 
a b c 
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Figure 5.29 Alcian blue stained sections of immature porcine 
osteochondral tissues following decellularisation with dCELL 3 
process at 42 °C. a) 73 days old, b) 74 days old and c) 77 days old. Scale 
bars = 500 µm. 
a b c 
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5.4.3.6 Decellularisation with 1 vs 5 pins per pot 
Pins from mature and immature animals showed no sign of cartilage 
damage, however, they were decellularised 1 pin per pot, as opposed to the 
usual 2 - 5, so that the pins from each individual pig could be identified. To 
determine whether the lack of cartilage damage seen in the previous study 
was due to having a single pin per pot and therefore altering the flow of 
solutions in each pot during agitation, two further sets of porcine (6 month 
old) osteochondral pins were decellularised with either one or five pins per 
pot. 
 
Figure 5.30 Osteochondral pins decellularised using the dCELL 3 
protocol at 42 °C with 1 pin per pot. Panel a) H&E stained tissue sections, 
scale bar = 500 µm, b) van Gieson stained tissue sections, scale bar = 1000 
µm, and panel c) alcian blue stained tissue sections, scale bar = 1000 µm. 
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Figure 5.31 Osteochondral pins decellularised using the dCELL 3 
protocol 42 °C with 5 pins per pot. Panel a) H&E stained tissue sections, 
scale bar = 500 µm, b) van Gieson stained tissue sections, scale bar = 1000 
µm, and panel c) alcian blue stained tissue sections, scale bar = 1000 µm. 
 
Stained sections of osteochondral pins decellularised with one pin per pot 
are shown in Figure 5.30. Minimal damage was seen, with the structure 
appearing normal, but with some loss of GAGs. When 5 pins per pot were 
decellularised, damage was seen in pins in two of the three pots (Figure 
5.31), the cartilage was thinner and the surface had become more rough, 
complete loss of cartilage GAGs was seen in one of the pins. 
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5.5 Discussion 
As discussed in the previous chapter, the aim of this study was to produce 
an acellular osteochondral scaffold for use in lesion repair. A protocol was 
developed to successfully decellularise bovine osteochondral tissues. The 
aim of the work in this chapter was to optimise the previously developed 
protocol for decellularisation of porcine osteochondral tissues. 
 
5.5.1 Decellularisation optimisation 
Following completion of the basic dCELL 1 protocol it was evident that cells 
were more easily removed from porcine tissues than bovine. Histologically, 
far fewer cell nuclei were present in porcine tissues than bovine tissues 
following decellularisation. The porcine cartilage DNA content was reduced 
by 77.5 %  whereas a non-significant reduction of only 20.9 % was seen for 
bovine cartilage. The inclusion of two cycles of 0.1 % (w/v) SDS and 
hypotonic washes in dCELL5 were necessary to fully decellularise bovine 
tissues, however with the apparent ease of decellularisation of porcine 
tissue, a shorter protocol was preferred to minimise tissue damage. As use 
of the water pik and extended PBS end wash were shown to significantly 
increase cell and DNA removal in bovine tissues compared to the basic 
protocol, the dCELL 3 protocol was performed on porcine osteochondral 
pins, and was successful. This was in contrast to a study by Kheir et al. 
(2011) in which 3 cycles of low concentration SDS and hypotonic washes 
were required to fully decellularise porcine tissues, however this work was 
performed on large osteochondral cuts, as opposed to 9 mm diameter pins 
used in the current study. 
Loss of cartilage proteoglycans was observed following decellularisation of 
porcine tissues using dCELL 3, and this adversely affected the mechanical 
properties of the tissue. Further optimisation with reduced SDS 
concentration and incubation times were employed to minimise GAG loss, 
however, following these protocols, cartilage damage was seen, with 
cartilage detaching from the bone and becoming gelatinous. Further analysis 
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was required to characterise the cartilage damage and to elucidate the 
cause. 
 
5.5.2 Cartilage damage 
Damaged tissue had a distinct histological appearance as evidenced with 
multiple staining techniques. The tissue became highly porous, with lacunae 
of chondrons becoming greatly enlarged and the collagen network between 
chondrons becoming clumped and net-like as opposed to evenly distributed. 
The cartilage surface became rough, likely due to a loss of tension in the 
collagen fibres which run parallel to the surface. Cartilage became very 
loosely attached to the bone, as lacunae which previously housed 
hypertrophic chondrons became stretched and enlarged, leaving only thin 
collagen fibres tying cartilage to the subchondral bone. No GAGs could be 
quantified in severely damaged tissues (6 h SDS) and there was a 
significant increase in water content, up to 95 %. 
The distinct histological appearance of damaged cartilage was also 
witnessed by Schwartz et al. (2012) when developing acellular nasal septum 
cartilage. Schwartz et al. employed a decellularisation process involving 
osmotic cell lysis with distilled water, following which sodium hydroxide (> pH 
12) was used to inactivate pathogens, denature DNA/RNA and remove 
cellular debris. Samples were defatted in 70 % (v/v) ethanol and GAGs and 
other non-collagenous proteins were denatured and removed using a 
guanidine hydrochloride (1 M) solution containing sodium acetate (0.05 N). 
Cartilages were finally sterilised using hydrogen peroxide (5% v/v). 
The histological appearance of the treated nasal septum cartilage was more 
pronounced in porcine (7 - 8 months old) compared to human (18 - 74 years 
old) cartilage. The process resulted in a significant GAG reduction from 4.82 
± 0.94 % to 1.50 ± 0.43 % as a percentage of dry weight, and an almost 
complete loss of alcian blue staining. They saw an increase in tissue 
porosity from 19 ± 12 % to 29 ± 12 %. They concluded that loss of GAG and 
increased porosity were advantageous for cell infiltration during 
recellularisation. 
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A study to produce acellular osteochondral tissues by Kheir et al. (2011), 
also used immature porcine tissue (4 months old), and employed a similar 
protocol to that described in this study, based on that of Stapleton et al. 
(2008). They used 50 mm x 10 mm x 10 mm osteochondral blocks from the 
porcine femoral groove and found that 6 cycles of hypertonic buffer and SDS 
in hypertonic buffer (0.1 %, w/v) were required to fully remove all cell nuclei 
and achieve a 98 % reduction in cartilage DNA, however, no histological 
damage to cartilage was apparent following this more harsh protocol. 
To further assess the cartilage damage seen in the current study, digestion 
of cartilage with α-chymotrypsin was performed to cleave denatured collagen 
which could then be quantified using the hydroxyproline assay. This was 
performed with the aim of identifying whether collagen damage was 
occurring during the decellularisation process and contributing to the 
histological appearance and tissue degeneration. No significant increase in 
denatured collagen was found compared to native tissue, suggesting that 
collagen fibres had remained intact. 
 
5.5.3 Investigation into cartilage damage 
To identify the cause of cartilage damage, many different factors associated 
with the decellularisation protocol were investigated . Although no collagen 
denaturation was observed, damage to other non-collagenous proteins may 
have occurred at high temperatures of incubation. Osteochondral pins 
decellularised at 45 °C  (reaching temperatures of 48 °C) disintegrated more 
readily than those incubated at 40 °C, however, cartilage damage was still 
present at lower temperatures. The increased damage at higher temperature 
may have been as a result of increased diffusion. As temperature had had 
an effect on the extent of damage, all subsequent protocols were performed 
at the lower temperature of 42 °C, as this would not range above 45 °C, and 
would remain at a higher temperature than 37°C, avoiding the optimal 
temperature for bacterial growth. 
As reduction in incubation temperature had not eliminated cartilage damage, 
each aspect of the decellularisation process was considered and removed 
from the process to determine the individual effect on cartilage stability. 
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Many phases of the decellularisation protocol had the potential to cause 
damage; freeze-thaw cycles create interstitial and intracellular ice crystals, 
which increase matrix permeability, hypotonic buffer has an osmotic effect 
on the cells and tissue, SDS denatures proteins and solubilises membranes 
(Seddon et al., 2004) and PAA causes protein damage by oxidative stress 
(Pruss et al., 1999). Although PBS washes alone were not thought to be 
damaging to the tissue, cartilage disintegration tended to occur during the 
final end wash, so this was also isolated as a potential damage causing 
factor. As a negative control, pins were washed in PBS alone. Surprisingly, 
all protocols, including the PBS alone control resulted in some degree of 
tissue damage. This indicated that damage was not as a direct result of any 
particular stage of the decellularisation process, and other protocols based 
on the same sequence of decellularisation treatments had not resulted in 
tissue damage (Booth et al., 2002; Stapleton et al., 2008; Kheir et al., 2011).  
Cartilage damage had occurred when osteochondral pins were incubated in 
PBS with aprotinin (10 KUI.ml-1) for 5 days. Advancing on protocols 
developed by Stapleton et al. (2008) and Kheir et al. (2011), EDTA, a matrix 
metalloproteinase inhibitor had been omitted from the PBS wash buffer in 
this study, as it also functions to decalcify bone and has been linked to 
cytotoxicity (Koulaouzidou et al., 1999). Pins were incubated in a PBS wash 
buffer containing EDTA (0.1 %, w/v) and aprotinin (10 KUI.ml-1) for 5 days, to 
see if addition of the MMP inhibitor reduced or prevented the cartilage 
damage. No damage was seen, however, neither was it seen in the PBS 
only positive control. Although addition of EDTA did not clarify the role of 
MMPs in cartilage damage, due to the lack of denatured collagen in 
damaged samples, it is unlikely that collagenase activity of MMPs was 
responsible for cartilage degradation. 
Another factor associated with the PBS wash buffer to consider was the 
tonicity. PBS is isotonic for cells, but may not necessarily be isotonic to the 
cartilage ECM. According to Baumgarten et al. (1985), the osmolality of 
normal synovial fluid is 404 ± 57 mOsmol.Kg-1, however following exercise 
this reduced to isotonic levels, 301 ± 19 mOsmol.Kg-1. Synovial fluid from 
knee joints of individuals suffering from OA and rheumatoid arthritis was 
found to have reduced osmolality, being 297.3 ± 16.9 mOsmol.Kg-1 and 
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279.6 ± 7.5 mOsmol.Kg-1 respectively (Shanfield et al., 1988). Having linked 
reduced osmolality of synovial fluid to arthritic joints, Bloebaum & Magee 
(1989) developed and patented a modified ringers solution containing 
mannitol for use as a hypertonic irrigating solution during arthroscopic 
lavage. In this study the osmolality of porcine synovial fluid was found to be 
329 ± 59 mOsmol.Kg-1. To increase the osmolality of the PBS wash buffers 
used for decellularisation, mannitol was added. A 1 % (w/v, 350 mOsmol. 
Kg-1) solution was used to match porcine synovial fluid and a 2 % (w/v, 400 
mOsmol.kg-1) solution of mannitol in PBS was used to match values stated 
for human synovial fluid. After incubation at 42 °C with agitation in PBS with 
mannitol for 5 days, all osteochondral pins appeared histologically 
undamaged, however as stated before, the PBS only control also did not 
show signs of damage. Potentially the retention of cells in the tissue was 
stabilising the structure, so mannitol enhanced PBS wash buffers were used 
as part of the dCELL 3 protocol. Following decellularisation with the mannitol 
solutions, both showed slight histological signs of damage, as did the 
decellularisation using PBS without mannitol. Use of hypertonic PBS did not 
prevent cartilage damage during decellularisation.  
It was noted that although porcine cartilage showed signs of damage 
following application of the dCELL 3 protocol, bovine tissues did not; the 
quality of the porcine source material was therefore considered a potential 
factor in cartilage degeneration. Characterisation of osteochondral tissues 
from different species in Chapter 3 highlighted differences in the maturity of 
porcine and bovine tissues. To assess the effect of skeletal maturity on 
cartilage degeneration, two further age ranges of pigs were selected. As pigs 
are skeletally mature from 2.5 years (Reinwald & Burr., 2008), a skeletally 
mature group aged between 2.4 and 3.6 years and a very immature group 
aged 3 months old were selected for decellularisation. Histologically the 
native osteochondral tissues from immature pigs showed characteristically 
thick cartilage with high cell density and indistinct cell orientation and intense 
alcian blue staining for GAGs (Julkunen et al., 2009), vascularisation was 
also seen throughout the young cartilage, indicative that the tissue was not 
fully formed and still growing, and the cartilage-bone interface was not clear 
and appeared full of hypertrophoc cells. Conversely, tissue from the older 
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pigs was fully mature, with much thinner cartilage, which had a lower cell 
density and much more defined cell orientation. The tissues from mature 
pigs showed a defined, thick subchondral bone plate. 
Upon decellularisation, neither the immature group nor the mature group 
showed any signs of cartilage damage. Although cartilage had become 
detached from the bone of 2/3 pins from immature pigs during washing, this 
was likely due to the poor attachment originally and shear stress applied to 
the attachment site during coring of osteochondral pins from the joint, and 
not due to the decellularisation process. Of interest was the fact that 
immature tissues appeared to be fully decellularised following application of 
dCELL 3, however mature porcine tissues (similarly to bovine osteochondral 
tissues) were not fully decellularised, likely due to inadequate solution 
infiltration through the dense subchondral bone plate. 
To identify which osteochondral pin came from which individual pig when 
assessing the effect of skeletal maturity on cartilage degradation, each pin 
was decellularised in a single pot. Usually 3-5 pins are decellularised in one 
pot at a time. A single pin agitated in a pot of solution will likely have different 
effect on how the fluid flows, and may affect the mechanical shear forces 
experienced by that single pin compared to a larger number of pins, 
explaining why neither mature nor immature porcine osteochondral pins 
showed cartilage damage. To this end one pin and five pins per pot were 
decellularised using the dCELL 3 protocol. Damage to varying degrees was 
seen in both conditions, so the number of pins per pot is not thought to 
influence cartilage damage.   
Of note throughout this study was the variability with which cartilage 
responded to any of the processes detailed. The presence or absence of 
damage and extent to which cartilage damage occurred was inconsistent 
within treatment groups and between processes. This unpredictability made 
it difficult to conclusively determine the effect of any treatment on porcine 
cartilage. The lack of consistency may be due to the stage of development of 
the porcine tissue, as minor variations in pig age could have had 
pronounced effects on the cartilage stability. 
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5.5.4 Conclusion 
Although initially a protocol was developed to successfully decellularise 
porcine tissues, further investigation revealed that the cartilage was 
damaged, which in some cases resulted in the cartilage dissolving 
completely in the decellularisation solutions, and in other cases resulted in 
the cartilage becoming devoid of GAGs, having a greatly increased porosity 
and water content and having drastically reduced biomechanical properties. 
High temperatures were found to increase the severity of cartilage damage, 
likely through increased diffusion. 
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Chapter 6 
Biocompatibility of acellular bovine 
osteochondral scaffolds 
6.1 Introduction 
A protocol was developed to successfully decellularise bovine osteochondral 
tissues in Chapter 4. Histological analysis of the acellular scaffold was 
performed and the DNA, GAG and hydroxyproline content quantified as well 
as an evaluation of the biomechanical properties. The tissue was found to 
have severely reduced GAG content, which resulted in reduced mechanical 
properties. To further characterise the effect of decellularisation on the 
osteochondral extracellular matrix, immunohistochemistry was used to 
locate specific matrix constituents.  
Furthermore, SDS used in the decellularisation has been reported to have 
cytotoxic effects when not effectively removed from decellularised tissue 
matrices  (Rieder et al., 2004). Residual SDS within the scaffold may prevent 
ingrowth of cells in vivo and result in graft failure. Residual SDS within the 
tissue was quantified and the contact cytotoxicity of the acellular scaffold 
was determined.    
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6.2 Aims and objectives 
Aims: 
The aim of the research in this chapter was to investigate changes to 
specific matrix proteins in bovine osteochondral tissues following 
decellularisation and to assess the biocompatibility of the acellular scaffold. 
Objectives: 
 To determine the biocompatibility of the acellular osteochondral 
matrix. 
o To determine the concentration at which SDS has cytotoxic 
effects on BHK and 3T3 cell lines. 
o To quantify the SDS removed from the tissues during wash 
cycles and determine the concentration of residual SDS left in 
bovine cartilage and bone following decellularisation. 
o To determine biocompatibility of the acellular scaffold in vitro 
using the contact cytotoxicity technique with BHK and 3T3 cell 
lines. 
Additional objectives were not pursued due to unforeseen issues with the 
initial biocompatibility testing. 
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6.3 Methods 
6.3.1 SDS quantification 
Reagents 
In addition to reagents listed in Section 4.4.1, the following reagents were 
used. 
 14C radiolabelled SDS in   750 ml SDS in hypotonic solution 
hypotonic buffer (0.1 % w/v,  75 µl 14C  SDS 
0.01 µCi.ml-1) 
 MicroScint™-20 
Method 
To quantify the SDS washed out of the decellularised tissues in each wash 
solution (n=3) and also to quantify the residual SDS in the decellularised 
tissues (n=3), the decellularisation protocol described in Section 4.4.2.14 
was performed using SDS in hypotonic solution which had been spiked with 
14C radiolabelled SDS, produced as described in Section 6.3.2.1. Solutions 
and tissues from the decellularisation were collected. 
A set of standards were produced from the spiked SDS solution to give SDS 
concentrations of 1000 µg.ml-1, 750 µg.ml-1, 500 µg.ml-1, 250 µg.ml-1, 125 
µg.ml-1, 50 µg.ml-1, 25 µg.ml-1, 10 µg.ml-1 and 0 µg.ml-1. Standard (40 µl), 
test solution (40 µl) or macerated decellularised cartilage or bone (40 mg) 
were added in triplicate to a flat bottomed 96 well optiplate™ and 
MicroScint™-20 (160 µl) was added to each well. Counts per minute were 
measured using Top count ™, with each well being counted for 20 min. A 
standard curve of counts per minute was produced from the known 
concentrations of SDS, from which the concentration of SDS in the test 
solutions and tissue could be interpolated. 
 
6.3.2 Determining the toxic concentration of SDS  
To determine the concentration at which SDS had cytotoxic effects on two 
cell lines, 3T3 and BHK cell lines were incubated with varying concentrations 
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of SDS solution. Cell culture was performed as described in Section 2.2.6. 
Cells were seeded at subconfluent numbers onto flat bottomed 96 well 
culture plates and incubated overnight at 37 °C in 5 % CO2 (v/v) in air. Once 
cells had attached, culture medium was aspirated and replaced with 200 µl 
of medium containing a known concentration of SDS or DMSO positive 
control (40 %, v/v) in cell culture medium. SDS was dissolved in appropriate 
cell culture medium for each cell type at concentrations of 750 µg.ml-1, 500 
µg.ml-1, 250 µg.ml-1, 100 µg.ml-1, 50 µg.ml-1, 25 µg.ml-1, 10 µg.ml-1, 5 µg.ml-1 
and 0 µg.ml-1 and sterilised by passing through a 2 µm filter. Cells were 
incubated in these test media for  24 h at 37 °C in 5 % CO2 (v/v) in air. 
Following incubation cell viability was determined using the ATPLite-M® 
assay. 
6.3.2.1 ATPLite-M® cell viability assay 
Cell viability was determined using the ATP-lite M® assay kit, where cellular 
adenosine triphosphate (ATP; present in all metabolically active mammalian 
cells) reacts with ᴅ-luciferin in the presence of luciferase to produce light 
which can be quantified using a scintillation counter. In cells which have 
undergone apoptosis, ATP will rapidly deplete, so little to no light will be 
detected.  
Cell culture medium was aspirated from cells cultured in a 96 well plate and 
50 µl of the appropriate cell culture medium was added to each well. 
Mammalian cell lysis solution (50 µl) from the ATPLite-M® assay kit was 
added to each well and the plate was shaken for 5 min on a microshaker. 
The contents from each well was transferred to a 96 well optiplate™ and 50 
µl substrate solution was added to each well. The plate was covered in foil 
and agitated for a further 5 minutes on a microshaker. Any air bubbles were 
removed by carefully flaming the plate before determining the luminescence 
of each well using Top count™ scintillation counter.  
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6.3.3 Contact cytotoxicity 
Bovine osteochondral pins (2 pins per pot from n=3 animals) were 
decellularised using dCELL 5 (Section 4.4.2.14). Each pin was dissected 
into small pieces as described in Figure 6.1 and 3 pieces from one pin were 
each placed in a well of a 6 well culture plate and secured using a steri-strip. 
A drop of cyanoacrylate contact adhesive was applied to the centre of one 
well on each plate to act as a positive control for cell growth inhibition and a 
steri-strip adhered to another as a negative control, a final well was left 
empty to observe normal cell growth.  
 
 
Figure 6.1 Dissection of osteochondral pins for contact cytotoxicity 
assay. Pins were cut along the dotted lines using a sterile scalpel blade to 
produce four rectangular osteochondral pieces exposing the innermost part 
of the pin.  
 
Plates were washed using PBS without calcium or magnesium three times 
for ten minutes each before being seeded with 3T3 (n=3) or BHK cells (n=3) 
at numbers appropriate to become confluent after 48 h. Plates were 
incubated for 48 h at 37 °C in 5 % CO2 (v/v) in air. Each well was examined 
microscopically to detect changes in cell morphology, vacuolisation, 
detachment and cell lysis. The medium was aspirated and each well washed 
in PBS before fixation of the monolayer with 10 % (v/v) NBF for 10 min. NBF 
was aspirated and Giemsa stain was applied to each well for 5 min. Excess 
Giemsa stain was then removed using tap water. Again, changes to the cells 
were visualised by light microscopy. 
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6.3.4 Modified protocol for the production of biocompatible 
bovine osteochondral scaffolds 
The protocol developed to decellularise bovine osteochondral pins (Section 
4.4.2.14) was augmented to include further PBS end washes, with the 
intention of improving SDS wash out to produce a biocompatible scaffold. 
Two extended protocols (7 day and 14 day extended PBS washes) were 
developed to determine the optimum end wash duration, where sufficient 
SDS wash out was achieved without unnecessarily extending the protocol. 
The basic 48 - 60 h weekend end wash protocol (Section 4.4.2.12) was 
augmented with 4 x 24 h PBS washes after the final weekend wash (7 day 
PBS end wash) or 4 x 24 h PBS washes, followed by a second 48 – 60 h 
PBS wash and a further 4 x 24 h  PBS washes (14 day PBS end wash). All 
PBS washes were performed at 42 °C with agitation. The three protocols (2 
day, 7 day and 14 day PBS end wash) were performed alongside each 
other, 2 pins per pot from n=3 animals were used for each protocol. 
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6.4 Results 
6.4.1 SDS quantification 
To quantify SDS washed out from tissues during decellularisation and to 
determine the concentration of residual SDS in the decellularised 
osteochondral matrix, tissues were decellularised using solutions spiked with 
radiolabelled SDS. Quantification of radiolabelled SDS was performed by 
adding scintilant to spiked solutions/ tissues and measuring the activity on a 
scintillation counter. A standard curve of SDS concentration against counts 
per minute was produced (Figure 6.2), from which unknown SDS 
concentrations could be interpolated. 
 
 
Figure 6.2 Linear relationship between SDS concentration and counts 
per minute. Data is shown as the mean (n=3) ± 95 % confidence limits. 
 
The concentration of SDS in each wash solution of the decellularisation 
process is shown in Figure 6.3. High concentrations of SDS were measured 
in the SDS wash solutions (750 ± 210 µg.ml-1), however this was lower than 
the 1000 µg.ml-1 expected from a 0.1 % (w/v) SDS solution. Error was high 
in the SDS solutions and some SDS from the solution would have entered 
the tissues, explaining the lower value. The hypotonic wash (24 h) after the 
first SDS incubation showed a relatively high concentration of SDS (59 ± 87 
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µg.ml-1) compared to the PBS wash (10 min) following the second SDS 
incubation, suggesting a more thorough wash out of SDS during that first 24 
h wash period. All solutions showed low concentrations of SDS, suggesting 
that SDS was still being washed out of the tissue during the last PBS wash. 
 
 
Figure 6.3 Concentration of SDS in decellularisation solutions 
following quantification of 14C SDS. Data is shown as the mean (n=3) ) ± 
95 % confidence limits. 
 
Quantification of SDS in the tissue showed that decellularised bovine 
cartilage contained 364 ± 43 ng.mg-1 SDS and decellularised bone contained 
374 ± 187 ng.mg-1 SDS (Figure 6.4), approximately 0.037 % (w/w) SDS per 
tissue wet weight. 
 
- 199 - 
 
Figure 6.4 Concentration of residual SDS in decellularised bovine 
cartilage and bone. Data is shown as the mean (n=3) ) ± 95 % confidence 
limits. 
 
6.4.2 SDS toxicity 
To determine the concentration at which SDS had cytotoxic effects, cell lines 
were incubated with varying concentrations of SDS in cell culture medium 
and incubated overnight. Cell viability was determined using the ATP-lite M® 
assay.  
The cytotoxic effect of varying concentrations of SDS on BHK and 3T3 cell 
lines can be seen in Figure 6.5. At SDS concentrations of 25 µg.ml-1 and 
below, no cytotoxic effect was seen with either cell line. At ≥ 50 µg.ml-1 SDS, 
BHK cells showed a significant reduction in counts per minute (CPM), 
indicating that reduced cell viability had occurred at these concentrations. 
3T3 cells only showed a significant reduction in CPM at SDS concentrations 
≥ 250 µg.ml-1 suggesting this cell type had lower sensitivity to SDS 
cytotoxicity.  
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Figure 6.5 Cytotoxicity of varying concentrations of SDS to BHK and 
3T3 cell lines. Data is shown as the mean (n=3) ) ± 95 % confidence limits. 
* Significant, p<0.05 (ANOVA). 
 
6.4.3 Contact cytotoxicity 
Decellularised tissues were incubated with either 3T3 cells (Figure 6.6) or 
BHK cells (Figure 6.7) for 48 h to determine contact cytotoxicity. Growth of 
both cell types appeared normal when seeded into a blank well of the culture 
plate. Those cultured with a steri-strip negative control also had normal 
morphology and grew up to and against the strip. Cells cultured with 
cyanoacrylate positive control did not adhere next to the glue and had a 
rounded morphology characteristic of dead cells.  3T3 cells cultured with 
decellularised cartilage and bone had normal morphology and grew up to the 
tissue. However when BHK cells were cultured with decellularised tissue one 
of the 3 tissues (Figure 6.7 d & e) showed cytotoxic effects, with cells not 
adhering next to the tissue and having a rounded ball morphology.  
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Figure 6.6 Contact cytotoxicity of decellularised bovine osteochondral 
tissues when cultured for 48 h with 3T3 cells. Panel a) cells only, panel 
b) cyanoacrylate positive control, panel c) steri-strip negative control, panel 
d) decellularised bovine bone, panel e) decellularised bovine cartilage. 100 x 
magnification, scale bars = 200 µm. 
a 
b 
d 
c 
e 
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Figure 6.7 Contact cytotoxicity of decellularised bovine osteochondral 
tissues when cultured for 48 h with BHK cells. Panel a) cells only, panel 
b) cyanoacrylate positive control, panel c) steri-strip negative control, panel 
d) decellularised bovine bone, panel e) decellularised bovine cartilage. 100 x 
magnification, scale bars = 200 µm. 
 
  
a 
b 
d 
c 
e 
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6.4.4 Modified protocol 
Following application of the 7 and 14 day PBS wash modified protocols 
(Section 6.3.5), cartilage damage occurred in all samples between the 4 and 
5 day point. The cartilage detached from a number of samples as observed 
with porcine tissues (Chapter 5). Further analysis could not be performed. 
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6.5 Discussion 
The aim of this study was to further characterise the decellularised bovine 
osteochondral matrix to identify whether the resultant scaffold was 
biocompatible. 
For acellular scaffolds to be used in patients, it is essential that they are not 
toxic or harmful. ISO 10993 is in place to ensure thorough and appropriate 
testing of all medical devices is completed during product development. 
Initial basic in vitro biocompatibility testing should be performed prior to in 
vivo testing and use in animal models to ensure the scaffold has no 
immediate toxic effects before more advanced immune responses can be 
investigated.  
SDS, a detergent included in the decellularisation process to solubilise 
cellular membranes has been shown to have cytotoxic effects when not 
thoroughly removed from dcellularised tissues (Rieder et al., 2004). SDS is 
able to impart a negative charge on proteins, which may inhibit cell 
attachment and proliferation, it is also able to denature proteins, which may 
affect cell survival (Seddon, 2004). 
Quantification of the residual SDS in the decellularised tissues, found that 
the majority of SDS was removed during wash steps, and that tissues only 
contained ~ 370 ng.mg-1 SDS per wet weight following decellularisation.  
However, incubation of cells with varying concentrations of SDS showed 
concentrations of ≥ 250 µg.ml-1 to be cytotoxic to 3T3 cells and even lower 
concentrations of ≥ 50 µg.ml-1 to be cytotoxic to BHK cells. Assuming 370 
ng.mg-1 SDS present in tissues is equivalent to 370 µg.ml-1, the residual 
SDS in decellularised tissues may have resulted in them being cytotoxic .  
Contact cytotoxicity assays with 3T3 cells did not show any cytotoxic effects 
of the tissues, however, BHK cells, which showed higher sensitivity to SDS 
did show cytotoxicity with one sample. It may be that, although the 
concentration of SDS in the tissues was high, it was not immediately 
accessible from the dense 3D solid tissues to the cell monolayer, as it would 
be expected that all samples would be cytotoxic with both cell types at this 
concentration.  
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As some cytotoxicity was seen, modifications to the protocol were included 
to increase the number and duration of PBS washes at the end of the 
process to improve SDS wash out. When additional PBS washes were 
included, tissue samples began to show signs of damage, as seen in porcine 
tissue. The cartilage shrivelled in from the bone and in cases became 
detached. It appeared that the same problem was present with bovine and 
porcine osteochondral decellularisation.  
The potential causes of cartilage damage were thoroughly investigated in 
Chapter 5, however the size of osteochondral pin decellularised is a 
common factor in porcine and bovine decellularisation processes which had 
not been investigated. To conclusively eradicate cartilage damage during the 
decellularisation process, further methods using larger osteochondral 
constructs were investigated in the next chapter.  
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Chapter 7 
Decellularisation of large osteochondral 
constructs 
7.1 Introduction 
Previously in this study, a protocol was developed for the decellularisation of 
osteochondral pins from the knee condyles of 6 month old pigs (Chapter 5). 
A limitation to this process was that the cartilage often became irreversibly 
damaged during decellularisation. The degree to which cartilage damage 
occurred varied greatly, resulting in a range of tissue morphologies from 
slight increase of porosity at the cartilage surface, to shrinkage in from the 
cut edges, complete loss of GAGs and increase in water content to 95 % 
(w/w), to the cartilage completely dissolving away in the decellularisation 
wash solutions. The cause of the damage was thoroughly investigated, 
however, no protocol could be developed which fully eradicated cartilage 
damage. Prior to studies with porcine cartilage, it had been shown that 
bovine cartilage pins from the knee condyles of 18 month old animals could 
be decellularised without sustaining any overt damage (Chapter 4), however, 
with increased wash cycles to reduce residual SDS levels in the tissue, the 
bovine cartilage pins also exhibited similar damage (Chapter 6). 
During the course of this study, Schwarz et al., (2012) reported upon the 
decellularisation of porcine and human nasal cartilage. It was of interest to 
note, that although not recognised by the authors as damaged, the histology 
images of the decellularised cartilage showed similar morphology to the 
damaged cartilage found in the present study. A similarity was that Schwarz 
et al. performed decellularisation on cylindrical cuts of cartilage (5 mm 
diameter discs, 1 mm depth). Collagen fibres in hyaline cartilage are under 
tension, this tension plays an important role in cartilage structure and 
function. The collagen network interacts with GAGs to resist repulsion 
between the negatively charged proteoglycans, holding the ECM together 
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(Mow et al., 2005). It was hypothesised that when extracting cartilage pins 
and producing a cut edge,  a loss of tension in the collagen fibres occurred 
and this facilitated the decellularisation solutions to cause damage to the 
tissue. In order to test this hypothesis it was logical to determine whether 
damage would occur when larger cuts or uncut cartilage (large bovine plates 
and whole porcine condyles) were subject to the decellularisation process 
and observing the effect on cartilage structure. 
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7.2 Aims and objectives 
Aims: 
The aim of the study presented in this chapter was to apply the  
decellularisation protocols developed in Chapter 5 for porcine cartilage and 
Chapters 4 and 6 for bovine cartilage to whole porcine condyles and large 
bovine osteochondral cuts and to identify any structural damage caused to 
the cartilage. 
Objectives: 
 To apply the decellularisation protocol for porcine cartilage pins to 
whole porcine medial condyles (with the cancellous bone removed). 
 To apply the decellularisation protocol for bovine pins to bovine 
osteochondral plates (40 mm long x 20 mm wide x 10 mm deep). 
 To qualitatively assess the decellularised osteochondral tissues using 
histology, to determine the histoarchitecture, GAG distribution and 
cellularity. 
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7.3 Methods 
7.3.1 Dissection of porcine medial condyles  
Whole porcine (6 months old) right legs (n=3) were dissected as described in 
Section 2.2.2.1 and 2.2.2.2. Following exposure of the femoral component of 
the knee, the femur was clamped and a hand saw used to cut into the bone 
between the two condyles. Another cut was made across the femur, from the 
base of the femoral groove to the back of the condyle, to release the condyle 
in its entirety. Using a hand drill with 5 mm diameter drill bit, the cancellous 
bone was drilled into from the underside and bone cutters used to hollow out 
the condyle, leaving approximately 10 mm subchondral bone underneath the 
cartilage surface. Condyles were stored frozen as described in Section 
2.2.2.4 until required. 
 
7.3.2 Dissection of bovine medial groove plates  
Bovine femurs (n=3) were dissected as described in Section 2.2.2.1 and 
2.2.2.2. Using callipers, a plate 20 mm wide x 40 mm long was measured 
and marked out on the cartilage surface using a scalpel. Using a hand saw, 
the shape was cut into the groove, and a final cut was made parallel to the 
cartilage surface through the bone to release the plate. A purpose built 
clamp was used to hold the plate and the subchondral bone was accurately 
trimmed to 10 mm depth using a hack saw (Figure 7.1). 
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Figure 7.1 Preparation of bovine osteochondral plates. a) a 20 mm x 40 
mm rectangle was marked out on the medial femoral groove and cut out 
using a saw. b) the plate was secured in a purpose deigned holder and the 
bone was cut to 10 mm deep using a saw. 
 
7.3.3 Porcine condyle decellularisation 
Porcine condyles (n=3) were decellularised one per 150 ml pot with 125 ml 
decellularisation solution as described in Section 5.3.2.2. Condyles were 
subject to additional 4 x 24 h PBS washes at 42 °C with agitation following 
the extended 48 - 60 h PBS wash. 
 
7.3.4 Bovine plate decellularisation 
Bovine osteochondral plates (n=3) were decellularised one per 150 ml pot 
with 125 ml decellularisation solution as described in Section 4.4.2.14. 
Plates were subject to additional 4 x 24 h PBS washes at 42 °C with 
agitation following the extended 48 - 60 h PBS wash. 
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7.3.5 Histological analysis 
7.3.5.1 Slide preparation 
Whole decellularised porcine condyles and bovine plates were fixed in 10 % 
(v/v) NBF and decalcified as described in Section 2.2.3.1 and 2.2.3.2. A 5 - 8 
mm thick slice was taken through the centre of the porcine condyle (medial 
to lateral side) which was then processed, wax embedded and sectioned as 
described in Section 2.2.3.3 and 2.2.3.4. Slices (5-8 mm thick) were also 
taken through the centre of the bovine plate across the plate width which 
were then processed, wax embedded and sectioned. 
7.3.5.2 Reverse processing 
Wax embedded bovine tissue blocks were melted in an oven at 60 °C 
overnight. Under vacuum with agitation in the Lecia TP 120 automated 
tissue processor, tissues were dewaxed through 2 x 2 h cycles of xylene and 
dehydrated in 2 x 2 h cycles of 100 % methylated spirits. Tissues were 
placed in 70 % methylated spirits for 15 min prior to being re-processed as 
described in Section 2.2.3.3. 
7.3.5.3 Wax block decalcification 
Wax embedded bovine tissue blocks were trimmed down to expose the 
sample using a microtome (Leica RM2125RTF). Blocks were then immersed 
in a 12.5 % (w/v) EDTA solution (Section 2.2.3.2.1) overnight at room 
temperature without agitation to decalcify the exposed surface to be 
sectioned. 
7.3.5.4 Sectioning and slide preparation 
Wax embedded tissues were sectioned and transferred to slides as 
described in Section 2.2.3.4. 
7.3.5.5 Histological staining 
Tissue sections were stained with H&E (Section 2.2.4.1), Alcian blue 
(Section 2.2.4.3), van Gieson (Section 2.2.4.4) and DAPI (Section 2.2.4.6) 
prior to being mounted and imaged microscopically. 
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7.4 Results 
7.4.1 Porcine whole medial condyles  
Porcine whole medial condyles (n=3) were decellularised as described in 
Section 7.3.3. Macroscopically, following decellularisation, cartilage 
appeared firm and smooth over the whole surface of the condyle, even 
following the prolonged PBS washes. The cartilage appeared to be intact. 
Histologically, the decellularised porcine osteochondral tissues appeared to 
be largely devoid of cells (Figure 7.2 – 7.7), however, a few isolated nuclei 
were still present in the calcified cartilage regions of the condyle (Figure 
7.7b). The cartilage of all three decellularised condyles did not show the 
increased porosity characteristic of damaged cartilage (Chapter 5), however 
a slight increase in chondron lacunae size in the superficial zone and 
surface roughening could be seen (Figure 7.2 – 7.4). The minimal disruption 
to collagens at the cartilage surface could be more clearly visualised with 
van Geison staining (Figure 7.8 – 7.10). Alcian blue staining showed low 
levels of GAGs throughout the superficial and middle cartilage zones (Figure 
7.11 & 7.13) and also in the deep zone (Figure 7.12) across the whole cross 
section of the condyle.  
 
7.4.2 Bovine osteochondral plates  
Bovine osteochondral plates were decellularised as described in Section 
7.3.4. Following decellularisation, cartilage appeared smooth, firm and white 
and appeared to be intact. Initially, as a result of technical error, samples 
were incompletely processed, attempts were made to reverse process the 
tissues and correctly reprocess as described in Sections 7.5.3.1 and 7.5.3.2. 
Incomplete processing rendered the tissues dry, crumbly and difficult to 
section, so blocks were directly decalcified to ease sectioning (Section 
7.3.5.3). Samples were successfully sectioned, however as a result of 
sample preparation, histological stains appeared more intense than in 
tissues which had been processed correctly. Histologically, bovine tissues 
showed incomplete decellularisation, with nuclei remaining in the deep 
calcified regions (Figures 7.14 – 7.19). The cut edges and cartilage surface 
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of all three bovine osteochondral cuts appeared porous, showing signs of 
damage, however the internal middle and deep zones were not damaged as 
shown by intense van Gieson staining of cartilage collagens (Figure 7.20 – 
7.22). The cut edges and surface also showed reduced intensity of alcian 
blue staining showing loss of GAGs in these regions directly in contact with 
the decellularisation solutions (Figure 7.23 – 7.25). Bovine osteochondral 
plates showed larger areas of damage than whole porcine condyles 
following decellularisation. 
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7.1 Discussion 
Previous attempts to decellularise porcine osteochondral tissues (Chapter 5) 
resulted in the cartilage becoming damaged, showing a large reduction in 
GAGs and increase in water content. Macroscopically, damaged tissues 
appeared soft, shrinking in from the edges of the bone plug and presented 
with a roughened dull surface. Histologically, cartilage showed increased 
porosity, with the smooth collagen network becoming a more mesh-like 
matrix full of holes and the size of chondron lacunae appeared increased. 
The work in Chapter 5 attempted to systematically elucidate the cause of 
cartilage damage, the high temperature of incubations in the 
decellularisation solutions was found to be a contributing factor, but it was 
not possible to identify a protocol that  fully eradicated the cartilage damage. 
Furthermore, the work carried out in Chapter 6 to determine the 
biocompatabiliy of decellularised bovine osteochondral scaffolds showed 
that increasing the duration of the terminal PBS wash cycles to greater than 
60 h also resulted in damage to bovine cartilage, which had not previously 
been seen.  
To further investigate the cause of cartilage damage, the preliminary work 
carried out in this Chapter used large osteochondral plates (2 mm x 4 mm, 
bovine) or whole condyles (porcine) to investigate the effect of having a 
reduced ratio of cut edges to cartilage area on cartilage stability during 
decellularisation. As reviewed in Chapter 1 and by Mow et al. (2005) the 
fibres of the cartilage collagen network have a characteristic orientation 
(Jeffery  et al., 1991) and are under tension, providing the tensile strength of 
the tissue. Proteoglycans are dispersed throughout the collagen network and 
bind water in the tissue, providing the compressive strength of the tissue 
(Roughley, 2006). It was hypothesised that preparing osteochondral tissues 
for decellularisation by cutting around the circumference of the pin had 
severed collagen fibres and resulted in loss of tension, particularly in fibres 
orientated parallel to the surface in the cartilage superficial zone. With the 
loss of tension, the collagen network would have reduced ability to counter 
the repulsive forces of negatively charged proteoglycans being held in close 
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proximity to one another, resulting in an increase in porosity allowing GAGs 
to be removed, more water to enter the tissue and the collagen fibres to 
therefore clump together. 
Porcine osteochondral blocks (50 mm in length, 10 mm in width and 10 mm 
in depth)  with a larger area to cut edge ratio than 9 mm diameter pins were 
successfully decellularised by Kheir et al. (2011) using a similar protocol to 
that described here. The osteochondral blocks were subject to  four cycles of 
freeze thaw (the final two in hypotonic solution) and then incubated through 
6 cycles of 24 h in hypotonic solution followed by 24 h in 0.1 % (w/v) SDS in 
hypotonic solution, both containing aprotinin and EDTA at 45 °C with 
agitation. Blocks were than treated with nuclease and sterilised using 0.1 % 
PAA (v/v). The process was completed by 2 x 30 min PBS washes and a 
short 24 h final PBS wash. Following use of this protocol, porcine 
osteochondral tissues were fully decellularised and remained intact. 
Histological analysis showed full removal of cell nuclei, however GAG 
content was greatly reduced. No collagen clumping, characteristic of 
cartilage damage was seen, however some loss of tension could be seen at 
the surface and superficial zone of cartilage sections stained specifically 
using an antibody against collagen type II. 
In contrast, Shwartz et al. (2012) used much smaller 5 mm diameter discs of 
human and porcine nasal septum cartilage with a large cut edge to area 
ratio. The decellularised tissue had the characteristic collagen clumping and 
loss of GAG seen in severely damaged cartilage in this study (Chapter 5), 
differing greatly to decellularisation results seen by Kheir et al. (2011). 
The size of osteochondral tissues used for decellularisation in this Chapter 
was therefore increased to minimise the ratio of cut edge to cartilage area. 
For bovine osteochondral tissues, the ratio of cut edge to cartilage area was 
reduced by using larger osteochondral plates (2 mm x 4 mm) as opposed to 
small pins (9 mm diameter). For porcine osteochondral tissues, only one cut 
edge was produced when separating the condyle from the groove, all other 
edges were natural cartilage edges on the condyle. 
Following decellularisation the bovine tissues were not fully decellularised 
and showed some damage, especially at the cut edge and cartilage surface. 
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The central cartilage regions retained GAG content and did not show the 
porous structure characteristic of damage histologically. The cartilage did not 
detach from the bone or appear damaged macroscopically, with the 
exception of the cut edges.  
Porcine tissues did not appear damaged macroscopically following 
decellularisation, but upon histological analysis, characteristic damage could 
be seen in the superficial zone of the cartilage and at the surface, however 
this damage appeared less severe than that seen in bovine cartilage. The 
tissues were almost completely decellularised apart from a few nuclei still 
present at the cartilage-bone interface and the tissue remained intact 
following extended washing in PBS.  
It was therefore demonstrated that reducing the ratio of cut edges to 
cartilage area greatly improved cartilage stability during the decellularisation 
processes, but did not completely eradicate cartilage damage. Additional 
steps should be taken to ensure complete decellularisation of porcine whole 
condyles and bovine blocks. It would then be possible to harvest acellular 
osteochondral pins of clinically relevant size from the least damaged regions 
of these decellularised large osteochondral constructs. 
Further biochemical and biomechanical testing is required to determine the 
degree of damage caused to decellularised whole condyles and determine 
whether the resultant tissues retained adequate biological and 
biomechanical function for use as a cartilage substitution biomaterial. 
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Chapter 8 
Discussion 
8.1 General Discussion 
The underpinning hypothesis of this study was that it was possible to 
generate an acellular xenogeneic osteochondral graft material of future 
clinical utility in osteochondral lesion repair. A novel regenerative cartilage 
repair material such as this is required, as joint damage is common in the 
active population. Osteochondral lesions as a result of trauma can in 
themselves cause pain, swelling and mechanical problems, reducing the 
quality of life for patients (Minas & Nehrer, 1997). Furthermore, some 
instances of osteoarthritis have been found to originate from initially minor 
cartilage lesions (Ding et al., 2005) which, due to their avascular nature are 
unable to undergo healing and repair, so degenerate over time with regular 
joint loading and articulation (Chaing & Jiang, 2009). Currently, for 
osteoarthritic joints, the only effective treatment is total joint arthroplasty. In 
the case of osteoarthritis which originates from cartilage lesions, early 
intervention therapies are available to prevent or delay the disease onset by 
repair of the initial lesion. Surgical therapies currently performed to preserve 
cartilage such as lavage and debridement (Chang et al., 1993; Moseley et 
al., 2002) and marrow stimulation techniques (Steinwachs et al., 2008) 
however have variable long term outcomes and often result in inferior 
fibrocartilage like repair materials. Similarly, perichondrial/periosteal grafting, 
mosaicplasty (Koulalis et al., 2004) and autologous chondrocyte implantation 
(Grande et al., 1989) may result in donor site morbidity amongst other 
complications (Minas & Nehrer, 1997; Lϋtzner et al., 2009). 
As current surgical techniques have been unable to restore fully functional 
hyaline cartilage, tissue engineering is seen as the way forward in 
developing adequate cartilage repair therapies with good long term 
prognosis, by optimising and balancing scaffold biomaterials with bioactive 
factors and cells (Vinatier et al., 2009). Biomaterials can be broadly labelled 
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as natural or synthetic. Synthetic materials currently being researched 
include polylactic acid (PLA; Giurea et al., 2003) and polyglycolic acid (PGA; 
Liu et al., 2002), they are easy to manufacture and their specific properties 
can be accurately controlled to mimic the natural ECM. The biomechanical 
properties of such materials can be tailored, however, often there are issues 
with tissue integration, a lack of biological cues and detrimental degradation 
products (Atala, 2007, Puppi et al., 2010). Natural biomaterials such as 
collagens (Frenkel et al., 1997) or hyaluronic acid (Grigolo et al., 2001) have 
the advantage of low toxicity and biological signalling, however there are 
issues regarding batch variation and they do not have adequate 
biomechanical properties (Puppi et al., 2010). 
The aforementioned biomaterials, although promising, do not show the same 
level of structural and biological complexity found in healthy cartilage which 
is key to the function and regeneration potential of the natural tissue. Recent 
tissue engineering approaches have been to decellularise or devitalise 
natural ECM scaffolds, thereby retaining the natural ECM constituents and 
structure as well as biological cues such as growth factors whilst removing 
immunogenic materials which would result in graft rejection (Crapo et al., 
2011, Benders et al., 2013).  
This tissue engineered acellular ECM approach is already being used 
clinically for a number of tissues including heart valves (Bach et al., 2005) 
and trachea (Macchiarini et al., 2008). Decellularised small intestinal 
submucosa (SIS) has been used clinically for over a decade to repair tissues 
such as skin, muscle and tendon (eg. Restore™, DePuy Orthopaedics; 
Surgisis®, Cook Biotech Inc.). For musculoskeletal tissue repair, 
decellularised ECM biomaterials including tendon (Ingram et al., 2007; 
Martinello et al., 2012) and meniscus (Stapleton et al., 2008) are undergoing 
development. The current study was performed with the aim of producing a 
decellularised osteochondral ECM scaffold from xenogeneic tissues which 
could be used either seeded with cells or as a standalone off-the-shelf 
product to enable effective long term repair of osteochondral lesions. 
This tissue engineered approach for cartilage or osteochondral repair has 
previously been researched in a number of studies and the current research 
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position was well summarised by Benders et al. (2013). Some approaches 
have focused on homogenising cartilage tissue by lyophilisation and grinding 
(Yang, Z et al., 2010) or shattering into fragments and centrifuging to 
produce microfilaments (Yang, Q et al., 2008) prior to decellularisation. 
Scaffolds produced from decellularised homogenised cartilage have the 
benefit of retaining bioactive cues for cell growth and are also more 
customisable, however, they lack the 3D architecture and structure of native 
cartilage and therefore have reduced biomechanical function. Other 
approaches have been to research the decellularisation of cell derived 
cartilage ECM (Elder et al., 2009). Decellularised cell-derived-ECM scaffolds 
have no issues of biocompatibility, however the need to culture cells renders 
the process time consuming and this approach requires cell harvesting from 
the patient, increasing the number of invasive procedures performed and 
potentially causing donor site morbidity. Yet another approach has been to 
develop methods to decellularise intact, native 3D cartilage tissues (Elder et 
al., 2010, Schwarz et al., 2012). The decellularisation of intact native 
cartilage tissues has the potential to produce an ECM with bioactive cues, 
and with the natural biological, biochemical and biomechanical composition 
and structure. 
Although protocols for whole native 3D cartilage decellularisation are 
currently under development, there are to date no reports of the clinical 
relevance/success of such products. Such approaches do not provide a 
subchondral bone component for integration and stability of a cartilage repair 
biomaterial upon implantation.  
Kheir et al. (2011) developed a process to decellularise porcine 
osteochondral tissues, whereby intact, full thickness, zonal cartilage, 
subchondral bone plate and trabecular bone were fully acellular and 
biocompatible and retained similar biological and biochemical composition 
compared to native tissue. In this decellularisation protocol, osteochondral 
blocks (50 mm in length, 10 mm in width and 10 mm in depth) were subject 
to four cycles of freeze thaw (the final two in hypotonic solution) and then 
incubated through 6 cycles of 24 h in hypotonic solution followed by 24 h in 
0.1 % (w/v) SDS in hypotonic solution, both containing aprotinin and EDTA 
at 45 °C with agitation. Blocks were then treated with nuclease and sterilised 
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using 0.1 % PAA (v/v). The process was completed by 2 x 30 min PBS 
washes and a short 24 h final PBS wash. The decellularised matrix had 
reduced GAG content compared to native cartilage which resulted in inferior 
biomechanical properties. Additionally the size and shape of the acellular 
osteochondral matrix was not appropriate for current surgical applications, 
such as mosaicplasty.  
The current study was intended to improve and progress the work of Kheir et 
al. (2011), Firstly by addressing the xenogeneic source material used for 
decellularisation, to identify a joint region and species which had similar 
biological, biochemical and biomechanical properties to human cartilage, 
and potentially find a tissue with high GAG content, to reduce the detrimental 
effect of GAG loss following decellularisation. The source material would 
also be shaped to a 9 mm diameter osteochondral pin, to enable the 
biomaterial to be used with current surgical techniques and equipment. 
Secondly, alterations to the established decellularisation protocol (Stapleton 
et al., 2008; Kheir et al., 2011) were investigated to minimise GAG loss and 
produce a biologically, biochemically and biomechanically acceptable 
osteochondral scaffold. The improved decellularised scaffold could then be 
investigated in terms of biocompatibility and regenerative capacity.  
A variety of source tissues have been used for articular cartilage 
decellularisation including immature 4 week old calf cartilage from the distal 
femur (Elder et al., 2010), 7 – 8 month old pig knee cartilage (Schwartz et 
al., 2012) and osteochondral tissues from the femoral groove of 4 month old 
pigs (Kheir et al., 2011). It has been well documented that the biomechanical 
properties of cartilage vary topographically (Shepherd & Seedhom, 1999b), 
as does the cartilage GAG content (Rogers et al., 2006) and thickness 
(Shepherd & Seedhom 1999a). It therefore seems sensible to constrain a 
decellularisation source cartilage to a specific joint region, rather than taking, 
for example, distal femoral knee cartilage as a whole, in order to avoid 
unnecessary variation in the properties of the final scaffold. Similarly, 
cartilage properties are also known to vary between species (Athanasiou et 
al., 1991; Kääb et al., 1998) and with age (Julkunen et al., 2009; Rieppo et 
al., 2009; Hamann et al., 2013). The properties of a decellularised scaffold 
will relate to those of the source material, so it was logical that donor 
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species, age and joint region should be investigated to determine the 
optimum starting material to produce a scaffold with acceptable properties 
for use in human patients. 
In the current study, cartilage from three common species were investigated; 
pig (6 month), cow (18 month) and sheep (aged ~12 month or > 4 year). 
Tissues were compared from the acetabulum and femoral head of the hip 
and the groove, medial and lateral condyles and medial and lateral tibial 
plateau of the knee of each species. Ovine cartilage, being from the smallest 
species, was thinnest (femoral groove cartilage was 0.86 mm in young 
sheep and 0.63 mm in old sheep) much thinner than values reported for 
human cartilage (1.76-2.59 mm, Shepherd & Seedhom 1999b). If implanted 
into a human knee joint, the ovine osteochondral pin would not be able to 
simultaneously align at the surface and at the cartilage-bone interface with 
the surrounding human tissue which would be problematic for integration 
and function. For this reason, ovine tissues were discounted as a potential 
source material. Additionally, mature ovine tissues showed signs of 
degeneration, being yellowed and stiffened suggesting the presence of 
advanced glycation end products (Bank et al., 1998). Both porcine and 
bovine tissues had comparable cartilage thickness to human (2.04 mm and 
1.52 mm respectively), and also showed high levels of sulphated 
proteoglycans, 78 ± 30 μg.mg-1 and 68 ± 8 μg.mg-1 GAG per wet weight 
cartilage respectively, compared to the 54.7 mg.g-1, 38.6 mg.g-1 (Vilim et al., 
1991) and 25 – 40 μg.mg-1 (Hollander et al., 1991) quoted for human femoral 
head cartilage. The biomechanical properties of each species differed, with 
bovine cartilage being stiffer than porcine on the whole, with an equilibrium 
elastic modulus of 0.66 MPa and 0.81 MPa respectively for cartilage from 
the lateral condyle, compared to an equilibrium aggregate modulus of 0.70 
MPa for human cartilage (Athanasiou et al., 1991). The relatively low 
stiffness of porcine cartilage was in contrast with the high GAG content 
measured which should infer compressive resistance, this highlighted the 
possible effects of cartilage maturity. Proteoglycans within the relatively 
immature porcine cartilage may not be as well developed and functional as 
those of mature tissues. Differences were seen between the properties of 
different joint regions, with cartilage from the femoral knee (condyles and 
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groove) tending to be thickest and having higher GAG content than other 
areas, the tissue in these regions also tended to be stiffer.  
Regrettably, biotribological analysis of cartilage was not performed in the 
current study. It has been reported that the coefficient of friction of cartilage 
is increased with GAG depletion (Katta et al., 2009), likely due to reduced 
biphasic and surface lubrication. Varying levels of proteoglycans, therefore, 
may have an impact on the frictional properties of cartilage from different 
species and/or joint regions. Information in the literature regarding this is 
limited for comparison due to the variation in testing conditions.  
A major limitation of this aspect of the current study is that animals of 
different ages were compared. This was due to the restricted availability of 
animals bred from the food chain for human consumption. In this case, it is 
difficult to discern which properties can be attributed to the species and 
which to the stage of cartilage maturation. This raises an intriguing point for 
consideration, is a mature or immature source tissue more appropriate for an 
acellular natural ECM scaffold? As highlighted previously, underdeveloped, 
immature cartilage may not have the same biomechanical function as 
mature human cartilage, which may restrict the success of such a material 
upon implantation. However, beneficially, immature cartilage is still 
undergoing growth and remodelling, it is more metabolically active than fully 
developed mature cartilage. It stands to reason that the growth factors and 
biological signals which are present, guiding tissue growth, may be 
advantageous if retained in a decellularised scaffold, to potentially improve 
recellularisation and neomatrix deposition by infiltrating host cells. 
Furthermore, immature porcine cartilage had an underdeveloped 
subchondral bone plate and vascularisation of the cartilage. These features 
may aid in the migration of host cells (including mesenchymal stem cells) 
from the surrounding bone marrow and cartilage. 
As the benefits of using a mature versus an immature tissue were unknown, 
it was decided that two tissues, immature porcine medial condyle and 
mature bovine medial groove osteochondral tissues should both be taken 
forward as source materials for the development of a decellularisation 
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protocol, based on the biological, biochemical and biomechanical properties 
investigated. 
Following a number of iterations, a protocol was optimised to decellularise 
bovine osteochondral pins. The method, based on that of Stapleton et al. 
(2008) and Kheir et al. (2011), comprised a novel incubation of 
osteochondral pins in PBS with proteinase inhibitors for 18 h followed by use 
of a water pik to physically remove bone marrow. In accordance with 
previous methods, tissues underwent four freeze/thaw cycles (two of which 
were in hypotonic buffer) to produce ice crystals to physically open up the 
matrix and produce an osmotic tension to lyse cells. Tissues were then 
subject to two cycles of washing in hypotonic buffer followed by 0.1% (w/v) 
SDS in hypotonic buffer to again lyse cells and solubilise cellular 
membranes, all solutions contained aprotinin (10 KIU.ml-1)to inhibit protease 
activity. One cycle of hypotonic and SDS washes was not sufficient to 
remove cells in the dense calcified cartilage and subchondral bone plate, 
however only two cycles were required, fewer than that of Kheir et al. (2011) 
and Stapleton et al. (2008),  likely due to the smaller size of tissue used. 
Osteochondral pins were then treated with nucleases to digest nucleic acids 
and sterilised using 0.1% (v/v) PAA. Following a final extended PBS wash 
the decellularised tissue had no visible whole cell nuclei, and a dry weight 
cartilage DNA content of 39 ng.mg-1. An undesirable effect of the 
decellularisation process was that the cartilage GAG content of the acellular 
scaffold was severely reduced from that of the native bovine cartilage. 
Porcine tissues were also successfully decellularised using the same 
method, however only a single incubation in SDS was required to fully 
remove cellular debris and reduce the DNA content to below 50 ng.mg-1. 
Again, GAG loss was seen, but the reduction was only 60 %.  
A decellularised matrix, as classified by Crapo et al. (2011), should have a 
DNA content of < 50 ng.mg-1. Reduction of DNA content is important as the 
phosphate backbone of residual nucleic acids can act as a nucleation site for 
calcification of implants  (Schoen & Levy, 2005). Whereas this would not be 
a problem for the bone component of the composite scaffold, calcification of 
cartilage may severely alter the equilibrium elastic modulus of the tissue and 
have detrimental effects on the friction coefficient. Such calcified cartilage 
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could cause severe damage to the opposing articulating surface and 
accelerate joint degeneration, rather than prevent or delay cartilage damage, 
as was the original intention of the cartilage lesion repair.  
It is also important to take into account the fragment length of any residual 
DNA in decellularised matrix. Keane et al. (2012), used DNA fragment length 
as an indication of decellularisation efficacy, to quantify potential residual 
cellular debris. It was shown that decellularised tissues with a larger residual 
DNA fragment length (500 – 1500 bp) had tended towards an inflammatory 
M1 macrophage response from the host. Whereas a constructive M2 
macrophage response was seen with more effectively decellularised porcine 
SIS with residual DNA of < 500 bp fragment length, although values were 
not significant in vivo. There was a significantly higher number of infiltrating 
macrophages in the SIS with large DNA fragment size. However, the study 
only used DNA quantification to test decellularisation efficacy and did not 
make any attempt to quantify other antigenic cell remnants such as 
intracellular cytoplasmic proteins and membrane components by any other 
means. Stapleton et al. (2008) assessed the fragment length of residual 
DNA in decellularised porcine meniscal tissue via agarose gel 
electrophoresis. Fresh tissue showed a clear band around 10,000 base 
pairs, no band could be seen for DNA extracted from decellularised 
meniscus. However, they later report a significant reduction in DNA 
concentration following decellularisation, so the lack of a band present for 
decellularised tissue may not be that the fragment length is too short to be 
detected, but that the amount of DNA is too small to be seen, as the same 
volume of extracted DNA was loaded into the gel, despite the fact that the 
concentration of DNA differed between native and decellularised tissues.   
It is also important to ensure DNA fragment size is minimal so to ensure that 
functional genomic material is not transferred to the host, which could be 
problematic, for example, the potential transfer of latent viral DNA. The risks 
from latent viral DNA are minimal however, as infection-independent 
horizontal gene transfer of porcine endogenous retrovirus (PERV) from 
porcine cells to phagocytic human fibroblasts has been shown to be 
inefficient, with the virus only transmitted to 0.22 % of co-cultured cells, and 
transient, with no detectable virus after 4 weeks. The virus was unable to 
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insert into the human genome and no viral replication occurred (Bisset et al., 
2007). A major concern when using porcine xenogeneic tissues is the 
transmission of PERV, as pigs are asymptomatic carriers (Bucher et al, 
2005). Whilst transmission of PERV has been seen in vitro (Patience et al., 
1997), it has not been observed in vivo (Irgang et al., 2003). As viruses are 
obligate intracellular parasites, destruction and removal of porcine cells from 
the xenograft should result in the complete removal of PERV’s also.  
In the current decellularisation protocol, nucleases (DNase and RNase) were 
used to cleave nucleic acids exposed following rupture of cytoplasmic and 
nuclear membranes (Stapleton et al., 2008; Kheir et al., 2011) . Cleavage of 
nucleic acids into small fragments enabled effective wash out, and the DNA 
content of decellularised cartilage was significantly reduced, however the 
fragment length of residual DNA was not quantified. Initial attempts were 
made to measure fragment length of residual DNA isolated from 
decellularised tissues using agarose gel electrophoresis, however potentially 
due to the low levels of DNA present, no DNA could be detected. It may be 
necessary in future studies to concentrate DNA extracts to enable better 
detection.  
Sterilisation of the natural scaffold is an important step in the 
decellularisation process to avoid disease transfer from viral, bacterial and 
fungal agents.  
Another concern regarding the medical use of animal materials is the risk of 
bovine spongiform encephalopathy (BSE) transmission (Laurencin & Al-
Amin, 2008). Transmissible spongiform encephalopathys (TSE) are chronic 
degenerative diseases characterised by the accumulation of the abnormal 
cellular glycoprotein known as prion protein. Bovine spongiform 
encephalopathy appeared in UK cattle in the mid 1980’s. This TSE is 
transmissible between species and the infectious prion protein in humans 
causes fatal Creutzfeldt-Jakob disease. Transmission has been seen to 
occur through human consumption of contaminated beef products, and so 
caution should be taken when using biological materials, especially bovine 
products for medical applications (Dormont, 1996; Wickham, 1996). 
Terminal sterilisation techniques currently used for xenotransplants are 
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ineffective against prion proteins and processes which are able to inactivate 
the protein would cause damage to delicate biological tissues (Dormont, 
1996). It is possible to minimise the risk of spongiform encephalopathy 
transmission from xenotransplant as different tissues have different levels of 
infectiousness. The brain and central nervous system are highly infectious, 
spleen tissue is infectious but 106 times less so than the brain. However, 
other tissues such as heart and bone have not been shown to transmit any 
TSE agent (Dormont, 1996). Therefore it is unlikely that any bovine 
osteochondral tissues, even from an animal with BSE, would be capable of 
transmitting spongiform encephalopathy to humans following transplantation. 
To eradicate the risk, it is a regulatory requirement to use tissues from 
certified BSE free cattle, as outlined in the Note for guidance on minimising 
the risk of transmitting animal spongiform encephalopathy agents via human 
and veterinary medicinal products (EMEA/410/01 REV 3) published in the 
official journal of the European Union (2011), however this would greatly 
increase the manufacturing costs.  
Terminal sterilisation is a more viable alternative to screening source tissues 
and sterile tissue processing. The current protocol used  0.1% (v/v) PAA to 
sterilise the decellularised osteochondral scaffolds. This method, although 
shown to be effective for other tissues (Lomas et al., 2003), has not been 
validated for osteochondral tissues. It may be that the dense nature of bone 
and cartilage inhibits penetration of PAA. Mirsadraee et al. (2006) developed 
a methodology to validate the sporicidal activity of 0.1 % (v/v) PAA on 
decellularised human pericardium. Bacillus Atrophaeus spores were applied 
directly to the surface of the decellularised tissue, or to filter paper which could 
only be accessed by permeation of the sterilisation solution through a layer of 
pericardium. Tissues and filter papers were macerated and cultured on tryptone 
soya agar plates, the number of colony forming units was compared between 
PAA treated and untreated tissues. A similar method was performed by Pruss et 
al. (1999)  to confirm virus inactivation by PAA in bone. These methods could 
be modified and used to validate PAA sterilisation of osteochondral tissues. 
Additionally, sterilised osteochondral tissues could be macerated and cultured 
on a variety of plates (agar, blood agar etc.) to observe the presence/absence 
of residual microbes. Other sterilisation methods such as ethylene oxide 
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treatment or γ irradiation could potentially provide more acceptable results in 
terms of tissue penetration, however the level of irradiation would need to be 
optimised in order to minimise tissue damage (Vangsness et al., 2003).  
Although bovine and porcine osteochondral tissues were successfully 
decellularised, a significant structural change was seen in the cartilage 
matrix. The GAG content of porcine cartilage was reduced by 60 %, and 
bovine cartilage was almost devoid of GAGs, with only 1 % of the original 
content remaining following decellularisation. SDS has been linked to GAG 
reduction, as the anionic detergent can disrupt protein-protein interactions 
(Seddon et al., 2004). It is hypothesised that ionic interactions with SDS 
disrupt link protein, a key attachment protein which links hyaluronan to 
aggrecan. This link protein disruption essentially would cleave the 
proteoglycan network of cartilage and enable wash out of aggrecan. The 
loss of GAGs from the cartilage tissue would lead to increased cartilage 
deformation as the fluid phase of load support was reduced. The effect of 
GAG loss on the biotribology of cartilage is currently unknown. It is unclear 
what the effect of altered biomechanical and biotribological properties of the 
osteochondral graft would be post implantation. However, previous studies 
have shown that the reduction of cartilage GAG content had deleterious 
effects on the coefficient of friction (Katta et al., 2009). It may be that ingress 
of host cells into the biomaterial post implantation would begin to produce 
proteoglycans to replenish those lost during decellularisation, without the 
temporarily reduced GAG concentration having adverse effects in the short 
term. Alternatively, it may be necessary to take a MACI-type approach and 
recellularise scaffolds prior to implantation with extracted autologous cells, 
this would potentially begin the production of proteoglycans ex vivo, 
improving or restoring tissue function. Furthermore, to produce an off the 
shelf product, without the need to culture a patient’s own cells, it may be 
possible to restore cartilage biochemistry using self-assembling peptides.  
Many peptides in nature undergo self-assembly; “the spontaneous 
association of molecules under equilibrium conditions into stable, structurally 
well-defined aggregates joined by noncovalent bonds” (Whitesides et al., 
1991). Synthesised, designed self-assembling peptides are not naturally 
occurring but are produced from natural building blocks. A number of fibrous 
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self-assembling peptide hydrogels have been identified as potential 
candidates for use as tissue engineering biomaterials. It is possible to alter 
the amino acid sequence to control peptide properties such as assembly (to 
control hydrogel pore size, fibre thickness and mechanical properties), 
chemical properties (to determine pH and ionic sensitivity and surface 
properties) or even to include biologically relevant amino acid sequences to 
alter the biological properties (Maude et al. 2013). A set of self-assembling 
peptides currently undergoing research and development are the P11 group 
of peptides. These peptides are of particular interest in tissue engineering 
approaches as their assembly can be triggered by a change in pH, ionic 
strength or, for some peptides, upon addition of a complementary 
counterpart, so they can be applied as a liquid and undergo gelation in situ 
and some peptides have shown to be cytocompatible (Maude et al. 2013). 
Such peptides in liquid form could be applied to the decellularised cartilage 
matrix alongside or covalently bonded to chondroitin sulphate or other 
GAGs, self-assembly could then be triggered, trapping the GAGs in the 
tissue. Research into such an approach is already underway to restore GAG 
content in spinal discs (Miles et al., 2012). 
The biocompatibility of the decellularised osteochondral xenograft required 
investigation prior to pre-clinical evaluation. ISO 10993 is in place to ensure 
thorough and appropriate testing of all medical devices is completed during 
product development. Initial basic in vitro biocompatibility testing should be 
performed prior to in vivo testing and use in animal models to ensure the 
scaffold has no immediate toxic effects before more advanced immune  
responses can be investigated.  
SDS used in the decellularisation process has been reported to have 
cytotoxic effects when not effectively removed from decellularised tissue 
matrices  (Rieder et al, 2004). Residual SDS within the scaffold may prevent 
ingrowth of cells in vivo and result in graft failure. Quantification of residual 
SDS using detection of C14 labelled SDS in decellularised bovine 
osteochondral tissues revealed a relatively high concentration of residual 
SDS, above cytotoxic levels, even though most SDS had been washed out 
into the wash solutions. Surprisingly, no cytotoxic effects were observed 
when decellularised osteochondral tissues were cultured with the 3T3 cell 
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line, however, when cultured with BHK cells, contact cytotoxicity was seen 
with one sample. This largely corroborates with the results of Kheir et al. 
(2011), in which three times as many SDS washes were applied to a larger 
tissue section with the same duration of terminal wash cycles as the current 
study, but no cytotoxicity was seen. It is likely that the three dimensional 
dense nature of the osteochondral tissue may give false positives for 
cytotoxicity and further testing should be performed to assess the 
biocompatibility of soluble extracts of the scaffold, or attempts to 3D culture 
cells with the scaffold. It did however appear that the acellular tissue was 
having some cytotoxic effect and alterations to the decellularisation protocol 
were required to improve biocompatibility. 
As porcine osteochondral tissues required a less extensive protocol for 
decellularisation, the protocol was altered in an attempt to retain a higher 
percentage of the cartilage GAG content. Upon changing the 
duration/concentration of the SDS wash it was found that cartilage was 
sustaining damage, and in cases completely disintegrating and dissolving 
away from the bone into the wash solutions. Analysis of damaged tissues 
revealed quantitatively a huge increase in water content, a large reduction in 
cartilage GAG content, however collagen denaturation was not occurring. 
Histologically, tissues appeared highly porous, had a roughened surface and 
the connection of cartilage to the bone in the hypertrophic cartilage region 
was stretched and tenuous. Furthermore, upon increasing the duration of the 
final PBS wash to improve biocompatibility of decellularised bovine cartilage, 
the same damage was also witnessed in bovine tissues. 
Such damage to articular cartilage has not been reported previously using 
SDS based decellularisation methods (Elder et al., 2010; Kheir et al., 2011). 
However, similar characteristics were witnessed when using more harsh 
protocols on nasal septum cartilage (Schwarz et al., 2012). Numerous 
iterations of the current decellularisation protocol were carried out to 
elucidate the cause of cartilage damage. None of the individual wash cycles 
of the protocol were found to be solely responsible for cartilage degradation, 
and surprisingly, incubation in PBS alone for the duration of the protocol lead 
to damage. The effect of solution osmolality and protease activity were ruled 
out, as were the number of pins decellularised per pot and the age/stage of 
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maturation of the source tissue. Only a decrease in incubation temperature 
was shown to reduce the extent of cartilage damage, however not to 
eliminate it.  
That porcine cartilage had sustained damage, simply with incubation in PBS 
with agitation at 42 °C, was surprising. This finding highlighted the relative 
fragility of cartilage when extracted from its natural environment.  
The stretching of the porcine cartilage matrix at the hypertrophic zone and 
detachment of the cartilage at the interface with bone suggests that this area 
is a weak spot. The number of large cells in this region makes it highly 
porous and removal of cells from this region may have further weakened the 
structure. The difference in structure in this region between porcine and 
bovine cartilage may provide a possible explanation as to why porcine 
cartilage was damaged more readily than bovine.  Bovine deep cartilage has 
linear columns of chondrocytes aligned perpendicularly to the bone, with 
defined areas of cartilage matrix between columns, and has fewer cells, 
rather than the clusters of large numbers of hypertrophic cells seen in 
porcine cartilage. Therefore the attachment of cartilage to bone may be 
stronger in the more mature bovine tissues. It has been widely accepted that 
collagen fibres are continuous between cartilage and bone to anchor the two 
tissues securely together (Mow et al., 2005). Other studies, however 
contradict this idea (Clark & Huber, 1990), so it may be that the attachment 
of cartilage to bone is not as secure as is commonly assumed. 
It was unexpected that neither immature porcine cartilage (4 months old), 
nor mature cartilage (2.4 – 4.2 years old) became damaged during the 
decellularisation process, whereas cartilage of 6 month old pigs did. Also of 
note was the relative inconsistency with which 6 month old porcine tissue 
became damaged. It is possible that at this transitional maturation stage 
porcine cartilage is comparatively unstable. Rieppo el al. (2009) reported 
that in porcine cartilage during maturation, the collagen structure was altered 
from fibres being aligned mostly parallel to the surface (4 months old) to 
developing the characteristic anisotropic fibre orientation of mature (21 
month old) cartilage. The current study highlighted other major 
characteristics of immature cartilage which are lost during maturation; 
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vascularisation and cartilage thickness. Cartilage also decreases in 
cellularity following maturation. It is clear that maturing tissues are 
undergoing major metabolic changes, greatly altering the structure of the 
tissue (Hamann et al., 2013). Following the anabolic processes of tissue 
formation, catabolic processes ensue to reduce cellularity, vascularisation 
and cartilage thickness as well as re-orientate collagen fibrils, during this 
transitional period prior to mature tissue homeostasis, it is possible that the 
tissue is more susceptible to damage, providing a possible explanation for 
why cartilage from 6 month old pigs was more readily, yet inconsistently 
damaged during decellularisation.  
It was hypothesised that by decellularising an osteochondral pin, the 
production of a cut edge was detrimental to cartilage stability; reducing 
tension in the collagen fibres aligned parallel to the cartilage surface and 
exposing the middle and deep zones of the cartilage, allowing solutions to 
enter more freely. This loss of tension in the collagen network would allow 
for swelling of the tissue with the ingress of decellularisation solutions. This 
would result in the subsequent wash out of proteoglycans, which are no 
longer confined and compressed by the collagen matrix. This would explain 
the hugely increased water content and absolute loss of GAGs seen in 
damaged tissues.   
If this theory is correct, a further explanation for the differences seen 
between the damage to porcine and bovine cartilage could be the relative 
permeability of each tissue. Despite having a higher GAG content, porcine 
cartilage was shown to be more permeable than bovine, so the rate at which 
solutions entered the structure and washed out the GAGs may have been 
higher. 
In an attempt to test this theory, larger osteochondral blocks (bovine) and 
entire condyles (porcine) were decellularised. Bovine tissues sustained 
damage at the cut edge, showing increased porosity and GAG loss, but did 
retain GAGs within the central region. Porcine condylar cartilage did still 
show some GAG reduction, as seen in successful pin decellularisation, 
however the structure appeared mainly intact, with only a slight increase in 
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matrix porosity seen at the cartilage surface, suggesting that the cut edge 
effect is important to consider during osteochondral decellularisation.  
Future work to fully elucidate the cause of cartilage damage should be 
undertaken if osteochondral decellularisation is to be further optimised. It 
would not be acceptable to put a decellularised product into large scale 
manufacture for clinical use without understanding the reason behind the 
damage highlighted in this study and having appropriate safeguards put in 
place to avoid damage occurring. To this end, it will be necessary to find 
improved, more definitive methods of detecting whether damage has 
occurred, either by quantitative analysis of tissues themselves, or by 
quantification of components lost into wash solutions. Additionally, more in 
depth immunohistochemical analysis may identify specific factors which are 
lost which can then potentially be quantified using ELISA or other 
quantitative means. Once such methods are applied, it may be possible to 
more accurately follow damage progression and identify when/how it is 
initiated.  
What is clear is that some level of structural alteration will occur with 
decellularisation, and it will be necessary to identify the tissue condition at 
which damage has occurred, but will not progress and is not detrimental to 
the cartilage function. It may therefore also be useful to characterise human 
osteochondral tissues, to identify the range of tissue properties with which 
the decellularised graft will need to be compatible, if it is to function correctly 
within the host post implantation. 
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8.2 Further future work 
Prior to in vivo testing, methods of graft rejection should be considered to 
reduce chances of failure. Intracellular cytoplasmic proteins and membrane 
components of cells in allografts and xenografts may elicit an immune 
response and lead to graft rejection. Xenogeneic grafts additionally have a 
cell surface sugar, galactose α1-3 galactose (α-gal), which is present in all 
mammals except for humans and old world monkeys (Galili et al., 1987). 
Due to the presence of a sugar similar in shape to α-gal on some human gut 
bacteria, humans have a high titre of pre-formed antibodies reactive against 
α-gal. Implantation of a graft material containing cells presenting α-gal 
results in hyperacute rejection of the graft (Bucher et al., 2005). Usually, 
initial exposure to circulating anti-α-gal antibodies occurs with endothelial 
cells of vascularised xenogafts. The binding of antibodies to α-gal on 
endothelial cells results in activation of the complement cascade; this 
recruits neutrophils and macrophages to the site and results in inflammation 
and blood clotting. Blood vessels in the xenograft become blocked, resulting 
in hypoxia and necrosis of the implanted tissue (Janeway, et al., 2005; 
Knight & Ingham, 2006). 
Acellular xenografts will not undergo the same mechanism of rejection as 
cellular vascularised grafts as described above, as hypoxia and necrosis are 
not relevant, however the presence of α-gal may well negatively impact on 
the degradation/remodelling of the implanted scaffold. Antibody binding to 
the α-gal epitope may activate the classical complement cascade, and 
soluble α-gal may also activate the alternative complement pathway. 
Complement triggered release of C5a and C3a will recruit 
polymorphonuclear cells (PMNs; such as neutrophils) and monocytes to the 
xenograft. PMNs perform phagocytosis as well as releasing pro-
inflammatory mediators and reactive oxygen species (ROS) which may 
result in destruction of the scaffold matrix. Monocytes recruited to the 
implanted material may differentiate into proinflammatory (M1) macrophages 
which will release pro-inflammatory cytokines (IL-1β and TNF-α), 
degradative enzymes and ROS (Boehler et al. 2011; Franz et al. 2011). The 
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continued release of proinflammatory cytokines may perpetuate the 
response and continued destruction of the implant.  
A further mechanism of adverse scaffold degradation is ‘frustrated 
phagocytosis’. As macrophages are unable to phagocytose particles larger 
than 5 µm, a number of cells can fuse to form foreign body giant cells 
(FBGCs) in response to foreign biomaterials. If unable to phagocytose the 
foreign material, FBGCs display a change in activity, with reduced 
phagocytosis activity and enhanced degradative capacity. The increased 
release of enzymes and ROS may result in the scaffold being resorbed, and 
only once all foreign material is remodelled will the inflammatory response 
subside (Franz et al. 2011). This adverse remodelling of acellular xenografts 
would impair functionality and minimise the regenerative capacity of such 
medical devices. Furthermore, indiscriminate release of degradative 
products could damage surrounding healthy host tissues and exacerbate the 
original tissue disorder.  
Immunohistochemical analysis of α-gal in osteochondral tissues by Kheir et 
al. (2011) revealed that chondrocytes of porcine cartilage did not positively 
stain for the epitope, however α-gal was present on cells of the subchondral 
bone. Stone et al. (1997) quantified low levels of α-gal in porcine and bovine 
cartilage. 
Due to the avascular nature of cartilage and the tissue density, cartilage is 
relatively immunoprivileged, so exposure of α-gal to circulating antibodies 
would be minimal with xenogeneic cartilage implantation. Stone et al. (1997) 
have reported that hyperacute rejection of porcine and bovine cartilage does 
not occur when implanted into old world monkeys, however tissues were 
subject to chronic inflammatory rejection. Upon implantation, the primate 
immune system increased the anti-α-gal activity 10 – 300 fold in response to 
α-gal containing cartilage tissues (Galili et al., 1997). Treatment of cartilages 
with α-galactosidase to remove the epitope resulted in anti-α-gal titres less 
than two fold greater than basal levels upon implantation (Stone et al., 
1998), however an immune response was still seen to other cartilage-
specific antigens. Of note was that these cartilage tissues were not 
implanted in situ into the avascular joint space, but into a suprapatellar 
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pouch, so would have had higher exposure to vascularisation and therefore 
circulating antibodies/lymphocytes. 
Analysis of the immune response to acellular porcine small intestinal 
submucosa (SIS) containing high levels of α-gal implanted into α1,3 
galactosyltransferase knockout mice was performed by Raeder et al. (2002). 
They found that the presence of α-gal delayed tissue remodelling and 
increased the inflammation duration in mice without the α1,3 
galactosyltransferase gene (GTKO mice), however the tissue was effectively 
remodelled to the same degree. A small number of acute inflammatory cells 
did remain in implants in the knockout mice. The time frame for complete 
tissue remodelling may well be increased in dense cartilage tissues from that 
seen with SIS, and inflammation may not subside as quickly. Therefore, it is 
imperative to ensure that the α-gal epitope is thoroughly removed from 
tissues to avoid adverse tissue damage as a result of prolonged 
inflammatory reactions. Tests to determine α-gal within the decellularised 
osteochondral tissues should be performed in future, prior to in vivo testing, 
if the scaffold is to be considered biocompatible. 
To overcome the issues with α-gal and afore mentioned BSE transmission, it 
may be possible to use human cadaveric osteochondral tissues as an 
allogeneic source material for decellularisation in the future. A protocol 
developed for mature bovine tissue would likely be successful for mature 
human tissue also. It would require careful selection of donor material, as 
stiffened, aged cartilage may not be a suitable repair material for young 
active patients.  
After the removal of α-gal from decellularised osteochondral tissues has 
been confirmed, in vivo testing should be performed to assess the 
immunogenicity of the scaffold. The approach commonly used is to 
subcutaneously implant small pieces of the decellularised tissue into a 
mouse model. Histological and immunohistochemical analysis of explants 
could then be performed to determine the presence or absence of immune 
cells (Stapleton et al. 2010) 
Prior to clinical trials in humans, the acellular osteochondral graft should be 
implanted in situ into a large animal model, such as a sheep or goat. This 
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would give a better indication of the immune response to the graft when it is 
implanted into the appropriate environment, and would also reveal whether 
integration of the graft with the surrounding recipient tissue has been 
successful. 
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8.3 Detailed approach to future work 
Four key objectives should be met in the further development of an acellular 
osteochondral graft in order to enable progress to a clinical therapy. Firstly, 
the mechanism of cartilage damage should be fully elucidated. Secondly, 
human host tissues should be characterised to determine the acceptable 
range of properties which an acellular graft may possess. Thirdly, the 
decellularisation process should be further optimised for use with large 
osteochondral tissue segments to produce a scaffold with levels of damage 
acceptable for implantation. Finally, the regenerative capacity of the scaffold 
should be investigated in vitro and in vivo prior to the commencement of 
human clinical trials. 
8.3.1 Mechanism of cartilage damage 
To fully understand the mechanism of cartilage damage it will first be 
necessary to further understand the damage which occurs during the 
decellularisation process by performing more in depth characterisation of 
damaged tissues. Analysis of collagen loss/damage could be achieved 
through immunohistochemical (IHC) analysis of minor collagens. 
Transmission electron microscopy (TEM) and atomic force microscopy 
(AFM) would allow more detailed qualification of the tissue collagens and 
differential scanning calorimetry (DSC) would enable quantitative 
assessment of collagen denaturation. 
The solutions used for decellularisation could be assessed using quantitative 
biochemical assays and TEM to determine what is being removed from 
tissues during damage development. Additionally, biomechanical testing and 
analysis of cartilage biotribology would potentially provide sensitive detection 
of subtle changes in tissue function due to low levels of structural damage. 
Once sensitive and quantitative methods for tissue damage detection and 
monitoring have been developed, the progression of damage over time 
could be observed and by determining the nature and progression of 
damage, the mechanism could potentially be elucidated. Once the 
mechanism is understood, alterations to the decellularisation process to 
avoid damage could be made accordingly. 
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8.3.2 Human tissue characterisation 
An acellular osteochondral scaffold should ideally mimic the structure and 
function of the surrounding recipient tissue to provide a successful repair 
material. Therefore it will be necessary to characterise human osteochondral 
tissues from appropriately aged donors using the biological, biochemical and 
biomechanical methods described in Chapter 3. Furthermore, assessment of 
cartilage biotribology using methods such as pin on plate friction testing or, 
preferably, whole natural joint friction testing would give further 
understanding of host tissue biomechanical properties. The properties of 
acellular osteochondral tissues produced using variations of the 
decellularisation process could then be compared to the range of properties 
observed for human tissues to determine which process, if any, provides an 
acceptable cartilage substitute biomaterial.  
8.3.3 Decellularisation of large osteochondral tissue segments 
Once the mechanism of cartilage damage has been determined, the 
processes to decellularise large osteochondral tissue segments could be 
optimised, as described in Chapter 4 and 5, to fully decellularise tissues 
whilst minimising damage. Such a process should produce a scaffold with 
acceptable levels of damage and properties comparable to those determined 
for human recipient cartilage. 
8.3.4 Regenerative capacity of acellular osteochondral scaffolds 
Before the acellular osteochondral scaffold could be tested in clinical trials, 
the biocompatibility and regenerative capacity of the biomaterial would 
require assessment in vitro and in vivo.  
8.3.4.1 In vitro assessment 
The methods described in Chapter 6 could be used for basic in vitro 
compatibility testing. The presence of residual cytotoxic SDS in the tissue 
should be quantified either using radiolabelled SDS or using a colourimetric 
assay with Stains-all dye. Contact cytotoxicity of the scaffold should be 
determined and the cytotoxicity of scaffold extracts could be measured by 
culturing with appropriate cell lines and their proliferative capacity measured 
using, for example, the ATPLite-M® assay.  
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In addition, as discussed previously, methods to assess the sterility of tissue 
scaffolds should be employed, such as incubating sterilised scaffold samples 
on agar plates or in nutrient broth. The scaffolds should also be inoculated 
with Bacillus atrophaeus spores and the efficacy of PAA for effectively killing 
the microbes determined. 
To predict the detrimental effects of α-gal on the in vivo response to the 
implanted scaffold, qualitative immunohistochemistry and quantitative 
antibody absorption assays followed by ELISA to detect α-gal in 
decellularised scaffolds should be performed. The capacity of the scaffold to 
bind antibodies to gal in human sera and activate complement could be 
determined. If the scaffold is found to be cytotoxic, non-sterile or to contain 
unacceptable levels of α-gal the decellularisation process will need to be re-
optimised to address these issues before in vivo studies are performed. 
Other in vitro predictions of scaffold performance could be performed. The 
presence of growth factors such as TGF-β within the scaffold could be 
assessed using ELISA and IHC to indicate how inductive the scaffold might 
be to recellularisation and regeneration. Testing of the scaffold in a whole 
natural joint simulator could give an idea of how the graft would perform 
biomechanically/biotribologically upon implantation. 
8.3.4.2 In vivo assessment 
Subcutaneous implantation of the acellular osteochondral scaffold into mice 
would allow assessment of the immune response to the biomaterial. 
Histological and immunohistochemical analysis of explants would allow 
characterisation of cell infiltrates. If there is an adverse response to the 
tissue, further alterations to the decellularisation protocol should be made to 
produce an immune-compatible scaffold. 
A proof of concept study should be performed in an appropriate large animal 
model, such as the sheep, to predict the clinical performance of the scaffold. 
Implantation of the scaffold in situ should give a more accurate 
representation of the local immune response and regeneration of the 
scaffold following histological and IHC analysis of explants. Furthermore, 
implantation into the joint using the appropriate surgical procedures would 
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provide details on the clinical utility of the scaffold and the performance of 
the implant in terms of joint function could be observed. 
Subject to acceptable performance in the proof of concept study, the 
acellular osteochondral scaffold could then be taken forward to pre-market 
medical device clinical trials to assess safety and clinical utility in humans.  
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8.4 Conclusion 
In conclusion, this study represents a major step forward in the 
understanding of cartilage decellularisation. The methods presented here 
are currently the most effective known for decellularisation of intact bovine 
cartilage, with no visible cell nuclei present and a residual DNA content of < 
50 ng.mg-1 in the decellularised cartilage matrix. However issues with 
cartilage disintegration need to be better understood and fully overcome 
before further necessary testing of the biocompatibility and regenerative 
capacity of such a scaffold material can be performed. This study has 
increased knowledge and understanding of the effects of decellularisation on 
osteochondral tissues which will form the basis for future development of a 
bioactive, acellular, natural tissue engineered repair material for 
osteochondral lesions to prevent or delay the onset of osteoarthritis. 
 
- 266 - 
Chapter 9 
References 
 
Altman, R.D. (1987) Overview of osteoarthritis. Am J Med, 83, 65-69. 
Antonsson, P., Heinegird, D., Oldberg, A. (1989) The keratan sulfate-
enriched region of bovine cartilage proteoglycan consists of a 
consecutively repeated hexapeptide motif. J Biol Chem, 264, 16170-
16173. 
Arden, N.K., Jordan, K.M., Thomas, L., Hassan, A., Ledingham, J. (2008) A 
randomised controlled trial of tidal irrigation vs corticosteroid injection 
in knee osteoarthritis: the KIVIS study. Osteoarthr Cartil, 16, 733-739. 
Arthritis Care. (2012) OA Nation 2012 [Online]. [Accessed 19th September 
2013]. Available from: http://www.arthritiscare.org.uk/Livingwith 
Arthritis/oanation-2012. 
Atala, A. (2007) Engineering tissues, organs and cells. J Tissue Eng Regen 
Med, 1, 83-96. 
Ateshian, G.A. (2009) The role of interstitial fluid pressurization in articular 
cartilage lubrication. J Biomechanics, 42, 1163-1176. 
Athanasiou, K.A., Rossenwasser, M.P., Buckwalter, J.A., Malinin, T.I.  Mow, 
V.C. (1991) Interspecies comparisons of in situ intrinsic mechanical 
properties of distal femoral cartilage. J Orthop Res 9, 330-40. 
Bach, D.S., Kon, N.D., Dumesnil, J.G., Sintek, C.F., Doty, D.B. (2005) Ten-
year outcome after aortic valve replacement with the freestyle 
stentless bioprosthesis. Ann Thorac Surg, 80, 480 –487. 
Badylak, S., Liang, R., Tullius, R., Hodde, J. (1999) Endothelial cell 
adherence to small intestinal submucosa: an acellular bioscaffold. 
Biomaterials, 20, 2257-2263. 
- 267 - 
Bae, D.K., Song, S.J., Yoon, K.H., Heo, D.B., Kim, T.J. (2013) Survival 
analysis of microfracture in the osteoarthritic Knee - minimum 10-year 
follow-up. Arthroscopy, 29, 244-250. 
Bank, R.A., Bayliss, M.T., Lafeber, F.P.J.G., Maroudas, A., TeKoppele, J.M. 
(1998) Ageing and zonal variation in post-translational modification of 
collagen in normal human articular cartilage. Biochem. J, 330, 345-
351. 
Barry, F.P., Gaw, J.U., Young, C.N., Neame, P.J. (1992) Hyaluronan-binding 
region of aggrecan from pig laryngeal cartilage: amino acid sequence, 
analysis of N-linked oligosaccharides and location of the keratan 
sulphate. Biochem. J, 286, 761-769. 
Bauer, M., Jackson, R.W. (1988) Chondral lesions of the femoral condyles: a 
system of arthroscopic classification. Arthroscopy,  4, 97-102. 
Baumgarten, M., Bloebaum, R.D., Ross, S.D.K., Campbell, P., Sarmiento, A. 
(1985) Normal human synovial fluid: osmolality and exercise-induced 
changes. J Bone Joint Surg Am, 67, 1336-1339. 
Benders, K.E.M., van Weeren, P.R., Badylak, S.F., Saris, D.I.B.F., Dhert, 
W.J.A., Malda, J. (2013) Extracellular matrix scaffolds for cartilage 
and bone regeneration. Trends Biotechnol, 31, 169-176. 
Bisset, L.R., Böni, J., Lutz, H., Schüpbach, J. (2007) Lack of evidence for 
PERV expression after apoptosis-mediated horizontal gene transfer 
between porcine and human cells. Xenotransplantation, 14, 13–24. 
Bloebaum, R.D., Magee, F.P. (1989) Hypertonic solution for arthroscopic 
surgery. US4872865. 
Boehler, R. M., Graham, J. G., & Shea, L. D. (2011) Tissue engineering 
tools for modulation of the immune response. Biotechniques, 51, 239-
254. 
Bolland, F., Korossis, S., Wilshaw, S.P., Ingham, E., Fisher, J., Kearney, 
J.N., Southgate, J. (2007) Development and characterisation of a full-
thickness acellular porcine bladder matrix for tissue engineering.  
Biomaterials, 28, 1061-1070. 
- 268 - 
Bolton, M.C., Dudhia, J., Bayliss, M.T. (1999) Age-related changes in the 
synthesis of link protein and aggrecan in human articular cartilage: 
implications for aggregate stability. Biochem J, 337, 77-82. 
Bornstein, P., Sage, E.H. (2002) Matricellular proteins: extracellular 
modulators of cell function. Curr Opin Chem Biol, 14, 608–616. 
Bouwmeester, P.S.J.M., Kuijer, R.,  Homminga, G.N., Bulstra, S.K., 
Geesink, R.G.T. (2002) A retrospective analysis of two independent 
cartilage repair studies: autogenous perichondrial grafting versus 
subchondral drilling 10 years post-surgery. J Orthop Res, 20, 267-
273. 
Brooks, P.M. (2006) The burden of musculoskeletal disease - a global 
perspective. Clin Rheumatol, 25, 778–781. 
Brown, B.N., Valentin, J.E., Stewart-Akers, A.M., McCabe, G.P., Badylak, 
S.F. (2009) Macrophage phenotype and remodeling outcomes in 
response to biologic scaffolds with and without a cellular component. 
Biomaterials, 30, 1482–1491. 
Bucher, P., Morel, P., Bühler, L.H. (2005) Xenotransplantation: an update on 
recent progress and future perspectives. Transplant Int, 18, 894–901.  
Buckwalter, J.A., Mankin, H.J. (1998) Articular cartilage. Part I: Tissue 
design and chondrocyte matrix interactions. J Bone Joint Surg Am,  
79, 600-611. 
Burton-Wurster, N., Borden, C., Lust, G., MacLeod, J.N. (1998) Expression 
of the (V+C)- fibronectin isoform is tightly linked to the presence of a 
cartilaginous matrix. Matrix Biol, 17, 193-203. 
Butnariu-Ephrat, M., Robinson, D., Mendes, D.G., Halperin, N., Nevo, Z. 
(1996) Resurfaacing of goat articular cartilage by chondrocytes 
derived from bone marrow. Clin Orthop Relat Res,  330, 234-243. 
Cao, E., Chen, Y., Cui, Z., Foster, P.R. (2003) Effect of freezing and thawing 
rates on denaturation of proteins in aqueous solutions. Biotechnol 
Bioeng, 82, 684-690. 
- 269 - 
Cassetta, L., Cassol, E.,  Poli, G. (2011) Macrophage Polarization in Health 
and Disease. ScientificWorldJournal, 11, 2391–2402. 
Cebotari, S., Mertsching, H., Kallenbach, K., Kostin, S., Repin, O., Batrinac, 
A., Kleczka, C., Ciubotaru, A., Haverich, A. (2002) Construction of 
autologous human heart valves based on an acellular allograft matrix. 
Circulation, 106, 63-68. 
Chaing, H., Jiang, C.C. (2009) Repair of articular cartilage defects: review 
and perspectives. J Formos Med Assoc, 108, 87-101. 
Chang, C.H., Lin, F.H., Lin, C.C., Chou, C.H., Liu, H.C. (2004) Cartilage 
tissue engineering on the surface of a novel gelatine-calcium-
phosphatebiphasic scaffold in a double-chamber bioreactor. J Biomed 
Mater Res, 71, 313–321. 
Chang, R.W., Falconer, J., Stulberg, S.D., Arnold, W.J., Manheim, L.M., 
Dyer, A.R. (1993) A randomised controlled trial or arthroscopic 
surgery versus closed-needle joint lavage for patients with 
osteoarthritis of the knee. Arthritis Rheum, 36, 289-296. 
Chen, C.H., Yeh, M.L., Geyer, M., Wang, G.J., Huang, M.H., Heggeness, 
M.H., Höök, M., Luo, Z.P. (2006) Interactions between collagen IX 
and biglycan measured by atomic force microscopy. Biochem 
Biophys Res Commun, 339, 204-208. 
Chen, F.H., Thomas, A.O., Hecht, J.T., Goldring, M.B., Lawler, J. (2005) 
Cartilage oligomeric matrix protein/thrombospondin 5 supports 
chondrocyte attachment through interaction with integrins. J Biol 
Chem, 280, 32655-32661. 
Chen, R.N., Ho, H.O., Tsai, Y.T., Sheu, M.T. (2004) Process development of 
an acellular dermal matrix (ADM) for biomedical applications. 
Biomaterials, 25, 2679-2686. 
Chu, C.R., Dounchis, J.S., Yoshioka, M., Sah, R.L., Coutts, R.D., Amiel, D. 
(1996) Osteochondral repair using perichondrial cells – a one year 
study in rabbits. Clin Orthop Relat Res, 340, 220-229. 
Clark, J.M., Huber, J.D. (1990) The structure of the human subchondral 
plate. J Bone Joint Surg Br, 72, 866-873. 
- 270 - 
Cohen, S.B., Meirisch, C.M., Wilson, H.A., Diduch, D.R. (2003) The use of 
absorbable co-polymer pads with alginate and cells for articular 
cartilage repair in rabbits. Biomaterials, 24, 2653-2660. 
Courtman, D.W., Pereira, C.A., Omar, S., Langdon, S.E., Lee, J.M., Wilson, 
G.J. (1995) Biomechanical and ultrastructural comparison of 
cryopreservation and a novel cellular extraction of porcine aortic valve 
leaflets. J Biomed Mater Res, 29, 1507-1516. 
Cox, B., Emili, A. (2006) Tissue subcellular fractionation and protein 
extraction for use in mass-spectrometry-based proteomics. Nat 
Protoc,  1, 1872 – 1878. 
Crapo, P.M., Gilbert, T.W., Badylak, S.F. (2011) An overview of tissue and 
whole organ decellularization processes. Biomaterials, 32, 3233-
3243. 
Cremer, M.A., Rosloniec, E.F., Kang, A.H. (1998) The cartilage collagens: a 
review of their structure, organization, and role in the pathogenesis of 
experimental arthritis in animals and in human rheumatic disease. J 
Mol Med, 76, 275–288. 
Cronklin, B.S., Richter, E.R., Kreutziger, K.L., Zhong, D.S., Chen, C. (2002) 
Development and evaluation of a novel vascular xenograft. Med Eng 
Phys, 24, 173-183. 
Daheshia, M., Yao, J.Q. (2008) The interleukin 1β pathway in the 
pathogenesis of osteoarthritis. J Rheumatol 35, 2306-2312. 
Danielson, K.G., Baribault, H., Holmes, D.F., Graham, H., Kadler, K.E., 
Lozzo R.V. (1997) Targeted disruption of decorin leads to abnormal 
collagen fibril morphology and skin fragility. J Cell Biol,  136, 729-742. 
Dausse, Y., Grossin, L., Miralles, G., Pelletier, S., Mainard, D., Hubert, P., 
Baptiste, D., Gillet, P., Dellacherie, E., Netter, P., Payan, E. (2003) 
Cartilage repair using new polysaccharidic biomaterials: macroscopic, 
histological and biochemical approaches in a rat model of cartilage 
defect. Osteoarthr Cartil, 11, 16-28. 
DiCesare, P.E., Carlson, C.S., Stolerman, E.S., Hauser, N, Tulli, H., 
Paulsson, M. (1996) Increased degradation and altered tissue 
- 271 - 
distribution of cartilage oligomeric matrix protein in human rheumatoid 
and osteoarthritic cartilage. J Orthop Res, 14, 946-955.  
DiCesare, P.E., Morgelin, M., Carlson, C.S., Pasumarti, S., Paulsson, M. 
(1995) Cartilage oligomeric matrix protein: isolation and 
characterization from human articular cartilage. J Orthop Res, 13, 
422-428.  
Ding, C., Garnero, P., Cicuttini, F., Scott, F., Cooley, H., Jones, G. (2005) 
Knee cartilage defects: association with early radiographic 
osteoarthritis, decreased cartilage volume, increased joint surface 
area and type II collagen breakdown. Osteoarthr Cartil, 13, 198-205. 
Ding, C., Garnero, P., Cicuttini, F., Scott, F., Cooley, H., Jones, G. (2005) 
Knee cartilage defects: association with early radiographic 
osteoarthritis, decreased cartilage volume, increased joint surface 
area and type II collagen breakdown. Osteoarthr Cartil, 13, 198-205. 
Doege, K.J., Coulter, S.N., Meek, L.M., Maslen, K., Wood, J.G. (1997) A 
human-specific polymorphism in the coding region of the aggrecan 
gene. J Biol Chem, 272, 13974-13979. 
Dormont, D., (1996) How to limit the spread of Creutzfeldt-Jakob disease. 
Infect Control Hosp Epidemiol, 17, 521-528. 
Dowson, D. (1995) Elastohydrodynamic and micro-elastohydrodynamic 
lubrication. Wear, 190, 125-138. 
Du, L., Wu, X., Pang, K., Yang, Y. (2010) Histological evaluation and 
biomechanical characterisation of an acellular porcine cornea 
scaffold. Br J Ophthalmol, 95, 410-414. 
Dudhia, J. (2005) Aggrecan, aging and assembly in articular cartilage. Cell 
Mol Life Sci, 62, 2241–2256. 
Edwards, C.A., O’Brien, J.R. (1980) Modified assay for determination of 
hydroxyproline in a tissue hydrolyzate, Clinica Chemica Acta, 104, 
161-167. 
- 272 - 
Elder, B.D., Eleswarapu. S.V., Athanasiou, K.A. (2009) Extraction 
techniques for the decellularization of tissue engineered articular 
cartilage constructs. Biomaterials, 30, 3749–3756. 
Elder, B.D., Kim, D.H., Athanasiou, K.A. (2010) Developing an articular 
cartilage decellularisation process toward facet joint cartilage 
replacement. Neurosurgery, 66, 722-727. 
European Commission (EMA) No, 410/01 rev.3 of 5 March 2011  Note for 
guidance on minimising the risk of transmitting animal spongiform 
encephalopathy agents via human and veterinary medicinal products.  
Farndale, R.W., Sayers, C.A., Barrett, A.J. (1982) AQ direct 
spectrophotometric microassay for sulphated glycosaminoglycans in 
cartilage structures. Connect Tissue Res, 9, 247-248. 
Felson, D.T. (2009) Developments in the clinical understanding of 
osteoarthritis. Arthritis Res Ther,  11, 203-214. 
Felson, D.T., Zhang, Y. (1998) An update on the epidemiology of knee and 
hip osteoarthritis with a view to prevention.  Arthritis Rheum, 41, 
1343-1355. 
Forster, H., Fisher, J. (1996) The influence of loading time and lubricant on 
the friction of articular cartilage. Proc IMechE Part H: J Engineering in 
Medicine, 210, 109-119. 
Forster, H., Fisher, J. (1999) The influence of continuous sliding and 
subsequent surface wear on the friction of articular cartilage. Proc 
IMechE Part H: J Engineering in Medicine,, 213, 329-345. 
Franz, S., Rammelt, S., Scharnweber, D., & Simon, J. C. (2011) Immune 
responses to implants–A review of the implications for the design of 
immunomodulatory biomaterials. Biomaterials, 32, 6692-6709. 
Fraser , J.R.E.,  Laurent, T.C., Laurent, U.B.G. (1997) Hyaluronan: its 
nature, distribution, functions and turnover. J Intern Med, 242, 27–33. 
Frenkel, S.R., di Cesare, P.E. (2004) Scaffolds for articular cartilage repair. 
Ann Biomed Eng, 32, 26-34. 
- 273 - 
Frenkel, S.R., Toolan, B., Menche, D., Pitman, M.I., Pachence, J.M. (1997) 
Chondrocyte transplantation using a collagen bilayer matrix for 
cartilage repair, J Bone Joint Surg Br, 79, 831-836. 
Freytes, D.O., Badylak, S.F., Webster, T.J., Geddes, L.A., Rundell, A.E. 
(2004) Biaxial strength of multilaminated extracellular matrix 
scaffolds. Biomaterials, 25, 2353–2361. 
Funamoto, S., Nama,K., Kimura, T., Murakoshi, A., Hashimoto, Y., Niwaya, 
K., Kitamura, S., Fujisato, T.,  Kishida, A. (2010) The use of high-
hydrostatic pressure treatment to decellularize blood vessels. 
Biomaterials, 31, 3590–3595. 
Gabriel, S.G., Michaud, K. (2009) Epidemiological studies in incidence, 
prevalence, mortality and comorbidity of the rheumatic diseases. 
Arthritis Res Ther, 11, 229. 
Galili, U., Clarks, M.R., Shohet, S.B., Buehler, J., Macher, B.A. (1987) 
Evolutionary relationship between the natural anti-Gal antibody and 
the Galα1->3Gal epitope in primates. Proc Natl Acad Sci USA, 84, 
1369-1373. 
Galili, U., LaTemple, D. C., Walgenbach, A. W., & Stone, K. R. (1997) 
Porcine and bovine cartilage transplants in cynomolgus monkey. 
Transplantation, 63, 646-651. 
Gerwin, N., Hops, C., Lucke, A. (2006) Intraarticular drug delivery in 
osteoarthritis.  Adv Drug Deliv Rev, 58, 226-242. 
Getgood, A., Bhullar, T.P.S., Rushton, N. (2009) Current concepts in 
articular cartilage repair. J Orthop Trauma, 23, 189-200. 
Getgood, A.M.J., Kew, S.J., Brooks, R., Aberman, H., Simon T., Lynn, A.K., 
Rushton, N. (2012) Evaluation of early-stage osteochondral defect 
repair using a biphasic scaffold based on a collagen–
glycosaminoglycan biopolymer in a caprine model. The Knee, 19, 
422–430. 
Gilbert, T.W., Wognum, S., Joyce, E.M., Freytes, D.O., Sacks, M.S.,  
Badylak, S.F. (2008) Collagen fiber alignment and biaxial mechanical 
- 274 - 
behavior of porcine urinary bladder derived extracellular matrix. 
Biomaterials, 29, 4775–4782. 
Gille, J., Behrens, P., Volpi, P., de Girolamo, L., Reiss, E., Zoch, W., Anders, 
S. (2013) Outcome of Autologous Matrix Induced Chondrogenesis 
(AMIC) in cartilage knee surgery: data of the AMIC Registry. Arch 
Orthop Trauma Surg, 133, 87–93. 
Giurea, A., Kleain, T.J., Chen, A.C., Goomer, R.S., Coutts, R.D., Akeson, 
W.H., Amiel, D., Sah, R.L. (2003) Adehsion of Perichondrial cells to a 
polylactic acid scaffold. J Orthop Res, 21, 584-589. 
Goldring, M.B. (1999) The role of cytokines as inflammatory mediators in 
osteoarthritis: Lessons from animal models. Connect Tissue Res, 40, 
1-11. 
Grande, D.A., Pitman, M.I., Peterson, L., Menche, D., Klein, M. (1989) The 
repair of experimentally produced defects in rabbit articular cartilage 
by autologous chondrocyte transplantation. J Orthop Res, 7, 208-218. 
Grauss, R.W., Hazekamp, M.G., Oppenhuizen, F., van Munsteren, C.J., 
Gittenberger-de Groot, A.C. DeRuiter, M.C. (2005) Histological 
evaluation of decellularised porcine aortic valves: matrix changes due 
to different decellularisation methods. Eur J Cardiothorac Surg. 27, 
566–571. 
Gray, H. (2000). Anatomy of the human body. [Online]. 20th edition. New 
York: Bartleby.com. [Accessed 19th September 2013]. Available from: 
www.bartleby.com/107/ 
Grigolo, B., Roseti, L., Fiorini, M., Fini, M., Giavaresi, G., Aldini, N.N., 
Giardino, R., Facchini, A. (2001) Transplantation of chondrocytes 
seeded on a hyaluronan derivative (Hyaff®-11) into cartilage defects 
in rabbits. Biomaterials, 22, 2417-2424. 
Halstead, J., Bergin, D., Keenan, A., Madden, J., McGonagle, D. (2010) 
Ligament and bone pathologic abnormalities more frequent in 
neuropathic joint disease in comparison with degenerative arthritis of 
the foot and ankle. Arthritis Rheum, 62, 2353–2358. 
- 275 - 
Hamann, N., Zaucke, F., Dayakli, M., Brüggemann, G.P., Niehoff, A. (2013) 
Growth-related structural, biochemical, and mechanical properties of 
the functional bone-cartilage unit. J Anat, 222, 248-259. 
Hartmann, C. (2006) A wnt cannon orchestrating osteoblastogenesis. 
Trends Cell Biol, 16, 151-158. 
Hecht, J.T., Hayes, E., Haynes, R., Cole, W.G. (2005) COMP mutations, 
chondrocyte function and cartilage matrix. Matrix Biol, 23, 525-533. 
Hedlund, H., Hedbom, E., Heinegård, D., Mengarelli-Widholm, S., Reinholt, 
F.P., Svensson, O. (1999) Association of the aggrecan sulphate-rich 
region with collagen in bovine articular cartilage. J Biol Chem,  274, 
8777-8781 
Hedlund, H., Mengarelli-Widholm, S., Heinegård, D., Reinholt, F.P., 
Svensson, O. (1994) Fibromodulin distribution and association with 
collagen. Matrix Biol, 14, 227-232.  
Hendrickson, D.A., Nixon, A.J., Grande, D.A., Todhunter, R.J., Minor, R.M., 
Erb, H., Lust, G. (1994) Chondrocyte-fibrin matrix transplants for 
resurfacing extensive articular cartilage defects. J Orthop Res, 12, 
485-497. 
Herrero-Beaumont, G., Roman-Blas, J.A., Castañeda, S., Jimenez, S.A. 
(Primary osteoarthritis no longer primary: three subsets with distinct 
etiological, clinical, and therapeutic characteristics. Semin Arthritis 
Rheum, 39, 71-80. 
Hoemann, C.D., Légaré, A., Buschmann, M.D. (2005) Tissue engineering of 
cartilage using an injectable and adhesive chitosan-based cell-
delivery vehicle. Osteoarthr Cartil, 13, 318-329. 
Hofmann, S., Garcia-Fuentes, M. (2011). Bioactive scaffolds for the 
controlled formation of complex skeletal tissues, regenerative 
medicine and tissue engineering - cells and biomaterials, Eberli, D. 
Ed., ISBN: 978-953-307-663-8, InTech, Available from: 
http://www.intechopen.com/books/regenerative-medicine-and-tissue-
engineering-cells-andbiomaterials/bioactive-scaffolds-for-the-
controlled-formation-of-complex-skeletal-tissues 
- 276 - 
Hollander, A.P., Atkins, R.M., Eastwood, D.M., Dieppe, P.A.,  Elson, C.J. 
(1991) Human cartilage is degraded by rheumatoid arthritis synovial 
fluid but not by recombinant cytokines in vitro. Clin Exp Immunol, 83, 
52-57. 
Homandberg, G.A., Wen, C., Hui, F. (1998) Cartilage damaging activities of 
fibronectin fragments derived from cartilage and synovial fluid. 
Osteoarthr Cartil, 6, 231-244. 
Homminga, G.N., Bulstra, S.K., Bouwmeester, P.M., van der Linden, A.J. 
(1990) Perichondrial grafting for cartilage lesions of the knee. J Bone 
Joint Surg Br,  72, 1003-1007. 
Hopkinson, A., Shanmuganathan, V.A., Gray, T., Yeung, A.M., Lowe, J., 
James, D.K., Dua, H.S. (2008) Optimization of amniotic membrane 
(AM) denuding for tissue engineering. Tissue Eng, 14, 371-381. 
Hubbard, M.J.S. (1996) Articular debridement versus washout for 
degeneration of the medial femoral condyle – a five year study. J 
Bone Joint Surg Br, 78, 217-219. 
Hui, W., Rowan, A.D., Richards, C.D., Cawston, T.E. (2003) Oncostatin M in 
combination with tumour necrosis factor α induced cartilage damage 
and matrix metalloproteinase expression in vivo and in vitro. Arthritis 
Rheum, 38, 3404-3418. 
Ingram, J., Korossis, S., Howling, G., Fisher, J., Ingham, E. (2007) The use 
of ultrasonication to aid recellularization of acellular natural tissue 
scaffolds for use in anterior cruciate ligament reconstruction. Tissue 
Eng, 13, 1561-1572. 
Irgang, M., Sauer, I.M., Karlas, A., Zeilinger, K., Gerlach, J.C., Kurth, R., 
Neuhaus, P., Denner, J. (2003) Porcine endogenous retroviruses: no 
infection in patients treated with a bioreactor based on porcine liver 
cells. J Clin Virol, 28, 141-154. 
Iwanaga, T., Shikichi, M., Kitamura, H., Yanase, H., Nozawa-Inoue, K. 
(2000) Morphology and functional roles of synoviocytes in the joint. 
Arch Histol Cytol, 63, 17-31. 
- 277 - 
Janeway, C.A., Travers, P., Walport, M., Shlomchik, M. (2005) 
Immunobiology: the immune system in health and disease. 6th 
edition. Hampshire, UK: Thompson Publishing Services. 
Jeffery, A.K., Blunn, G.W., Archer, C.W., Bently, G.(1991) Three-
dimensional collagen architecture in bovine articular cartilage. J Bone 
Joint Surg Br, 73, 795-801. 
Johnson, K., Farley, D., Hu, S.I., Tarkeltaub, R. (2003) One of two 
chondrocyte-expressed isoforms of cartilage intermediate-layer 
protein functions as an insulin-like growth factor 1 antagonist. Arthritis 
Rheum, 48, 1302-1314. 
Julkunen, P., Harjula, T., Iivarinen, J., Marjanen, J. Seppänen, K. Nähri K., 
Arokoski, J., Lammi, M.J., Brama, J.S., Jurvelin, J.S., Helminen, H.J. 
(2009) Biomechanical, biochemical and structural correlations in 
immature and mature rabbit articular cartilage, Osteoarthr Cartilage, 
17, 1628-1638. 
Kääb, M.J., Gwynn, I.A.P., Nötzli, H.P. (1998) Collagen Fibre arrangement in 
the tibial plateau articular cartilage of man and other mammalian 
species. J Anat, 193, 23-34. 
Katta, J., Jin, Z., Ingham, E., Fisher, J. (2008) Biotribology of articular 
cartilage – a review of the recent advances. Med Eng Phys, 30, 1349-
1363. 
Keane, T.J., Londono, R., Turner, N.J., Badylak, S.F. (2012) Consequences 
of ineffective decellularization of biologic scaffolds on the host 
response. Biomaterials, 33, 1771-1781. 
Kheir, E., Stapleton, T., Shaw, D., Jin, Z., Fisher, J., Ingham, E. (2011) 
Development and characterization of an acellular porcine cartilage 
bone matrix for use in tissue engineering. J Biomed Mater Res, 99, 
283–294. 
Kim, B.S., Yoo, J.J., Atala, A. (2004) Peripheral nerve regeneration using 
acellular nerve grafts. J Biomed Mat Res, 68, 201-209. 
Kim, T.K., Sharma, B., Williams, C.G., Ruffner, M.A., Malik, A., McFarland, 
E.G., Elisseeff, J.H. (2003) Experimental model for cartilage tissue 
- 278 - 
engineering to regenerate the zonal organization of articular cartilage. 
Osteoarthr Cartil, 11, 653-664. 
Kirkley, A., Birmingham, T.B., Litchfield, R.B., Giffin, J.R., Willits, K.R., 
Wong, C.J., Feagan, B.G., Donner, A., Griffin, S.H., D’Ascanio, L.M., 
Pope, J.E., Fowler, P.J. (2008) A randomized trial of arthroscopic 
surgery for osteoarthritis of the knee. N Engl J Med, 359, 1097-1107. 
Kiviranta, I., Jurvelin, J., Tammi, M., Säämänen, A., Helminen, H.J. (1987) 
Weight bearing controls glycosaminoglycan concentration and 
articular cartilage thickness in the knee joints of young beagle dogs. 
Arthritis Rheum, 30, 801-809. 
Knight, R.,  Ingham, E. (2006). Allogeneic cells and tissues. In: Akay, M. ed. 
Wiley Encyclopedia of Biomedical Engineering. John Wiley & Sons, 
Inc. 
Knudson, C.B., Knudson, W. (2001) Cartilage proteoglycans. Semin Cell 
Dev Biol, 12, 69-78. 
Kon, E., Gobbi, A., Filardo, G., Delcogliano, M., Zaffagnini, S., Marcacci, M. 
(2009) Arthroscopic second-generation autologous chondrocyte 
implantation compared with microfracture for chondral lesions of the 
knee: prospective nonrandomized study at 5 years. Am J Sports Med, 
37, 33-41. 
Korossis, S.A., Booth, C., Wilcox, H.E., Watterson, K.G., Kearney, J.N., 
Fisher, J., Ingham, E. (2002) Tissue engineering of cardiac valve 
prostheses II: Biomechanical characterisation of decellularised 
porcine aortic heart valves. J Heart Valve Dis, 11, 463-471. 
Koulalis, D., Schultz, W., Heyden, M., König, F. (2004) Autologous 
osteochondral grafts in the treatment of cartilage defects of the knee 
joint. Knee Surg Sports Traumatol Arthrosc, 12, 329-334. 
Koulaouzidou, E.A., Margelos, J., Beltes, P., Kortsaris, A.H. (1999) Cytotoxic 
effects of different concentrations of neutral and alkaline EDTA 
solutions used as root canal irrigants. J Endod, 25, 21-23. 
Kreuz, P.C., Müller, S., Ossendorf, C., Kaps, C., Erggelet, C. (2009) 
Treatment of focal degenerative cartilage defectswith polymer-based 
- 279 - 
Autologous chondrocyte grafts: four year clinical results. Arthritis Res 
Ther,   11, 33-44. 
Kvist, A.J., Johnson, A.E., Mörgelin, M., Gustafsson, E., Bengtsson, E., 
Lindblom, K., Aszódi, A., Fässler, R., Sasaki, T., Timpl, R., Aspberg, 
A. (2006) Chondroitin sulphate perlecan enhances collagen fibril 
formation: implications for perlecan chondrodysplasias, J Biol Chem, 
128, 33127-33139. 
Lai, W.M., Hou, J.S., Mow, V.C. (1991) A triphasic theory for the swelling 
and deformation behaviours of articular cartilage. J Biomech Eng, 
113, 245-258 
LaPrade, R.F., Botker, J., Herzog, M., Agel, J. (2009) Refrigerated 
osteoarticular allografts to treat articular cartilage defects of the 
femoral condyles. A prospective outcomes study. J Bone Joint Surg 
Am,  91, 805-811.  
Laurencin, C.T., Saadiq, F. (2008) Xenotransplantation in orthopaedic 
surgery. J Am Acad Orthop Surg, 16, 4-8. 
Lawrence, R.C., Felson, D.T., Helmick, C.G., Arnold, L.M., Choi, H., Deyo, 
R.A., Gabriel, S., Hirsch, R., Hochberg, M.C., Hunder, G.G., Jordan, 
J.M., Katz, J.N., Kremers, H.M., Wolfe, F. (2008) Estimates of the 
prevalence of arthritis and other rheumatic conditions in the United 
States. Arthritis Rheum,28, 26-35. 
Lee, D.K. (2008) A preliminary study on the effects of acellular tissue graft 
augmentation in acute achilles tendon ruptures. J Foot Ankle Surg, 
47, 8-12. 
Lefebvre, V., Behringer, R.R., de Crombrugghe, B. (2001) L-Sox5, Sox6 and 
Sox9 control essential steps of the chondrocyte differentiation 
pathway. Osteoarthr Cartil, 9, S96-S75. 
Liu, Y., Chen, F., Liu, W., Cui, L., Shang, Q., Xia, W., Wang, J., Cui, Y., 
Yang, G., Liu, D., Wu, J., Xu, R., Buonocore, S.D., Cao, Y. (2002) 
Repairing Large Porcine Full-Thickness Defects of Articular Cartilage 
Using Autologous Chondrocyte-Engineered Cartilage. Tissue Eng, 8, 
709-721. 
- 280 - 
Lomas, R.J., Cruse-Sawyer, J.E., Simpson, C., Ingham, E., Bojar, R.,  
Kearney, J.N. (2003) Assessment of the biological properties of 
human split skin allografts disinfected with peracetic acid and 
preserved in glycerol. Burns, 29, 515-525. 
Lotz, M., Moats, T., Villiger, P.M. (1992) Leukaemia inhibitory factor is 
expressed in cartilage and synovium and can contribute to the 
pathogenesis of arthritis. J Clin Invest, 90, 888-896. 
Lützner J, Kasten P, Günther KP, Kirschner S (2009) Surgical options for 
patients with osteoarthritis of the knee. Nat Rev Rheumatol, 5, 309-
316. 
Macchiarini, P., Jungebluth, P.,  Go, T.,  Asnaghi, M.A., Rees, L.E., Cogan, 
T.A.,  Dodson, A., Martorell,J., Bellini, S., Parnigotto, P.P., Dickinson, 
S.C., Hollander, A.P., Mantero, S., Conconi, M.T.,  Birchall, M.A. 
(2008) Clinical transplantation of a tissue-engineered airway. Lancet, 
372, 2023–2030. 
Marijnissen, W.J.C.M., van Osch, G.J.V.M., Aigner, J., van der Veen, S.W.,  
Hollander, A.P., Verwoerd-Verhoef, H.L., Verhaar, J.A.N. (2002) 
Alginate as a chondrocyte-delivery substance in combination with a 
non-woven scaffold for cartilage tissue engineering. Biomaterials, 23, 
1511-1527. 
Martel-Pelletier, J., Boileau, C., Pelletier, J.P., Roughley, P.J. (2008) 
Cartilage in normal and osteoarthritis conditions. Best Pract Res Clin 
Rheumatol, 22, 315-384. 
Martinello, T., Bronzini, I., Volpin, A., Vindigni, V., Maccatrozzo, L., 
Caporale, G., Bassetto, F., Patruno, M. (2012) Successful 
recellularization of human tendon scaffolds using adipose-derived 
mesenchymal stem cells and collagen gel. J Tissue Eng Regen Med, 
http://dx.doi.org/10.1002/term.1557 
Maude, S., Ingham, E., & Aggeli, A. (2013) Biomimetic self-assembling 
peptides as scaffolds for soft tissue engineering. Nanomedicine, 8, 
823-847. 
- 281 - 
McCullen, S.D., Autefage, H., Callanan, A., Gentleman, E., Stevens, M.M. 
Anisotropic fibrous scaffolds for articular cartilage regeneration. 
Tissue Eng, 18, 2073- 2083. 
McGonagle, D., Tan, A.L., Carey, J., Benjamin, M. (2010) The anatomical 
basis for a novel classification of osteoarthritis and allied disorders. J 
Anat, 216, 279–291. 
McLure, S.W.D., Fisher, J., Conaghan, P.G., Williams, S. (2012) Regional 
cartilage properties of three quadruped tibiofemoral joints used in 
musculoskeletal research studies. Proc IMechE Part H: J Engineering 
in Medicine, 226, 652–656. 
Melrose, J., Hayes, A.J., Whitelock, J.M., Little, C.B. (2008) Perlecan, the 
“jack of all trades” proteoglycan of cartilaginous weight-bearing 
connective tissues. BioEssays, 3, 457-469. 
Mendler, M., Eich-Bender, S.G., Vaughan, L., Winterhalter, K.H., Bruckner, 
P. (1989) Cartilage contains mixed fibrils of collagen types II, IX, and 
XI. J Cell Biol, 108, 191-197. 
Miles, D. E., Mitchell, E., Kapur, N., Wilcox, R. K., & Aggeli, A. (2012) Design 
of self-assembling peptide/glycosaminoglycan hydrogels for spinal 
therapies.  J Tissue Eng Regen Med, 6, 40. 
Mills, C.D., Kincaid, K., Alt, J.M., Heilman, M.J., Hill, A.M. (2000) M-1/M-2 
macrophages and the Th1/Th2 paradigm. J Immunol, 164, 6166-
6173. 
Minas, T. (2001) Autologous chondrocyte implantation for focal chondral 
defects of the knee. Clin Orthop Relat Res, 391, 349-361. 
Minas, T., Nehrer, S. (1997) Current concepts in the treatment of articular 
cartilage defects. Orthopedics, 20, 525-538. 
Mirsadraee, S. (2006) Tissue Engineering of Pericardium. PhD, University of 
Leeds. 
Moradi, B., Schönit, E., Nierhoff, C., Hagmann, S., Oberle, D., Gotterbarm, 
T., Schmitt, H., Zeifang, F. (2012) First-generation autologous 
chondrocyte implantation in patients with cartilage defects of the 
- 282 - 
knee: 7 to 14 years’ clinical and magnetic resonance imaging follow-
up evaluation. Arthroscopy, 12, 1851-1861. 
Moseley, J.B., O’Malley, K., Petersen, N.J., Menke, T.J., Brody, B.A., 
Kuykendall, D.H., Hollingsworth, J.C., Ashton, C.M., Wray, N.P. 
(2002) A controlled trial of arthroscopic surgery for osteoarthritis of 
the knee. N Engl J Med, 347, 81-88. 
Mow, V.C., Gu, W.Y., Chen, F.H. (2005) Structure and function of articular 
cartilage and meniscus. In: Family name, Mow, V.C., Huiskes, R. eds. 
Basic orthopaedic biomechanics and mechano-biology. Philadelphia: 
Lippincott Williams & Wilkins,181-258. 
Mow, V.C., Holmes, M.H., Lai, W.M. (1984) Fluid transport and mechanical 
properties of articular cartilage: a review. J Biomechanics, 17, 377-
394. 
Muir, H. Bullough, P.,  Maroudas, A. (1970) The distribution of collagen in 
human ar,ticular cartilage with some of its physiological implications. J 
Bone Joint Surg Br, 52, 554-63. 
Müller, F.A., Müller, L., Hofmann, I., Greil, P., Wenzel, M.M., Staudenmaier, 
R. (2006) Cellulose-based scaffold materials for cartilage tissue 
engineering. Biomaterials, 27, 3955-3963. 
National Institute for Health and Care Excellence. (2008) The use of 
autologous chondrocyte implantation for the treatment of cartilage 
defects in knee joints. [TA89]. London: National Institute for Health 
and Care Excellence. 
Nikitovic, D., Katonis, P., Tsatsakis, A., Karamanos, N.K., Tzanakakis, G.N. 
(2008) Lumican, a small leucine-rich proteoglycan. IUBMB Life, 60, 
818-823. 
O’Driscoll, S.W., Keeley, F.W., Salter, R.B. (1988) Durability of regenerated 
articular cartilage prodused by free autogenous periosteal grafts in 
major full-thickness defects in joint surfaces under the influence of 
continuous passive motion. A follow up report at one year. J Bone 
Joint Surg Am,  70, 595-606. 
- 283 - 
Oliveira, J.T., Martins, L., Picciochi, R., Malafaya, P.B., Sousa, R.A., Neves, 
N.M., Mano, J.F., Reis, R.L. (2010) Gellan gum: a new biomaterial for 
cartilage tissue engineering applications. J Biomed Mater Res, 93, 
852-863. 
Outerbridge, R.E. (1961) The etiology of chondromalacia patellae. J Bone 
Joint Surg Br, 43, 752-757. 
Pan, Y., Xiong, D. (2009) Friction properties of nano-hydroxyapatite 
reinforced poly(vinyl alcohol) gel composites as an articular cartilage. 
Wear, 266, 699-703 
Patience, C., Takeuchi, Y., Weiss, R.A., (1997) Infection of human cells by 
an endogenous retrovirus of pigs. Nat Med, 3, 282-286. 
Paul, J.P. (1976) Force actions transmitted by joints in the human body. P 
Roy Soc Lond B Bio, 192, 163-72. 
Pawaskar, S.S., Fisher, J., Jin, Z. (2010) Robust and general method for 
determining surface fluid flow boundary conditions in articular 
cartilage contact mechanics modelling, J Biomech Eng-T ASME, 132, 
1-8. 
Pawaskar, S.S., Grosland, N.M., Ingham, E., Fisher, J., Jin, Z. (2011) 
Hemiarthroplasty of hip joint: An experimental validation using porcine 
acetabulum. J Biomechanics, 44, 1536–1542. 
Pettenger, M.F., Mackay, A.M., Beck, S.C., Jaiswal, R.K., Douglas, R., 
Mosca, J.D., Moorman, M.A., Simonetti, D.W., Craig, S., Marshak, 
D.R. (1999) Multilineage potential of adult human mesenchymal stem 
cells. Science, 284, 143-147. 
Poole, C.A. (1997) Articular cartilage chondrons: form, function and failure. J 
Anat, 191, 1-13. 
Pruss, A., Kao, M., Kiesewetter, H., von Versen, R., Pauli G. (1999) Virus 
safety of avital bone tissue transplants: evaluation of sterilization 
steps of spongiosa cuboids using a peracetic acid–methanol mixture. 
Biologicals, 27, 195–201. 
- 284 - 
Puppi, D., Chiellini, F., Piras, A.M., Chiellini, E. (2010) Polymeric materials 
for bone and cartilage repair. Prog Polym Sci, 35, 403–440. 
Raeder, R. H., Badylak, S. F., Sheehan, C., Kallakury, B., & Metzger, D. W. 
(2002) Natural anti-galactose α1, 3 galactose antibodies delay, but do 
not prevent the acceptance of extracellular matrix xenografts. Transpl 
Immunol, 10, 15-24. 
Reing, J.E., Brown, B.N., Daly, K.A., Freund, J.M., Gilbert, T.W., Hsiong, S., 
Huber, A., Kullas, K.E., Tottey, S., Wolf, M., Badylak, S.F. (2010) The 
effects of processing methods upon mechanical and biologic 
properties of porcine dermal extracellular matrix scaffolds. 
Biomaterials, 31, 8626–8633. 
Reinwald, S., Burr, D. (2008) Review of nonprimate, large animal models for 
osteoporosis research. J Bone Miner Res, 23, 1353–1368. 
Rhee, D.K., Marcelino, J.,  Baker, M., Gong, Y., Smits, P., Lefebvre, V., Jay, 
G.D., Stewart, M., Wang, H., Warman, M.L., Carpten, J.D. (2005) The 
secreted glycoprotein lubricin protects cartilage surfaces and inhibits 
synovial cell overgrowth. J Clin Invest, 115, 622-631. 
Rieder, E., Kasimir, M., Silberhumer, G., Seebacher, G., Wolner, E., Simon, 
P., Weigel, G. (2004) Decellularization protocols of porcine heart 
valves differ importantly in efficiency of cell removal and susceptibility 
of the matrix to recellularization with human vascular cells. J Thorac 
Cardiovasc Surg, 127, 399-405. 
Rieppo J., Hyttinen, M.M. Halmesmaki, E., Ruotsalainen, H., Vasara, A., 
Kiviranta, I., Jurvelin, J.S., Helminen, H.J. (2009) Changes in spatial 
collagen content and collagen network architecture in porcine articular 
cartilage during growth and maturation. Osteoarthr Cartil, 17, 448-
455. 
Rogers, B. A., Murphy, C. L., Cannon, S. R., Briggs, T. W. R. (2006) 
Topographical variation in glycosaminoglycan content in human 
articular cartilage. J Bone Joint Surg Br, 88,1670-1674. 
- 285 - 
Roughley, P.J. (2001) Articular cartilage and changes in arthritis, 
noncollagenous proteins and proteoglycans in the extracellular matirx 
of cartilage. Arthritis Res, 3, 342-347. 
Roughley, P.J., (2006) The structure and function of cartilage proteoglycans. 
Eur Cell Mater, 12, 92-101. 
Roughley, P.J., White, R.J. (1980) Age-related changes in the structure of 
the proteoglycan subunits from human articular cartilage. J Bio Chem, 
255, 217-24. 
Samouillan, V., Lamure, A., Maurel, E., Dandurand, J., Lacabanne, C., 
Ballarin, F., Spina, M. (2000) Characterisation of elastin and collagen 
in aortic bioprostheses. Med Biol Eng Comput, 38, 226-231. 
Saxne, T., Heinegård, D. (1992) Cartilage oligomeric protein: a novel marker 
of cartilage turnover detectable in synovial fluid and blood. Br J 
Rheumatol, 31, 583-591. 
Schaefer, D., Martin, I., Jundt, G., Seidel, J., Heberer, M., Grodzinsky, A., 
Bergin, I., Vunjak-Novakovic, G., Freed, L.E. (2002) Tissue 
engineered composites for the repair of large osteochondral defects. 
Arthritis Rheum, 46, 2524-2534. 
Schindler, O.S. (2011) Current concepts of articular cartilage repair. Acta 
Orthop Belg, 77, 709-726. 
Schoen, F.J., Levy, R.J. (2005) Calcification of tissue heart valve substitutes: 
progress toward understanding and prevention. Ann Thorac Surg, 79, 
1072– 80. 
Schwarz, S., Koerber, L., Elsaesser, A.F., Goldberg-Bockhorn, E., Seitz, 
A.M., Dürselen, L., Ignatius, A., Walther, P., Breiter, R., Rotter, N. 
(2012) Decellularized cartilage matrix as a novel biomatrix for 
cartilage tissue-engineering applications. Tissue Eng, 18, 2195-2209. 
Scott, J.E. (1992) Supramolecular organization of extracellular matrix 
proteoglycans, in vitro and in the tissues. FASEB J, 6, 2639- 2645. 
- 286 - 
Seddon, A.M., Curnow, P., Booth, P.J. (2004) Membrane proteins, lipids and 
detergents: not just a soap opera. Biochim Biophys Acta, 1666, 105– 
117. 
Segat, D., Paulsson, M., Smyth, N. (2001) Matrillins: structure, expression 
and function. Osteoarthr Cartil, 9, S29-S35. 
Shanfield, S., Campbell, P., Baumgarten, M., Bloebaum, R.D., Sarmiento, A. 
(1986) Synovial fluid osmolality in osteoarthritis and rheumatoid 
arthritis. Clin Orthop Relat Res, 235, 289-295. 
Shen, G. (2005) The role of type X collagen in facilitating and regulating 
endochondral ossification of articular cartilage. Orthod Craniofacial 
Res, 8; 11–17. 
Shepherd, D.E.T., Seedhom, B.B. (1999a) Thickness of human articular 
cartilage in joints of the lower limb. Ann Rheum Dis, 58, 27-34. 
Shepherd, D.E.T., Seedhom, B.B. (1999b) The ‘instantaneous’ compressive 
modulus of human articular cartilage in joints of the lower limb. 
Rheumatology, 38, 124-132. 
Simon, W.H., Freidenberg, S., Richardson, S., (1973) Joint congruence: a 
correlation of joint congruence and thickness of articular cartilage in 
dogs. J Bone Joint Surg Am,  55, 1614-1620. 
Sinnatamby,  C.S. (2011). Last’s anatomy: regional and applied. 11th edition. 
London: Churchill Livingsone. 
Sokal, R.R., Rohlf, .F.J. (1995) Biometry: the principals and practice of 
statistics in biological research. 3rd edition. New York: W.H. Freeman 
and company. 
Solheim, E., Hegna, J., Øyen, J., Austgulen O.K., Harlem T., Strand, T. 
(2010) Osteochondral autografting (mosaicplasty) in articular cartilage 
defects in the knee: Results at 5 to 9 years. The Knee, 17, 84–87. 
Solheim, E., Hegna, J., Øyen, J., Harlem T., Strand, T. (2013) Results at 10 
to 14 years after osteochondral autografting (mosaicplasty) in articular 
cartilage defects in the knee. The Knee, 20, 287–290. 
- 287 - 
Stapleton, T. (2008b) Development and characterisation of an acellular 
porcine medial meniscus for use in tissue engineering. PhD, 
University of Leeds. 
Stapleton, T., Ingram, J., Fisher, J., Ingham, E. (2010) Investigation of the 
regenerative capacity of an acellular porcine medial meniscus for 
tissue engineering applications. Tissue Eng, 17, 231–242. 
Stapleton, T., Ingram, J., Katta, J., Knight, R., Korossis, S., Fisher, J., 
Ingham, E. (2008) Development and characterization of an acellular 
porcine medial meniscus for use in tissue engineering. Tissue Eng, 
14, 505-518. 
Steadman, J.R., Briggs, K.K., Rodrigo, J.J., Kocher, M.S., Gill, T.J., Rodkey, 
W.G. (2003) Outcomes of microfracture for traumatic chondral defects 
of the knee: average 11-year follow-up. Arthroscopy, 19, 477-484. 
Steinwachs, M.R., Guggi, T.H., Kreuz, P.C. (2008) Marrow stimulation 
techniques. Injury, 39, 26-31  
Steplewski, A., Hintze, V., Fertala, A. (2007) Molecular basis of organization 
of collagen fibrils. J Struct Biol, 157, 297–307. 
Stockwell, R.A. (1971) The interrelationship of cell density and cartilage 
thickness in mammalian articular cartilage, J Anat, 109, 411-421. 
Stockwell, R.A. (1976) The cell density of human articular and costal 
cartilage. J Anat, 101, 753-763. 
Stone, K. R., Ayala, G., Goldstein, J., Hurst, R., Walgenbach, A., & Galili, U. 
(1998) Porcine cartilage transplants in the cynomolgus monkey: III. 
Transplantation of [alpha]-galactosidase-treated porcine cartilage. 
Transplantation, 65, 1577-1583. 
Stone, K. R., Walgenbach, A. W., Abrams, J. T., Nelson, J., Gillett, N., & 
Galili, U. (1997) Porcine and bovine cartilage transplants in 
cynomolgus monkey: I. A model for chronic xenograft rejection. 
Transplantation, 63, 640-645. 
- 288 - 
Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T., Tomoda, K., 
Yamanaka, S. (2007) Induction of pluripotent stem cells from adult 
human fibroblasts by defined factors. Cell, 131, 861-872. 
Taylor, S.D., Tsiridis, E., Ingham, E., Jin, Z., Fisher, J., Williams, S. (2011) 
Comparison of human and animal femoral head chondral properties 
and geometries. Proc IMechE Part H: J Engineering in Medicine, 226, 
55-62. 
Teichtahl, A.J., Wluka, A.E., Proietto, J., Cicuttini, F.M. (2005) Obesity and 
the female sex, risk factors for knee osteoarthritis that may be 
attributable to systemic or local leptin biosynthesis and its cellular 
effects. Med Hypotheses, 65, 312-315. 
Thambya, A., Nather, A., Goh, J. (2006) Mechanical properties of articular 
cartilage covered by the meniscus. Osteoarthr Cartilage, 14, 580-588. 
Unsworth, A. (1991) Tribology of human and artificial joints. Proc IMechE 
Part H: J Engineering in Medicine, 205, 163-172. 
Valderrabano, V., Miska, M., Leumann, A., Wiewiorski, M. (2013) 
Reconstruction of osteochondral lesions of the talus with autologous 
spongiosa grafts and autologous matrix-induced chondrogenesis. Am 
J Sports Med, 41, 519-527. 
van Susante, J.L.C., Buma, P., Homminga, G.N., van den Berg, W.B., Veth, 
R.P.H. (1998) Chondrocyte-seeded hydroxyapatite for repair of large 
articular cartilage defects. A pilot study in the goat.  Biomaterials, 19, 
2367-2374. 
Vangsness, C.T., Garcia, I.A., Mills, C.R., Kainer, M.A., Roberts, M.R., & 
Moore, T.M. (2003) Allograft transplantation in the knee: tissue 
regulation, procurement, processing, and sterilization. Am J Sports 
Med, 31, 474-481. 
Vavken, P., Joshi, S., Murray, M.M, (2009) Triton-X Is most effective among 
three decellularization agents for ACL tissue engineering. J Orthop 
Res, 27, 1612–1618. 
Verzjil, N., DeGroot, J, Zaken C.B., Braun-Benjamin, O., Maoudas, A., Bank, 
R.A., Mizrahi, J., Schalkwijk, C.G., Thorpe S.R., Baynes J.W., 
- 289 - 
Bijlsma, J.W., Lafeber, F.P.J.G., TeKoppele, J.M. (2002) Crosslinking 
by advanced glycation end products increases the stiffness of the 
collagen network in human articular cartilage. Arthritis Rheum, 46, 
114–123. 
Vilim, V., Krajickova, J. (1991) Proteoglycans of human articular cartilage. 
Biochem J, 273, 579-85. 
Vinatier, C., Mrugala, D., Jorgensen, C., Guicheux, J., Noël, D. (2009) 
Cartilage engineering: a crucial combination of cells, biomaterials and 
biofactors. Trends Biotechnol, 27, 307-314. 
Vuolteenaho, K., Moilanen, T., Knowles, R.G., Moilanen, E. (2007) The role 
of nitric oxide in osteoarthritis. Scand J Rheumatol, 36, 247-258. 
Wagener, R., Ehlen, H.W.A., Koa Y., Kobbe, B., Mann, H.H., Sengle, G., 
Paulsson, M. (2005) The matrilins – adaptor proteins in the 
extracellular matrix. FEBS Lett, 579, 3323–3329. 
Wakayama, T., Tabar, V., Rodriguez, I., Perry, A.C.F., Studer, L., 
Mombaerts, P. (2001) Differentiation of embryonic stem cell lines 
generated from adult somatic cells by nuclear transfer. Science, 292, 
740-742 
Wakitani, S., Goto, T., Pineda, S.J., Young, R.G., Mansour, J.M., Caplan, 
A.I., Goldberg, V.M. (1994) Mesenchymal cell-based repair of large, 
full-thickness defects of articular cartilage. J Bone Joint Surg Am,  67, 
579-592. 
Walker, P.S., Dowson, D., Longfield, M.D., Wright, V. (1968) “Boosted 
lubrication” in synovial joints by fluid entrapment and enrichment. Ann 
Rheum Dis, 27, 512-520. 
Whitesides, G.M., Mathias, J.P., & Seto, C.T. (1991) Molecular self-
assembly and nanochemistry: a chemical strategy for the synthesis of 
nanostructures. Science, 254, 1312-1319. 
Wickham, E.A. (1996) Potential transmission of BSE via medicinal products. 
BMJ, 312, 988. 
- 290 - 
Woods, T., Gratzer, P.F. (2005) Effectiveness of three extraction techniques 
in the development of a decellularized bone–anterior cruciate 
ligament–bone graft. Biomaterials, 26, 7339–7349. 
Wu, S., Liu, Y., Bharadwaj, S., Atala, A., Zhang, Y. (2011) Human urine-
derived stem cells seeded in a modified 3D porous small intestinal 
submucosa scaffold for urethral tissue engineering. Biomaterials, 32, 
1317-1326. 
Yang, Q., Peng, J., Guo, Q., Huang, J., Zhang, L., Yao, J., Yang, F Wang, 
S., Xu, W., Wang, A., Lu, S. (2008) A cartilage ECM-derived 3-D 
porous acellular matrix scaffold for in vivo cartilage tissue engineering 
with PKH26-labeled chondrogenic bone marrow-derived 
mesenchymal stem cells. Biomaterials, 29, 2378-2387. 
Yang, Z., Shi, Y., Wei, X., He, J., Yang, S., Dickson, G., Tang, J., Xiang, J., 
Song, C., Li, G. (2010) Fabrication and repair of cartilage defects with 
a novel acellular cartilage matrix scaffold. Tissue Eng, 16, 865-876. 
 
- 291 - 
Appendix A  
Materials 
 
Table 1 Equipment used throughout the study. 
Equipment Model Supplier 
Automatic Pipettes Gilson P2-P1000 Anachem Ltd 
Balances (Accuracy: 
0.01g/0.0001g) 
GR200/GX2000 Jencons PLC 
Bench top centrifuge 5415R Eppendorf 
Class II safety cabinet Heraeus 85 Kendro 
CO2 Incubator MCO-20AIC SANYO Biomedical Europe 
BV 
Freeze drier  Modulyod-230 Thermo Savant 
Freezer (-20 °C) Electrolux 3000 Jencons PLC 
Fridge Electrolux ER8817C Jencons PLC 
Fume cupboard/Fume hood - Whiteley 
Histology cassettes CMB-160-030R Thermo Fisher Scientific Ltd 
Histology water bath MH8515 Barnstead  
Hot plate E18.1 hotplate Raymond A Lamb 
Hot wax dispenser E66 was dispenser Raymond A Lamb 
Incubator  Heraeus Jencons PLC 
Instron material testing 
machine 
3365 Instron 
Linear variable differential 
transformer (LVDT) 
RDP DS-200H Electrosence 
Liquid nitrogen Dewar  BIO65 Jencons PLC 
Luminescence counter and 
liquid scintillation counter  
Packard TopCount NX Perkin Elmer 
 
Magnetic stirrer Stuart SB161 Scientific Laboratory 
Systems Ltd 
Micro- osmometer 3MO Plus Freezing Point 
Osmometer 
Advanced Instruments 
Micro-plate Multiscan Spectrum 1500 Thermo Scientific 
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spectrophotometer 
Microscope (Inverted) Olympus IX71 Microscopes, Medical 
Diagnostics Systems and 
Olympus Patient Systems 
Ltd 
Microscope (upright) Olympus BX51 Microscopes, Medical 
Diagnostics Systems and 
Olympus Patient Systems 
Ltd 
Microtome RM2125 RTR Leica Microsystems 
Nanodrop 
Spectrophotometer 
ND-1000 Labtech Int 
Neubauer 
haemocytometer 
MNK-420-010N Fischer scientific 
Orbital Shaker IKA KS130 basic Jencons PLC 
Oven (hot air)   
pH meter Jenway 3010 VWR International 
Piezo-electric force 
transformer 
060-1896-02 Electrosence 
Pipette boy Acu Integra biosciences 
Plate Shaker IKA KS130 basic Jencons PLC 
Slide holder E102 Raymond A Lamb 
Tissue Processor TP11020 Leica Microsystems 
Vortexer Topmix FB15024 Fisher Scientific 
Water Bath Grant Jencons PLC 
Water Pik Ultra Water 
Flosser 
WP100 WaterPik 
Water purifier Option 7 ELGA 
Wax oven Windsor E18/31 Scientific Laboratory 
Supplies 
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Table 2 Chemicals/reagents used throughout the study. 
Chemical/Reagent Supplier 
1,9 dimethylene blue Sigma-Aldrich 
14C  labelled SDS Hartmann Analytical 
Acetic Acid Thermo Fisher Scientific Ltd 
Acetone European Bios 
Alcian blue Atom Scientific 
Aprotinin (10,000 KUI) Mayfair house 
ATP-Lite-M® assay Perkin Elmer Ltd 
Bovine Serum Albumin Sigma-Aldrich 
Calcium Chloride VWR International 
Calf thymus DNA Sigma-Aldrich 
Chloramine T Sigma-Aldrich 
Chondroitin sulphate B Sigma-Aldrich 
Citric acid VWR International 
Cyanoacrylate Sigma-Aldrich 
DABCO Sigma-Aldrich 
DABCO Sigma-Aldrich 
DAPI Sigma-Aldrich 
Dimethyl sulfoxide (DMSO) Sigma-Aldrich 
di-sodium hydrogen orthophosphate VWR International 
DMSO Sigma-Aldrich 
Dnase Sigma-Aldrich 
DNase Sigma-Aldrich 
Dneasy blood & tissue kit Qiagen 
DNeasy blood and tissue kit Qiagen 
DPX mountant Thermo Fisher Scientific Ltd 
Dulbecco’s modified Eagle’s medium (DMEM) Gibco Life Technologies Ltd. 
Dulbecco's modified Eagles medium Invitrogen Ltd 
Dulbecco's PBS tablets Oxoid 
Eosin VWR International 
Ethanol Thermo Fisher Scientific Ltd 
Ethylenediaminetetraacetic acid (EDTA) VWR International 
Fast green Sigma 
Foetal bovine serum Lonza 
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Formic acid Sigma-Aldrich 
Gentamycin Sigma-Aldrich 
Glasgows modified Eagle’s medium (GMEM) Gibco Life Technologies Ltd. 
Glycerol Sigma-Aldrich 
Glycerol Sigma-Aldrich 
Haematoxylin (Gill’s no. 3) Sigma-Aldrich 
Haematoxylin (Mayers) Thermo Fisher Scientific Ltd 
Haematoxylin (Weigert’s) Atom Scientific 
Hirudin Sigma-Aldrich 
Hydrochloric acid  VWR International 
Hydrogen peroxide  Sigma-Aldrich 
ImmEdge Hydrophobic Barrier Pen Vector laboratories 
Isopropanol Thermo Fisher Scientific Ltd 
L-cystine hydrochloride  Sigma-Aldrich 
L-glutamine Lonza 
Magnesium Chloride Thermo Fisher Scientific Ltd 
Mannitol Sigma-Aldrich 
Methanol Vichers Laboratories 
MicroScint™-20 Perkin Elmer Ltd 
Miller'S STAIN Raymond A Lamb 
Monosodium citrate Sigma-Aldrich 
Neutral buffered formalin (10% v/v) Genta Medical 
Oxalic acid Thermo Fisher Scientific Ltd 
Papain Sigma-Aldrich 
Paraffin wax Thermo Fisher Scientific Ltd 
PBS with Ca2/Mg2+ lonza 
PBS without Ca2/Mg2+ Lonza 
p-dimethylaminobenzaldehyde Sigma-Aldrich 
Penicillin  Lonza 
Peracetic acid Sigma-Aldrich 
Perchloric acid BDH 
Periodic acid Sigma-Aldrich 
pH standards (4, 7, 10) Scientific Laboratory Supplies Ltd 
Piric acid Sigma-Aldrich 
Potassium permanganate Thermo Fisher Scientific Ltd 
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Propan-1-ol VWR International 
rans-4-hydroxy-L-proline Sigma-Aldrich 
RNAse Sigma-Aldrich 
RNase Sigma-Aldrich 
Safranin O Acros 
Schiff’s Reagent Sigma-Aldrich 
Sirius red  Raymond A Lamb 
Sodium acetate Thermo Fisher Scientific Ltd 
Sodium azide G Biosciences 
Sodium chloride Thermo Fisher Scientific Ltd 
sodium di-hydrogen orthophosphate VWR International 
Sodium dodecyl sulphate (SDS) Sigma-Aldrich 
Sodium formate VWR International 
Sodium hydrogen carbonate VWR International 
Sodium Hydroxide VWR International 
Steri-Strip Medisave 
Streptomycin Lonza 
Sulphuric acid Sigma-Aldrich 
Trigene Scientific Laboratory Supplies Ltd 
Trizma base Sigma-Aldrich 
Trypan blue Sigma-Aldrich 
Trypsin Sigma-Aldrich 
Trypsin/EDTA solution  Sigma-Aldrich 
Tryptone phosphate broth (TPB) Sigma-Aldrich 
Tween 20 Sigma-Aldrich 
Ultra Vision One detection system, HRP polymer Thermo Fisher Scientific Ltd 
Ultra Vision One Large Volume Detection System, 
DAB plus substrate System Thermo Fisher Scientific Ltd 
Virkon Scientific Laboratory Supplies Ltd 
Xylene Genta Medical 
α-chymotrypsin Sigma-Aldrich 
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Table 3 General consumables used throughout the study. 
Item Model/Size Supplier 
Cryovials Cryolife™ Nunc International Corporation 
Glass coverslips MIC3228 Scientific Laboratory Supplies Ltd 
Microtome Blades SD3050835 Fisher Scientific 
Parafilm M  - Sigma-Aldrich 
Scalpel blade Size 22A Fisher Scientific 
Superfrost Plus microscope slide MIC3022 Scientific Laboratory Supplies Ltd 
Syringe needles - Thermo Fisher Schientific Ltd 
 
 
Table 4 Plasticware used throughout the study. 
Item Model/Size Supplier 
Bijous 5 ml Scientific Laboratory 
Supplies Ltd 
Cell culture flasks T75, 75 cm2 Thermo Fisher Scientific Ltd 
Disposable plastic syringes 1 ml, 2 ml, 5 ml, 10 ml, 20 
ml, 50 ml 
Scientific Laboratory 
Supplies Ltd 
Pipette tips (filtered and 
non-filtered) 
10 μl, 20 μl, 200 μl, 1000 μl Star Labs 
OptiplateTM 96-well PerkinElmerTM 
Sterile containers 60 ml, 150 ml, 250 ml Scientific Laboratory 
Supplies Ltd 
Stripette (disposable 
pipettes) 
1 ml, 2 ml, 5 ml, 10 ml, 25 
ml 
Sigma-Aldrich Ltd 
Universals 25 ml Scientific Laboratory 
Supplies Ltd 
Well plates, Nunc® (flat 
bottomed) 
6-well, 12-well, 24-well, 48-
well, 96-well plates 
Nunc International 
Corporation 
 
  
- 297 - 
Appendix B  
Publications 
 
 Fermor, H.L., McLure, S.W.D., Taylor, S.D., Russell, S.L., Williams, 
S., Fisher, J., Ingham, E. Biological, biochemical and biomechanical 
characterisation of articular cartilage from the porcine, bovine and 
ovine hip and knee. Bio-Med Mater Eng, In press. 
 
 Fermor, H.L., McLure, S.W.D., Taylor, S.D., Russell, S.L., Williams, 
S., Fisher, J., Ingham, E. (2012) Biological, biochemical and 
biomechanical characterisation of cartilage from the porcine, bovine 
and ovine hip and knee. J Tissue Eng Regen Med, 6, 66-66. 
(Published abstract) 
 
 Hasan, J., Jones, G., Fermor, H.L., Fisher, J., Ingham, E. Priority date 4th 
September 2013. Filed UK Patent – Composite connective tissue and 
bone implants. No. GB1215725.1. 
 
  
- 298 - 
Appendix C  
Presentations 
 
 Fermor, H.L., Russell, S.L., Williams, S., Fisher, J. Ingham, E. (2011) 
Engineering of natural cartilage substitution biomaterials. TCES, 
Leeds, UK.  
 
 Fermor, H.L., McLure, S.W.D., Taylor, S.D., Russell, S.L., Williams, 
S., Fisher, J., Ingham, E. (2011) Biological, biochemical and 
biomechanical characterisation of articular cartilage from the porcine, 
bovine and ovine hip and knee. BiTEG, York, UK. 
 
 Fermor, H.L., McLure, S.W.D., Taylor, S.D., Russell, S.L., Williams, 
S., Fisher, J., Ingham, E. (2012) Biological, biochemical and 
biomechanical characterisation of articular cartilage from the porcine, 
bovine and ovine hip and knee. Regener8, Gateshead, UK. 
 
 Fermor, H.L., McLure, S.W.D., Taylor, S.D., Russell, S.L., Williams, 
S., Fisher, J., Ingham, E. (2012) Biological, biochemical and 
biomechanical characterisation of articular cartilage from the porcine, 
bovine and ovine hip and knee. TERMIS, Vienna, Austria. 
 
 Fermor, H.L., Russell, S.L., Williams, S., Fisher, J., Ingham, E. (2013) 
Development of an acellular xenogenic osteochondral biomaterial. 
ORS, San Antonio, TX, USA. 
